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Abstract
Temporal lobe epilepsy is the most common partial epilepsy syndrome seen in adult 
humans. The hippocampus is a key structure in the evolution of temporal lobe 
seizures. The axons of the dentate granule cells, the mossy fibres, constitute a major 
hippocampal excitatory input. Inhibitory phenomena at mossy fibre synapses may 
therefore prevent seizure propagation through the hippocampus. One such inhibitory 
phenomenon is heterosynaptic depression. In this thesis I studied the role of GABAb 
receptors in temporal lobe epilepsy. In particular I studied changes in GABAb 
receptor-mediated heterosynaptic depression at the mossy fibre synapse following 
status epilepticus. I have shown that status epilepticus, triggered by either perforant 
path stimulation or pilocarpine administration, was followed 24 hours later by a loss 
of GABAb receptor-mediated heterosynaptic depression among populations of 
mossy fibres. This was accompanied by a decrease in the sensitivity of mossy fibre 
transmission to the exogenous GABAb receptor agonist baclofen. Autoradiography 
revealed a reduction in GABAb receptor binding in stratum lucidum after status 
epilepticus. I then addressed the question: what is the source of the GABA that 
mediates heterosynaptic depression? I have also shown that the GABAb receptor 
agonist baclofen has antiepileptic properties. In addition, GABAb receptors do not 
appear to be involved in the function of the antiepileptic drug tiagabine. Failure of 
GABAb receptor-mediated modulation of mossy fibre transmission may contribute 
to the development of spontaneous seizures after status epilepticus. The GABAb 
receptor may be useful as a target for antiepileptic drugs.
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Chapter 1: General Introduction
1.1 The study of epileptology
Throughout the ages people have been fascinated by the epileptic condition. The 
ancient Babylonians described epilepsy over three thousand years ago and the first 
known description is on a cuneiform tablet, which is housed at the British Museum, 
London. The Babylonians thought epilepsy had been sent by demons and sacrifices 
were offered to these demons in order to find a cure (Temkin, 1971). Different 
spirits were thought to cause different forms of seizures and detailed descriptions of 
these seizure types can be found in Babylonian texts. In 460 BC Hippocrates used 
the term epilepsy (from the Greek “epilambanein” meaning to seize or attack) to 
describe seizures and referred to the condition of recurrent seizures as the “sacred 
disease”. Hippocrates believed that epilepsy did not come from spirits, demons or 
gods but was due to brain dysfunction. This perception was developed further in the 
18th and 19th centuries. As neurology became a discipline distinct from psychiatry, 
the concept of epilepsy as a brain disorder became more widely accepted. During 
this time, the function of the brain was being studied and breakthroughs were being 
made that would shape modem neurology. In Berlin, around 1870, two German 
physicians, Gustav Theodor Fritsch and Eduard Hitzig performed experiments that 
involved stimulation of the cortex in awake dogs, and demonstrated that specific 
parts of the cortex are involved in movements of the contralateral limbs. They 
applied a galvanic current to the surface of the cerebral hemispheres and observed 
that stimulating specific cortical regions consistently caused movements in particular
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muscles. Their work was continued by David Ferrier in London, who performed 
electrical stimulation of the cortex to map localization of function in such species as 
monkeys, dogs, jackals, cats and rodents, and ablation experiments in the brains of 
monkeys to confirm the results of his stimulation experiments (Ferrier, 1876).
The pathophysiology of epilepsy was first studied by one of the founders of modem 
neurology, John Hughlings Jackson. In 1873 he proposed a definition: “Epilepsy is 
the name for occasional, sudden, excessive, rapid and local discharges of grey 
matter”. He also suggested that the character of the seizures depended on the 
location and function of the site of the discharges. He correlated ictal symptoms (the 
word ictus is used to refer to the actual fit itself) with the anatomical location of 
cerebral lesions that were identified on post-mortem examination. More recently, it 
is often stated that epilepsy arises due to an imbalance between excitation and 
inhibition, involving glutamate and y amino-butyric acid (GABA) respectively 
(Tasker and Dudek, 1991). This view has emerged because blocking GABAa 
receptors induces epileptiform activity (Collins et al, 1983) and drugs that increase 
GABAergic inhibition stop seizures (Gale, 1992). However, this idea does not 
always hold true, as will be seen in this discussion.
1.2 Social Impact
Epilepsy is the most common acquired chronic neurological disorder. It has a world 
wide incidence of approximately 50-100 cases per 100,000 persons (higher in 
undeveloped countries) and a prevalence of between 4 and 10 per 1000 persons
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(Sander, 1997). The life time risk of developing epilepsy is reported to be 2-5 % 
(Sander and Shorvon, 1996). Despite ongoing research and the emergence of new 
generation antiepileptic drugs, about 50% of patients treated with modem 
antiepileptic drugs continue to experience seizures (Pitkanen and Sutula, 2002), and 
about one third of epilepsy patients are refractory to treatment (Schmidt, 2002). 
Epileptic seizures may result in injury or death, especially tonic-clonic seizures 
(Kirby and Sadler, 1995). A diagnosis of epilepsy carries an excess mortality that is 
2-3 times higher than that for the general population (Cockerell et al, 1994). Causes 
of this excess mortality include underlying disease such as stroke or brain tumour, 
suicide, accidents resulting from seizures, including drowning, status epilepticus and 
sudden unexpected death in epilepsy (SUDEP). SUDEP has been estimated to 
account for about 500 deaths each year in the UK (National Sentinel Clinical Audit 
of Epilepsy-Related Death, 2002). If epilepsy is intractable to medical treatment, 
then surgical management can be considered (Hirsch et al, 2000). In patients with 
temporal lobe epilepsy, this usually involves removal of the hippocampus and part 
of the anterior temporal lobe of the cerebral cortex (Spencer, 2002). Modem imaging 
techniques, cellular electrophysiological recording methods and molecular 
technologies are being applied to improve our understanding and treatment of 
epilepsy.
1.3 Modem definitions
John Hughling Jackson’s definition of epilepsy has been developed into the modem 
definition of a seizure. A seizure is now defined as a clinical manifestation presumed
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to result from an abnormal and excessive discharge of a set of neurons in the cortex 
(Hopkins et al, 1995). It is important to note that a seizure is a clinically observed 
event, which therefore means that an electrical event recorded in vitro is not a 
seizure. The characteristics of a particular seizure depend on the site of abnormal 
discharge within the brain. Seizures can either be either partial or generalised. A 
partial seizure occurs due to discharge of a localised group of cortical neurons 
whereas a generalised seizure occurs when generalised neuronal activity starts 
simultaneously in both hemispheres. These two categories are further subdivided 
into other seizure types. These are distinguished on clinical grounds and with the use 
of electroencephalography (EEG) (Table 1.1).
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T able 1.1 Seizure classification
1. Partial (focal) seizures:
A. Simple -  motor, somatosensory, autonomic, psychic
B. Complex
a. Impaired consciousness at outset
b. Simple partial followed by impaired consciousness
C. Partial (focal) seizures evolving to generalized tonic-clonic (GTC)
a. Simple to GTC
b. Complex to GTC
2. Generalized seizures (convulsive or non-convulsive):
A. Absences
a. Absence seizures
b. Atypical absence seizures
B. Myoclonic
C. Clonic
D. Tonic
E. Tonic-clonic
F. Atonic
G. Combinations
3.Unclassified epileptic seizures
Consciousness is normal in simple partial seizures but impaired in complex partial 
seizures. The term “seizure” is not synonymous with “epilepsy”. An individual may 
have an isolated seizure but this does not necessarily mean they have epilepsy. A 
commonly used modem definition of epilepsy is “the propensity to have seizures” 
and this encompasses many different epilepsy syndromes (Table 1.2).
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Table 1.2 Epilepsy Classification
(Engel et al, 2004)
EPILEPSY SYNDROMES AND RELATED CONDITIONS
Benign familial neonatal seizures 
Early myoclonic encephalopathy 
Ohtahara syndrome
* Migrating partial seizures of infancy 
West syndrome
Benign myoclonic epilepsy in infancy 
Benign familial and non-familial infantile seizures 
Dravet's syndrome 
HH syndrome
* Myoclonic status in nonprogressive encephalopathies 
Benign childhood epilepsy with centrotemporal spikes
Early onset benign childhood occipital epilepsy (Panayiotopoulos type)
Late onset childhood occipital epilepsy (Gastaut type)
Epilepsy with myoclonic absences 
Epilepsy with myoclonic-astatic seizures 
Lennox-Gastaut syndrome 
Landau-Kleffner syndrome
Epilepsy with continuous spike-and-waves during slow-wave sleep (other than LKS) 
Childhood absence epilepsy 
Progressive myoclonus epilepsies 
Idiopathic generalized epilepsies with variable phenotypes 
Juvenile absence epilepsy 
Juvenile myoclonic epilepsy 
Epilepsy with generalized tonic-clonic seizures only 
Reflex epilepsies
Idiopathic photosensitive occipital lobe epilepsy 
Other visual sensitive epilepsies 
Primary reading epilepsy 
Startle epilepsy 
Autosomal dominant nocturnal frontal lobe epilepsy 
Familial temporal lobe epilepsies 
♦Generalized epilepsies with febrile seizures plus 
♦Familial focal epilepsy with variable foci 
Symptomatic (or probably symptomatic) focal epilepsies 
Limbic epilepsies
Mesial temporal lobe epilepsy with hippocampal sclerosis 
Mesial temporal lobe epilepsy defined by specific etiologies 
______ Other types defined by location and etiology___________________________
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Neocortical epilepsies
Rasmussen syndrome
Other types defined by location and etiology 
* Syndromes in development
CONDITIONS WITH EPILEPTIC SEIZURES THAT DO NOT REQUIRE A 
DIAGNOSIS OF EPILEPSY
Benign neonatal seizures
Febrile seizures
Reflex seizures
Alcohol withdrawal seizures
Drug or other chemically-induced seizures
Immediate and early post traumatic seizures
Single seizures or isolated clusters of seizures
Rarely repeated seizures (oligo-epilepsy)__________________________________
Most seizures are self-limiting and last from seconds to a few minutes. A seizure 
event can be divided into four stages. The prodrome occurs days to hours before the 
seizure itself, and consists of altered behaviour or mood. The aura is a simple partial 
seizure that occurs prior to the major seizure and is a subjective or motor event 
perceived by the patient. Since an aura involves perception, this term is not usually 
used in animals, as it is not clear whether they experience aura in the same way 
humans do. The seizure itself is termed the ictus. There then follows a post-ictal 
period in which neurological abnormalities can occur. Occasionally seizure activity 
becomes prolonged; this is known as status epilepticus (SE). SE is defined as a 
single seizure of more than 30 minutes duration, or a series of epileptic seizures 
during which function is not regained between ictal events in a period lasting more 
than 30 minutes (Hopkins et al, 1995). This definition has recently been modified by
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some workers for practical purposes to a period of seizure activity lasting five 
minutes or longer (Lowenstein et al, 1999).
1.4 Temporal lobe epilepsy
Temporal lobe epilepsy (TLE) is the most common epilepsy in adult humans. It is 
characterised by simple or complex partial and secondarily generalised seizures in 
various combinations. Febrile seizures and a familial history of epilepsy are often 
associated. The onset tends to be in childhood or young adulthood. The simple 
partial seizures tend to be autonomic, psychic or sensory. The most common form is 
an epigastric rising sensation. The complex partial seizures tend to follow the pattern 
of motor arrest, then oro-alimentary automatism, followed by other automatisms. 
There is an association between febrile seizures in infancy and temporal lobe 
epilepsy although the exact nature of this relationship is unclear. Many cases of 
febrile seizures appear to be benign, but prolonged complex febrile seizures are 
more consistently associated with subsequent temporal lobe epilepsy (Abou-Khalil 
et al, 1993). EEG may reveal asymmetry of background activity, temporal spikes, 
sharp and/or slow waves. Patients with intractable TLE often exhibit a pathological 
lesion known as hippocampal, or mesial temporal sclerosis, which will be discussed 
in more detail later. Recent experimental and human studies suggest that the 
development of epilepsy does not stop at the time of diagnosis, but that recurring 
seizures may contribute to the progression of the disorder. This progression may be 
associated with continuing molecular, cellular, or network changes.
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1.5 Epileptogenesis
How does a normal brain develop the propensity to have seizures? Epileptogenesis is 
the process whereby structural and functional changes occur following a brain insult 
that result in epilepsy. Such insults include status epilepticus, febrile seizures, 
hypoxic-ischaemic injury and head trauma. In experimental models, insults such as 
chemoconvulsants and electrical stimuli are applied in order to stimulate 
epileptogenesis. These insults often result in an immediate selective neuronal loss, 
which is most prominent in areas CA1 and CA3 of the hippocampus. There then 
follows a latent period of variable length and it is presumed that structural and 
functional changes occur during this time which eventually lead to epilepsy. This 
latent period is also presumed to occur in humans after such insults as status 
epilepticus and head trauma. The latent period lasts from days to weeks following 
pilocarpine or kainic acid induced status epilepticus and can be several years in 
humans that have suffered head trauma (Herman, 2002). This latency suggests that 
either epileptogenesis is a long process, or that a second insult is necessary for 
epilepsy to occur. This “second hit hypothesis” suggests that an initial insult results 
in lowered seizure threshold, and then a later insult, the ‘second hit’ results in the 
expression of epilepsy (Walker et al, 2002c).
During the latent period, between insult and the expression of epilepsy, several 
functional and structural changes occur. Axons of the dentate granule cells (Proper 
et al, 2000), intemeurons (Magloczky et al, 2000) and CA1 pyramidal neurons 
(Esclapez et al, 1997) undergo re-organisation and form functional aberrant circuits;
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a process known as sprouting. Intemeuronal populations are lost (Houser and 
Esclapez, 1996) and may receive fewer excitatory inputs (Doherty and Dingledine, 
2001). GABAa receptors undergo altered subunit composition (Buhl et al, 1996; 
Kapur and Macdonald, 1997). Glutamatergic mechanisms also undergo changes 
including increased NMDA receptor activation (Lieberman and Mody, 1999). 
Research is currently underway to identify drugs that can be given in the latent 
period which will prevent the later development of epilepsy. This is important for 
the treatment of people that have suffered such insults as status epilepticus or head 
trauma so that development of epilepsy can be prevented.
1.6 Synchronous activity
Hypersynchronicity is often stated as being a part of the abnormal activity seen in 
the epileptic brain. Although increased synchronous activity is often linked with 
epileptiform activity, it was recently reported that before a seizure (during the 
preictal period) there is a decrease in synchronization, as measured by depth 
electrodes implanted into the hippocampi of epileptic patients (Mormann et al,
2003). From this study, decreased synchronization appears to be a consistent change 
which can be used to predict the onset of a seizure. During the seizure itself, neurons 
fire in a hypersynchronous manner. There have been several theories proposed as to 
how hypersynchronous firing occurs in the epileptic hippocampus. Intrinsic 
properties of CA3 pyramidal cells and high connectivity between cells allow 
generation of synchronized rhythmic bursts when GABAa receptors are blocked and 
it is proposed that this type of activity is analagous to interictal epileptiform activity
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(Miles and Wong, 2003). It has recently been shown that GABAa receptor activation 
can be depolarising when the reversal potential for ions passing through GABAa 
receptors is more positive than resting potential (Stein and Nicoll, 2003). 
Depolarising GABAergic activity has been implicated in the synchronization of 
neuronal activity. Synchronous activity was recorded in the subiculum in slices of 
brain tissue from temporal lobe epilepsy patients which was similar to interictal 
activity recorded in scalp EEGs from the same patients. It was associated with 
depolarising potentials in subicular pyramidal cells which were blocked by GABAa 
receptor antagonists (Cohen et al, 2002). Non-synaptic forms of communication 
between neurons may also play a role in synchronising neurons, including electrical 
coupling through gap junctions, and ephaptic and field effects (Jefferys, 1995). 
Jefferys and Haas (1982) showed that oscillations occurred in CA1 in the absence of 
synaptic transmission. Draguhn et al (1998) showed that if they blocked chemical 
synaptic transmission in hippocampal slices by using a calcium free solution for 
their experiments, high frequency oscillations became more prominent although 
postsynaptic field potentials ceased. They then showed that these oscillations could 
be reversibly suppressed by octanol, halothane or carbenoxolone which have the 
common effect of blocking gap junctions. The oscillations were prolonged in the 
presence of NH4CI, which causes intracellular alkalinisation and enhances gap 
junction coupling. Synchronous inhibitory activity has also been implicated in 
epilepsy. Synchronous inhibition in the brain was first observed during normal 
physiological activity (Freund and Buzsaki, 1996). Several models of normal 
physiological rhythmic activity, including oscillations at theta (4-12Hz) (Cobb et al,
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1995) and gamma frequencies (30-80 Hz) (Traub et al, 1999), depend on 
synchronous inhibitory activity. Bracci et al (1999) studied tetanically induced 
oscillations in CA1. They showed that the development of synchronized action 
potentials was induced by GABAa receptor mediated slow depolarisations and that 
the synchronization was caused by field effects. There is also burgeoning evidence 
that inhibitory synchronous activity is linked to epilepsy. Synchronous intemeuronal 
bursting is proposed to cause high concentrations of GABA release and promote 
depolarizing responses (McBain, 1994). Velazquez and Carlen (1999) showed that 
epileptiform events in slices, produced by applying high frequency trains to Schaffer 
collaterals, recruit progressively more intemeurons into a synchronized network. 
They suggest that GABAergic activity as well as glutamatergic activity is necessary 
for epileptiform activity in their model. Khazipov and Holmes (2003) recently 
demonstrated that kainate induced epileptiform activity in vivo in the gamma 
frequency band results primarily from synchronous inhibition provided by 
hippocampal intemeurons. It seems then that the view of epilepsy as reduced 
inhibition or increased excitation is overly simplistic.
1.7 The hippocampus
The hippocampus is a key structure in temporal lobe epilepsy. Pathological changes 
are observed in the hippocampus in some patients with drug resistant TLE. Its 
anatomy and relation to other local structures is complex. It is part of a region of the 
brain known as the limbic system. In 1878 Broca observed that the mammalian brain 
has a horseshoe shaped rim of grey matter that surrounds the junction between the
20
diencephalon and each cerebral hemisphere. He referred to this rim of cortex as the 
limbic lobe (from the Latin limbus meaning “border”). This tissue is now referred to 
as the limbic system although there is some debate as to its boundaries. Table 1.3 
lists the structures that most authors include within the limbic system. Some authors 
suggest that certain regions of the thalamus, fornix and the mammillary bodies are 
also included.
Table 1.3 Key structures of the limbic system
Cingulate and parahippocampal gyri
Hippocampus
Amygdala
Septal nuclei
Hypothalamus
Parts of midbrain reticular formation 
Olfactory areas
The hippocampal formation consists of six cytoarchitectonically distinct regions: 
dentate gyrus, hippocampus (or hippocampus proper), subiculum, presubiculum, 
parasubiculum and entorhinal cortex. During development the medial edge of the 
temporal lobe expands so that the hippocampus ends up occupying the floor of the 
temporal horn of the lateral ventricle. The hippocampus itself is a curved and 
recurved sheet of cortex folded into the medial surface of the temporal lobe. The 
subiculum is a transitional zone continuous with the hippocampus proper at one of
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its edges and the cortex of the parahippocampal gyrus at the other edge. The alveus 
is a thin layer of white matter which separates the hippocampus from the lateral 
ventricle. It consists of fibres that arise from the pyramidal cells of the hippocampus 
and that are directed towards subcortical termination sites or to the contralateral 
hippocampal formation. The hippocampus proper is also known as the Cornu 
Ammonis (CA) or literally the horn of Ammon, after an Egyptian deity with the 
head of a ram. It can be divided into 4 fields (CA1-4). The palisade of cell somata 
starts from the end of the subiculum and continues from CA1 through to CA4 which 
is positioned between the blades of the dentate gyrus. The cerebral cortex is 
generally a six-layered structure. However, the six-layered entorhinal cortex 
becomes four-layered at the subiculum and then three-layered at the Comu 
Ammonis. The hippocampus proper consists of 1) molecular, 2) pyramidal and 3) 
polymorphic layers. This can be further divided into 5 strata. These are: stratum 
oriens, stratum pyramidalis, stratum radiatum, stratum lacunosum and stratum 
moleculare.
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Septal pole of hippocampus
Fornix
Temporal pole 
of hippocampus
Figure 1.1: The hippocampus o f the rat in situ (from Amaral and Witter, The Rat 
Nervous System, 1995, Academic Press).
Table 1.4 Components of the strata of the hippocampus
Stratum Cell types and structures
S. oriens: axons of pyramidal neurons, 
somata and dendrites of basket 
cells, intemeurons
S. pyramidalis: pyramidal cell somata, 
intemeurons
S. radiatum: apical dendrites of pyramidal 
neurons, CA3-CA3 
associational connections, CA3- 
CA1 Schaffer collateral 
connections, intemeurons
S.lacunosum + S. moleculare: perforant path axons from 
entorhinal cortex, intemeurons
Area CA3 has an additional layer between s.pyramidale and s.radiatum, called 
stratum lucidum which contains the axons of the dentate granule cells
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Molecular layer 
Sir alum lacunosutn 
N  Tangential fibersLayer of polymorphic cells
Layer of pyramidal 
cells,
Stratum lucidum^  
Stratum rad io -^  
t t m / e
■i '< •
'Molecular layer 
'Grannie layer 
Layer of polymorphic cellsFimbria Fascia doitala
Fig* 235.—Diagram of tlie structure and connections of the hippocampus. The arrows show 
the direction of conduction; A , molecular layer, and B, pyramidal cell layer of the subiculum;
F, hippocampal fissure. (Cajal.)
Figure 1.2: Diagram showing the connections o f the hippocampus (Cajal)
(Blackstad et al, 1970), which are termed mossy fibres. Intemeurons are scattered 
throughout all of these layers. The dentate gyms is also a three-layered structure 
consisting of: molecular layer, granule cell layer and polymorphic cell layer.
1.8 Hippocampal sclerosis
Bouchet and Cazauvieilh were the first to make an association between pathological 
changes in the hippocampus and epilepsy in 1825 (Temkin, 1971) during their work 
on potential links between mental disorders and epilepsy. During these studies they 
observed pathological changes in the hippocampus in five epileptic patients. The 
hippocampi had become firm in texture. They termed this pathological change 
“sclerosis”. Then in 1880, Sommer reviewed the literature on the role of the
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hippocampus in epilepsy. He was probably the first person to associate the 
hippocampus with temporal lobe seizures. He postulated that hippocampal cells 
were vulnerable to insults and that the resulting Ammon’s horn sclerosis was the 
cause of epilepsy (Fisher et al, 1998). In 1899 Bratz described the microscopic 
appearance of hippocampal sclerosis (HS):-
1. Destruction of pyramidal neurons in Ammon’s Horn (hippocampus proper), 
particularly in CA1
2. Loss of hilar neurons and CA4 pyramidal neurons (endfolium sclerosis)
3. Granule cell loss
He also showed that epilepsy is not always associated with hippocampal sclerosis. 
He thought that hippocampal sclerosis caused certain types of seizures rather than 
being a result of seizures. Certainly there is evidence that hippocampal sclerosis 
could indeed cause seizures. Most patients with refractory mesial TLE have 
hippocampal sclerosis (Babb and Brown, 1987). There is usually cell loss in both 
hippocampi although it tends to be asymmetrical. Unilateral hippocampal atrophy is 
often seen in these patients which is characterised on MRI by reduced volume and 
increased signal on T2 scans. The location of the seizure focus frequently 
corresponds to the side of the atrophic hippocampus (Fish and Spencer, 1995). 
Removal of the sclerotic tissue during temporal lobe resection successfully “cures” 
80 % of patients (Arruda et al, 1996). However, among patients with hippocampal
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atrophy, around 10% have bilateral atrophy. In these patients surgical success is 
achieved not by removing the more or less atrophied hippocampus, but by removing 
the seizure focus as identified by EEG recordings (Fish and Spencer, 1995). Later in 
the twentieth century an alternative explanation developed. A study by Scheibel et al 
(1974) demonstrated a positive correlation between the chronicity of the seizure 
disorder and the severity of the hippocampal damage which led many to believe that 
hippocampal sclerosis was an eventual consequence of chronic seizures rather than a 
cause. From the 1950s onwards, workers started to associate hippocampal sclerosis 
with prior cerebral injury early in life. Retrospective studies frequently show that 
hippocampal sclerosis is associated with prolonged febrile seizures in childhood 
(Lewis, 1999; Davies et al 1996), but see Tarkka et al (2003). However hippocampal 
sclerosis sometimes is present in the absence of any apparent initial precipitating 
injury. Despite the link between febrile seizures and TLE, many children who have 
had febrile seizures do not develop hippocampal sclerosis or TLE (Tarkka et al, 
2003). It can be seen then that there is a complex relationship between early cerebral 
injury, temporal lobe epilepsy and hippocampal sclerosis.
The question then arises: how does hippocampal sclerosis contribute to 
epileptogenesis? Re-organisation of mossy fibre axons (“sprouting”) occurs in both 
animal models and human patients with TLE into the inner molecular layer of the 
dentate gyrus. The role of these aberrant fibres has been a subject of controversy. 
The two lines of thought are either that sprouted fibres synapse onto dentate granule 
cells and form recurrent excitatory synapses, or that they synapse mainly onto
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intemeurons, thus increasing inhibition in the epileptic hippocampus. There are 
several lines of evidence showing that sprouted fibres make aberrant connections 
with granule cells both in animal models of epilepsy (Okazaki et al, 1995; 
Buckmaster et al, 2002) and human patients (Zhang and Hauser, 1999), resulting in 
functional recurrent excitatory synapses (Tauck and Nadler, 1985). More recently, 
Buckmaster et al (2002) provided evidence that most new synapses made by 
sprouted mossy fibres were with GABA-negative dendritic spines. In contrast to 
these findings Sloviter (1992) suggested that mossy fibre sprouting restores 
inhibition by innervation of intemeurons by the sprouts and electron microscopic 
studies have revealed that sprouted mossy fibres probably synapse onto intemeurons 
as well (Kotti et al, 1997). What are the functional consequences of sprouting and is 
it necessary for epileptogenesis to occur? Longo and Mello (1997) showed that if 
sprouting is inhibited by cycloheximide (a protein synthesis inhibitor) in laboratory 
models of epilepsy, epileptogenesis still occurs. In contrast with this work however, 
Williams et al (2002) failed to prevent sprouting with cycloheximide although they 
did show that spontaneous seizures could develop in the absence of Timm-stain 
positive mossy fibre sprouting. Similarly, spontaneous recurrent seizures develop 
even in the absence of sprouting in a modified kainic acid model of epilepsy (Zhang 
and Hauser, 1999). But, in this last study, the presence of sprouting and neuronal cell 
loss was associated with more severe seizures. These results do not necessarily mean 
that mossy fibre sprouting is not important in increasing hippocampal excitability; 
they just demonstrate that sprouting is not required for recurrent seizures to develop.
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1.9 Animal Models
There are animal models of epileptic activity in such diverse species as Drosophila 
and non-human primates. These can be separated into models of seizures and models 
of epilepsy, although some models can be considered to be both. For example if 
flurothyl is administered to rodents they have a generalised seizure but do not 
develop spontaneous seizures. In contrast, if status epilepticus is induced by 
administration of pilocarpine the animal develops spontaneous seizures after a latent 
period of days to weeks. Thus the former case is a model of seizure activity but not 
of epilepsy, and the latter is a model of an acutely precipitated seizure leading to a 
chronic epileptic state. Some studies refer to models as “acute” e.g. maximal 
electroshock, pentylenetetrazol -  models that produce immediate seizure activity -  
and “chronic” models that involve an insult such as status epilepticus which is 
followed by spontaneous seizures following a latent period. Also, study of the latent 
period may reveal changes that are relevant to epileptogenesis. There are also many 
species in which epilepsy occurs spontaneously, often due to a known or suspected 
genetic predisposition e.g. dogs, rats, mice, hamsters.
Transgenic mice with seizure disorders have also been developed (Upton and 
Stratton, 2003). These become important when considering that at least 40-50% of 
all forms of human epilepsy are idiopathic generalised epilepsies, which are 
characterised by lack of antecedent disease and have a presumed genetic origin. 
Transgenic models include those engineered with functionally identical mutations to 
those in human inherited epilepsy, models which have single altered genes to
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determine whether those genes are involved in epileptogenesis and lastly, 
spontaneous mutations in mice, which have provided a source of potential candidate 
genes.
There are several different ways in which recurrent seizures can be induced in a 
normal animal (Fisher, 1989). These include administration of chemoconvulsants 
(either locally or systemically) and electrical stimulation of the brain. 
Chemoconvulsants that are used to produce animal models of epilepsy include 
pilocarpine, kainic acid, pentylenetetrazol and penicillin. Electrical protocols include 
maximal electroshock, amygdala kindling, and perforant path stimulation. 
Epileptiform activity can also be induced in a brain slice in vitro. This can be 
achieved by applying drugs, electrical stimuli, manipulating ion concentrations, or 
combinations of these. Such drugs include 4-aminopyridine, pilocarpine and the 
GABAa receptor antagonist bicuculline. Raising the concentration of potassium or 
lowering the concentration of magnesium can also induce epileptiform activity. The 
activity in these in vitro models can then be measured by making extracellular field 
potential recordings in the desired region or using multiple electrode arrangements. 
Propagation of epileptiform activity through a slice can also be monitored by 
measuring intrinsic optical signal (IOS). IOSs are generated in vitro by changes in 
light scattering properties through refraction and reflection and/or by changes in 
light absorption. These phenomena are mainly secondary to cell swelling leading to 
alterations in the extracellular space volume (D'Arcangelo et al, 2001). The 
relevance of synchronised bursts in the limited network of the slice preparation to
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the in vivo situation is uncertain, especially since certain synchronised bursts in vivo 
have been proposed to be very different from seizures and even to have an 
antiepileptic effect (de Curtis and Avanzini, 2001). In this work I used both a 
chemical (systemic pilocarpine) and electrical (stimulation of the perforant path) 
stimulus to induce status epilepticus in rats.
Table 1.5 Commonly used models of epilepsy, seizures, and epileptiform 
activity
A) In vivo i) Chemical Pilocarpine (+/- lithium)
Kainic acid
Tetanus toxin
Pentylenetetrazol
Fluorothyl
Penicillin
ii) Electrical Kindling
Perforant path stimulation
Maximal Electroshock
iii) Genetic Spontaneous
Transgenic
B) In  vitro (slice preparations) 4-aminopyridine
Low magnesium
Pilocarpine
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1.9.1 Pilocarpine model
Turski et al (1983) were the first to demonstrate that systemic administration of 
pilocarpine, an agonist of muscarinic acetylcholine receptors, induced limbic 
seizures in rats. The seizures consisted of staring spells, olfactory and gustatory 
automatisms and motor limbic seizures that developed over 1-2 hours and built up 
progressively into limbic status epilepticus. The earliest electrographic alterations 
that they observed were in the hippocampus; these then propagated to the amygdala 
and cortex. A pattern of cell loss occurred in the hippocampus that is similar to 
human patients with TLE. The pilocarpine model can be used to ask different 
questions depending on the time period studied. We can study a) the immediate 
consequences of SE, b) the changes that occur during epileptogenesis (i.e. the period 
between SE and the onset of spontaneous seizures) or c) the period of spontaneous 
recurrent seizures.
1.9.2 Perforant path stimulation
Sloviter and Damiano (1981) developed a model of seizure induced neuronal 
damage which involved continuous electrical stimulation of the perforant path of 
urethane anaesthetised rats for twenty-four hours. The electrophysiological and 
pathological findings were similar to other models such as the kainic acid model.
The stimulation evoked granule cell population spikes (due to the summation of 
action potentials from many neurons), epileptiform discharges and reduced dentate 
inhibition, which could be quantified by measuring loss of paired pulse inhibition. 
Hilar intemeurons and CA3 pyramidal neurons were damaged. McIntyre et al (1982)
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then modified the model by stimulating the perforant path in unanaesthetised 
previously kindled rats for sixty minutes at a frequency of 60 Hz. Since the process 
of kindling itself induces epilepsy, models were then developed in which the 
perforant path was stimulated in naive rats and self-sustaining status epilepticus was 
eventually induced (Mazarati et al, 1998). Several different stimulating protocols 
have been used, including either intermittent or continuous stimulation. The 
stimulation protocol that I used had been modified by Walker et al (1999) from 
previous protocols described by Sloviter and Damiano (1981) and Rogers et al 
(1989). This consists of continuous stimulation of the perforant path at 20 Hz for 
two hours via electrodes implanted into the angular bundle. Activity is recorded in 
the dentate gyrus via another electrode throughout the procedure. In this model, 
electrographic and behavioural seizure activity becomes self-sustaining and persists 
after the stimulation has stopped.
These limbic seizures can be graded according to their severity using Racine’s 
classification of kindled seizures (Table 1.6).
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Table 1.6 : Development of kindled seizures after Racine (1972).
Stage Seizure type
1 Mouth and facial movements
2 Head nodding
3 Forelimb clonus
4 Rearing
5 Rearing and falling
1.10 The mossy fibre -  CA3 synapse
There are approximately 15 million dentate granule cells in the human dentate gyrus 
and about one million in the rat. They are unusual neurons, in that new dentate 
granule cells are formed throughout life, which are generated from stem cells located 
in the hilus (Palmer et al, 2000) and then migrate outwards into the granule cell layer 
(Kaplan and Bell, 1984). Despite the development of new cells throughout life, the 
number of granule cells does not apparently increase as the animal gets older 
(McEwen, 1999). Each cell gives rise to a single unmyelinated mossy fibre axon 
which leaves the dentate gyrus and forms fine collaterals that provide input to 
inhibitory intemeurons and excitatory mossy cells within the dentate hilus. The main 
axons synapse onto the proximal apical dendrites of the CA3 pyramidal cells in 
stratum lucidum (Henze et al, 2000). The mossy fibres travel transversely through
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the hippocampus in a lamellar arrangement (Andersen et al, 1969). The propagation 
of limbic seizures through the hippocampus has been demonstrated by recording 
activity in vivo in animal models (Collins et al, 1983). The hippocampal circuitry is 
often described in a simplified manner as a trisynaptic excitatory loop. Neurons from 
the entorhinal cortex project via the perforant path to granule cells. They project 
their axons, the mossy fibres, to CA3. Schaffer collaterals then project to CA1 and 
CA1 neurons project back to the entorhinal cortex via the subiculum.
Entorhinal
Cortex
Dentate
gyrus
CA1
Sub
CA3
V-VI
Figure 1.3: the “trisynaptic” circuit o f the hippocampus. Sub -  subiculum. Roman 
numerals refer to layers o f entorhinal cortex.
Mossy fibres also synapse with other cell types in the hippocampus. Each mossy 
fibre makes approximately 11-18 synapses with CA3 pyramidal cells, 140-150 with 
cells of the hilus (which are mainly inhibitory) and 40-50 synapses with inhibitory 
intemeurons within stratum lucidum (Acsady et al, 1998; Claiborne et al, 1986).
34
The dentate gyms is often considered to be a gate or barrier to seizure activity 
propagating towards the hippocampus (Collins et al, 1983). However, the 
hippocampal input is also regulated at the mossy fibre - CA3 synapse and inhibitory 
phenomena occuring at this synapse will gate seizure activity into the hippocampus 
proper. Presynaptic group II metabotropic glutamate receptors (Kamiya et al, 1996) 
and GABAb receptors (Min et al, 1998; Vogt and Nicoll, 1999) are present on 
mossy fibre terminals and depress transmitter release from mossy fibres when 
activated. The regulation of inhibitory gating at this synapse and the mechanisms 
underlying changes in this gating during the development of epilepsy are the main 
subjects of this thesis.
1.10.1 Mossy fibre pharmacology
Mossy fibres release glutamate which targets AMPA and small numbers of NMD A 
receptors (Jonas et al, 1993), kainate receptors (Castillo et al, 1997), and group I 
metabotropic glutamate receptors (Kapur et al, 2001) on CA3 pyramidal cells. They 
also contain high concentrations of vesicular zinc (Frederickson et al, 2000) which is 
released from mossy fibres in a frequency dependent manner (Li et al, 2001). The 
role of mossy fibre zinc is not fully understood. Although Lu et al (2000) and Li et al 
(2001) argued that it plays a critical role in the induction of mossy fibre long-term 
potentiation (LTP), Vogt et al (2000) reported that mossy fibre LTP was intact in the 
mocha mouse in which the ZnT3 transporter which is responsible for packaging of 
zinc into vesicles is absent. The role of zinc in mossy fibre LTP thus remains
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unclear. Mossy fibre zinc also modulates GABAa receptors (Ruiz et al, 2004) and 
NMD A receptors (Molnar and Nadler, 2001). Mossy fibres also release 
ATP/adenosine which plays an automodulatory role via presynaptic Al receptors 
(Yamamoto et al, 1993). Tonic inhibition at presynaptic Al receptors contributes to 
the release properties at this synapse (Moore et al, 2003). They also contain several 
peptides including dynorphin (Terman et al, 2000), enkephalin (Racz et al, 1998), 
cholecystokinin (Chandy et al, 1995), neuropeptide Y (Marksteiner et al, 1990) and 
neurokinin-B (Schwarzer et al, 1995). Dynorphin is released during high frequency 
stimulation and causes a heterosynaptic depression of neighbouring mossy fibres via 
kappa receptors on mossy fibre terminals (Weisskopf et al, 1993). Brain-Derived 
Neurotrophic Factor (BDNF) is also expressed at high concentrations in mossy 
fibres (Conner et al, 1997), and may serve a regulatory function in network 
excitability. Finally, although the mossy fibre-CA3 synapse has traditionally been 
considered to be an excitatory synapse, mossy fibres also contain the GABA 
synthesizing enzyme glutamic acid decarboxylase (GAD) and GABA itself in both 
rodents (Sloviter et al, 1996) and primates (Sandler and Smith, 1991). They contain 
mRNA for the vesicular transporter for GABA, VGAT, which is age dependent 
(Gutierrez et al, 2003) and increases after synaptic stimulation of mossy fibres in 
slices (Lamas et al, 2001). Bergersen et al (2003) have recently shown that 
glutamate and GABA are co-localised in mossy fibre terminals and that the GABA 
is spatially correlated with synaptic vesicles. The anatomical demonstration of the 
co-localisation of GABA and glutamate is not evidence that the synapse necessarily 
releases both transmitters. Recently however, Walker et al (2001) showed that
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GABAa receptor mediated IPSCs with characteristics typical of mossy fibre 
responses can be recorded in CA3 pyramidal neurons when stimuli designed to 
recruit mossy fibres are applied to acute hippocampal slices from healthy guinea- 
pigs. Also, Gutierrez and Heinemann (2001) recorded a GABAergic signal in CA3 
pyramidal cells using a stimulus designed to selectively recruit mossy fibres in 
kindled rats that was not present in controls. The physiological role of GABA 
release from mossy fibres is not known. Since the GABA concentration in mossy 
fibres is increased after seizures, it could lead to a compensatory increase in 
inhibition after sustained epileptic activity. There is some evidence that GABA is 
only released at mossy fibres in juvenile control animals but not in adults (Gutierrez 
et al, 2003) suggesting that mossy fibre GABA could also have a role in 
development (Walker et al, 2002b; Kasyanov et al, 2004).
1.10.2 Mossy fibre physiology
Mossy fibre synapses are unusual in that they show marked use-dependent 
facilitation even at low frequencies (Salin et al, 1996); thus on increasing the 
stimulation frequency from 0.05 Hz to 0.2 Hz, there is a 2-fold increase in the 
amplitude of the field EPSP. They have presynaptic GAB AB receptors (Hirata et al, 
1992) that inhibit voltage gated Ca** channels when activated and so reduce 
transmitter release. Presynaptic group II metabotropic glutamate receptors also 
suppress transmitter release at mossy fibre synapses (Kamiya et al, 1996). The 
activation of postsynaptic group I metabotropic glutamate receptors on the CA3 
pyramidal neurons induces release of Ca++ from internal stores (Kapur et al, 2001).
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The mossy fibre synapse is also influenced by inhibitory activity at several different 
levels. Since each mossy fibre synapses with more inhibitory cells than excitatory 
cells (Acsady et al, 1998) the inhibitory effects of mossy fibres on the hippocampal 
circuitry may be substantial. However, the extent to which this alters the strength of 
mossy fibre input to CA3 pyramidal neurons is not fully understood because of the 
complexity of the numerous intemeuron types that are activated by hippocampal 
input (Urban et al, 2001). Also, mossy fibres synapse with CA3 pyramidal cell 
dendrites at a proximal position and so firing of CA3 pyramidal neurons is not likely 
to be strongly influenced by GABAergic synapses that are positioned more distally. 
It is likely then that presynaptic receptors on the mossy fibre synapse that depress 
transmitter release have a more dominant role in limiting mossy fibre transmission 
than feedforward inhibition from the dentate gyrus. Vogt and Nicoll (1999) and Min 
et al (1998) observed that a high frequency train of impulses applied to one mossy 
fibre pathway depresses transmission in an adjacent mossy fibre pathway. This 
phenomenon was termed heterosynaptic depression (HD). In the guinea-pig 
hippocampus this is mediated by GABAb receptors and metabotropic glutamate 
receptors. If heterosynaptic depression was altered after status epilepticus this could 
alter hippocampal excitability. I therefore asked the questions:
Is heterosynaptic depression present in the adult rat hippocampal mossy fibre 
synapse?
Is it altered after SE ?
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1.10.3 Long-term potentation (LTP) at the mossy fibre synapse
LTP is a synaptic phenomenon that is considered to be currently the best 
experimental model for the synaptic basis of learning and memory. It is a long-term 
increase in synaptic strength that can occur subsequent to repetitive high frequency 
activity or paired pre- and post-synaptic activity. LTP that is dependent on 
simultaneous (within 100-150 ms) pre- and post-synaptic activity is termed 
“Hebbian” (or “associative”) after a learning rule proposed by Hebb in 1949. The 
Hebb rule states that synapses increase in strength when there is conjunctive 
presynaptic and postsynaptic activity. Two distinct types of LTP are recognised on 
the basis of their requirement for the synaptic activation of N-methyl-D-aspartate 
(NMDA) receptors. Most forms of LTP, such as that at the Schaffer collateral 
synapse in CA1, are NMDA receptor dependent. It is the unique properties of the 
NMDA receptor that provide a Hebbian nature to these forms of LTP. At resting 
membrane potentials, NMDA receptors are blocked by magnesium. The block is 
only released when the membrane is depolarised by activation of other receptors 
such as AMP A receptors. At the mossy fibre-CA3 synapse however, LTP is 
independent of NMDA receptor activation (Harris and Cotman, 1986). Interestingly, 
depending on the induction protocol, mossy fibre LTP can be Hebbian or non- 
Hebbian. Long-lasting high frequency stimulation induces LTP regardless of the 
level of postsynaptic hyperpolarisation (Langdon et al, 1995) whereas brief 
stimulation induces LTP that also requires depolarisation of the postsynaptic cell. 
This form requires calcium influx via post-synaptic voltage dependent L type 
calcium channels (Kapur et al, 1998) thus requiring postsynaptic depolorization
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which activates the channels. If induced by long-lasting stimulation however, 
calcium release from postsynaptic intracellular stores is sufficient to induce LTP 
(Yeckel et al, 1999).
More recently the role of the kainate receptor in presynaptic calcium entry has been 
recognised. Kainate receptors have now been shown to be involved in both the 
induction of mossy fibre LTP and in synaptic facilitation of mossy fibre synaptic 
transmission (Bortolotto et al, 1999; Contractor et al, 2001; Lauri et al, 2001 ; 
Schmitz et al, 2001). However the subtype of kainate receptor responsible for these 
properties has been a subject of controversy. The selective GLUks (previously 
known as GluR5) antagonist LY382884 blocks both processes (Lauri et al, 2001) but 
broad spectrum glutamate receptor antagonists, such as kynurenic acid and CNQX, 
which are active at GLUk5 receptors have been reported not to block the induction of 
mossy fibre LTP (Weisskopf and Nicoll, 1995; Yeckel et al, 1999). In fact, gene 
knockout studies support a role for GLUk6 (G1uR6) but not GLUks receptors in 
mossy fibre LTP and synaptic facilitation (Contractor et al, 2001). Recent work has 
resolved some of the controversy. Lauri et al (2003) report that calcium entry 
through kainate receptors leads to calcium release from intracellular stores, which 
plays a role in both synaptic facilitation and the induction of LTP. Ih channels have 
also been implicated (Mellor et al, 2002) although this is controversial (Chevaleyre 
and Castillo, 2002).
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1.12 The CA3 network
What is the role of the CA3 region of the hippocampus? It has been proposed that 
CA3 acts as an autoassociative network. It is ideally suited for this task because of 
its abundant excitatory connections among pyramidal neurons. The term 
“autoassociative” refers to a system of memory storage. In this type of system, 
memories are stored as a pattern of neural activity that can be recalled when a 
fragment of the memory is presented to the network. The recall of this memory is 
known as “completion”. Such a network can learn each memory in one trial. The 
architecture of such a memory system has been proposed by Rolls and Treves, 
(2003). It has been hypothesized that memories are initially stored in the 
hippocampus and then transferred to the neocortex as more experience is gained and 
more generalised memories can be stored (McClelland and Goddard, 1996).
1.13 Altered inhibition in epilepsy
Blocking GABAergic inhibition produces seizures. Therefore a loss of GABAergic 
inhibition could be a key event in epileptogenesis. Loss of inhibition is frequently 
observed in epilepsy models and tissue from patients. Paradoxically though, other 
studies have reported increased inhibition in epilepsy. Sloviter proposed the 
“dormant basket cell hypothesis” to account for data obtained in rats that had been 
exposed to prolonged perforant path stimulation under urethane anaesthesia 
(Sloviter, 1983; Sloviter, 1987; Sloviter, 1991b). He observed that principal cell 
disinhibition and hyperexcitability immediately followed prolonged seizure 
discharges, correlated closely with selective neuronal injury to hilar neurons and
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CA3 pyramidal cells, and were similar to those changes produced acutely by 
bicuculline (Sloviter, 1991b). He suggested that principal cell disinhibition might be 
caused by the loss of mossy cell activation of dentate basket cells and the loss of 
CA3 pyramidal cell excitation of area CA1 basket cells (Sloviter, 1991b). Findings 
by Bekenstein and Lothman (1993) supported the hypothesis as have several 
subsequent studies (Mangan et al, 1995; Jefferys and Traub, 1998; Morin et al, 1999; 
Doherty and Dingledine, 2001; Denslow et al, 2001). In contrast, Esclapez et al
(1997) argued that in CA1, inhibition remained intact. Sloviter later suggested that if 
inhibitory intemeurons do indeed survive, perhaps a weak glutamate receptor 
agonist might restore inhibition by selectively activating surviving inhibitory 
intemeurons (Sloviter, 1991b) This has subsequently been supported by Khalilov et 
al (2002) in which a GluR5 subunit-containing glutamate receptor agonist 
selectively excites hippocampal intemeurons and evokes hippocampal principal cell 
inhibition. Despite a lot of evidence that there is decreased inhibition in the epileptic 
hippocampus, there have been several conflicting findings. In the dentate gyms, both 
decreased and increased inhibition has been observed. An increase in paired-pulse 
inhibition of granule cells has been observed in several epilepsy models. This was 
observed in the amygdala kindling model (Tuff et al, 1983) and in the kainic acid 
model (Haas et al, 1996; Buckmaster and Dudek, 1997). Granule cells from epileptic 
rats have increased GABAa receptor current density when compared with controls 
(Gibbs et al, 1997) and there are more GABAa receptors per synapse in kindled 
animals when compared with controls (Otis et al, 1994; Nusser et al, 1998). There 
are a number of explanations for these contrasting findings. First, studies are often
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not directly comparable because they use different animal models. Second, 
inhibition is measured in different ways including: paired pulse inhibition, miniature 
inhibitory post-synaptic current (mIPSC) and spontaneous inhibitory post-synaptic 
current (IPSC) frequency, and evoked inhibitory post-synaptic potential (IPSP). 
Third, it has been proposed that results may differ depending on the septotemporal 
level of the hippocampus examined (Bernard et al, 2000). In vivo studies in rats tend 
to concentrate on the more accessible septal level of the hippocampus, however 
tissue resected from humans includes the anterior (the human equivalent to the rat 
temporal) region (NB in the human the hippocampal poles are termed anterior and 
posterior, in contrast to the rat that is described as having temporal and septal poles). 
It is here that hilar neuron loss is most severe (Babb et al, 1984) and where the 
number of GAD-positive (Buckmaster and Jongen-Relo, 1999) and somatostatin- 
and parvalbumin-immunoreactive intemeurons are most reduced (Buckmaster and 
Dudek, 1997). Therefore, reduced granule cell inhibition and intemeuron loss in the 
temporal dentate gyms may be missed in studies of the septal dentate gyms. Several 
workers have reported changes in the expression and function of GABAa receptors 
in epilepsy. There is an increase in membrane GABAa receptors in the dentate gyms 
which is reflected in an increase in the efficacy of GABA in activating whole cell 
currents and increase in mIPSC amplitude (Otis et al, 1994; Gibbs et al, 1997; 
Nusser et al, 1998). As well as an increase in receptor density, GABAa receptor 
function is also altered in TLE. GABAa receptors on dentate granule cells become 
sensitive to blockade by zinc in contrast to GABAa receptors in controls which are 
zinc insensitive (Buhl et al, 1996; Gibbs et al, 1997). This is due to altered subunit
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composition from receptors containing predominantly alphal and alpha2 subunits to 
receptors containing much higher levels of the alpha4 subunit (Brooks-Kayal et al, 
1998). This potentially leads to a zinc-induced collapse of inhibition in the dentate 
gyrus and a breakdown of the barrier function of the dentate gyrus (Heinemann et al, 
1992; Lothman et al, 1992; Buhl, 1996; Gibbs et al, 1997).
1.14 GABAb receptors
In 1980, a GABA receptor was identified that was markedly different from the 
classical GABA receptor (Bowery et al, 1980). It was activated by GABA but was 
not sensitive to the classical GABA receptor antagonists such as bicuculline and its 
action was independent of chloride. Its most striking characteristic was that the 
spasmolytic drug baclofen (p parachlorophenyl GABA), mimicked the effects of 
GABA at this receptor. Ligand-binding studies identified distinct attachment sites 
for baclofen on central neuronal membranes (Hill and Bowery, 1981). This 
previously unknown receptor was termed GABAb to differentiate it from the 
classical bicuculline-sensitive GABA receptor, which was in turn termed GABAa-
GABAa receptors are ligand-gated ion channels and form part of the ionotropic 
receptor superfamily. GABAb receptors on the other hand, are coupled to G proteins 
(Wojcik and Neff, 1984; Karbon and Enna, 1985) and are thus classed as 
metabotropic receptors. They occur both pre- and post- synaptically. They inhibit 
adenylate cyclase activity, cause post-synaptic hyperpolarization and inhibit 
transmitter release.
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1.14.1 Structure of the GABAb receptor
The GABAb receptor belongs to the G protein coupled receptor superfamily, which 
also includes metabotropic glutamate receptors and calcium sensing receptors. It is 
most similar to class C receptors which contain a large extracellular amino terminal 
domain. It contains a classic seven membrane spanning domain structure and an 
intracellular carboxy-terminal tail (Couve et al, 2000). The GABAbi subunit was 
cloned by Kaupmann at al (1997). However, the recombinant GABAbi subunit 
exhibited extremely low binding affinities for agonists when compared to wild-type 
GABAb receptors and the coupling to GABAb effector systems in heterologous cells 
was inefficient (Kaupmann et al, 1998). It was subsequently realised by Couve et al
(1998) that the GABAb(i) protein was not trafficked to the cell membrane but 
remained associated with the ER. It was thus suspected that a trafficking protein 
might be required for functional expression (McLatchie et al, 1998). This hypothesis 
was proven when the second GABAb receptor subunit was discovered by Kaupmann 
et al (1998). Heterodimerisation between GABAb(i> and GABAb(2) is necessary to 
form a functional receptor because GABAb(2) trafficks GABAb(i) to the surface and 
GABAb(2) links to the G protein (Robbins et al, 2001). The GABAB(i) subunit is 
necessary for agonist activation (Margeta-Mitrovic et al, 2000; Calver et al, 2001; 
Galvez et al, 2000; Pagano et al, 2001). Thus, the agonist binds to a site on the 
GABAb(i) subunit which produces a conformational change in the protein complex 
that allows GABAb(2) to activate the G protein coupled signalling system.
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1.14.2 GABAb receptor effector systems
GABAb receptors mediate their effects via the adenylate cyclase system and calcium 
and potassium ion channels (Hill, 1985; Gage, 1992). GABAb receptor activation is 
mediated by G proteins in the pertussis toxin-sensitive family Gia/Goa, especially 
Gi2<x (Odagaki et al, 2000; Odagaki et al, 2001). In brain slices it has been shown that 
activation of GABAb receptors inhibits adenylate cyclase via G proteins and leads to 
a reduced level of intracellular cyclic AMP. Activation of presynaptic GABAb 
receptors suppresses calcium influx into presynaptic terminals (Isaacson and Hille, 
1997), primarily via inhibition of P/Q-(Barral et al, 2000; Mintz and Bean, 1993) 
and N-type (Easter and Spruce, 2002) calcium channels. Postsynaptic GABAb 
receptors increase potassium conductance in neuronal membranes and may be 
associated with multiple types of potassium channels (Luscher et al, 1997).
1.14.3 Modulation of epileptiform activity by GABAb receptor agonists and 
antagonists
Drugs that act on GABAb receptors modulate seizure activity. However, they can be 
pro- or anti-epileptic depending on the model and seizure type. Baclofen suppresses 
epileptiform activity in hippocampal slices induced by high [K+] (Ault et al, 1986; 
Swartzwelder et al, 1986a), bicuculline (Ault et al, 1986), kainic acid (Ault et al, 
1986), or stimulus trains (Swartzwelder et al, 1986a; Swartzwelder, 1986b). In vivo, 
baclofen prevents rapid amygdala kindling (Wurpel, 1994) and suppresses flurothyl- 
(Garant et al, 1993), pentylenetetrazol (De Sarro et al, 2000) and stimulus train- 
(Stringer and Lothman, 1990) induced seizures. Consistent with the notion that
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GABAb activation is antiepileptic, the GABAb antagonist SCH 50911 is 
proconvulsive in rats undergoing ethanol withdrawal syndrome (Carai et al, 2002 ). 
In contrast, baclofen also has pro-epileptic properties under certain conditions. It 
induces spontaneous rhythmic sharp waves in hippocampal slices (Lewis et al, 
1989). Baclofen can also induce ictal-like activity in hippocampal slices perfused 
with low [Mg24] or 4-aminopyridine (Dreier and Heinemann, 1991; Motalli et al, 
1999; Swartzwelder et al, 1987; Watts and Jefferys, 1993; Avoli et al, 2004). 
GABAb receptor activation is also strongly implicated in the genesis of absence 
seizures (Hosford et al, 1992; Snead, 1992; Vergnes et al, 1997).
1.14.3 Altered GABAb receptors in epilepsy
Altered GABAb receptor function is implicated in epilepsy, although most work has 
been directed at the role of GABAb receptors in the pathogenesis of absence 
seizures. However, GABAb receptors undergo changes in TLE, in both human 
patients and experimental models. Haas et al (1996) measured paired pulse 
suppression of recurrent IPSPs (disinhibition) in rats two weeks after kainic acid 
induced SE and reported a downregulation of GABAB receptors in the polysynaptic 
recurrent inhibitory circuit in the dentate gyrus. They proposed that this is one 
mechanism that could induce an enhancement of dentate inhibition after seizures. 
Wasterlain et al (1996) showed loss of GABAb mediated slow inhibitory 
postsynaptic potentials (IPSPs) recorded from dentate granule cells following 
unilateral stimulation of the perforant path. Wu and Leung (1997) reported reduced 
paired pulse depression of IPSCs recorded in CA1 after kindling that persisted for at
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least 21 days due to downregulation of presynaptic GABAb receptors. A decrease in 
efficacy of presynaptic GABAb receptors in glutamatergic terminals was shown in 
the basolateral amygdala after amygdala kindling (Asprodini et al, 1992). Kokaia 
and Kokaia (2001) reported changes in GABAb immunoreactivity in the 
hippocampus after kindling.
In addition to altered GABAb receptors in experimental epilepsy models, changes 
have also been identified in human patients with TLE. Munoz et al (2002) showed 
loss of GABAb staining on dentate granule cells in tissue from TLE patients. 
Billinton et al (2001) and Princivalle et al (2002) demonstrated altered binding to 
GABAb receptors in tissue from TLE patients using autoradiography. They 
demonstrated reduced GABAb density in CA1, CA2, CA3, hilus and dentate gyrus. 
However when corrected for cell loss, CA1 GABAb receptor expression appeared 
significantly upregulated. In addition they found increased affinity at CA3 and hilar 
GABAb receptors.
1.14.4 The role of GABAb receptors in absence epilepsy
Absence epilepsy is a condition characterised by generalised seizures that occur 
most commonly in childhood. During absence seizures, patients stare and cease 
normal activity for a few seconds, then return immediately to normal and have no 
memory of the event (Chang and Lowenstein, 2003). These seizures have a typical 
EEG pattern which consists of 3 Hz generalised spike-wave discharges. The 
mechanism that generates these seizures originates in the thalamocortical circuitry. It
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was shown in the feline generalised penicillin model of epilepsy that both the cortex 
and the thalamus are needed to generate 3 Hz spike and wave seizures (Avoli and 
Gloor, 1982a,b). The same circuitry is also involved in the production of sleep 
spindles; these phenomena are related to absence seizures and occur in the same 
stages of sleep (Kellaway, 1985). The cellular elements involved in the evolution of 
these seizures and sleep spindles have been studied in detail (Steriade et al, 1993; 
McCormick et Bal, 1997). Thalamocortical relay cells receive input from various 
brain regions. They make excitatory projections to the cortex. Cortical neurons, in 
turn, have excitatory connections with the thalamus. The thalamic reticular nucleus 
(nRT) consists of a layer of almost pure GABAergic neurons and is located in the 
lateral part of the thalamus. It receives collaterals from the thalamocortical and 
corticothalamic axons. These collaterals excite the cells of the nRT which then 
project back to the thalamus and connect with other nRT cells via inhibitory 
synapses.
McCormick, Bal and collaborators developed a slice preparation from the lateral 
geniculate nucleus of the ferret (von Krosigk et al, 1993). This preserves the 
circuitry needed to generate spindle wave oscillations and absence-like 3 Hz rhythm. 
Release of GABA from nRT cells (known as perigeniculate cells, PGN, in this 
region of the thalamus) induces IPSPs in thalamocortical cells. Upon recovery from 
one of these IPSPs, the thalamocortical cells are capable of generating large calcium 
spikes on which are often superimposed a burst of action potentials. These action 
potentials in turn generate EPSPs onto GABAergic PGN cells. This triggers calcium
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spikes in these cells with superimposed action potentials and thus the network 
oscillation continues. This is the type of oscillation that occurs in spindle wave 
activity; a normal part of sleep characterised by discharges occurring at a frequency 
of about 10 Hz. These studies in ferrets demonstrate that different oscillatory 
patterns can be produced in the thalamus depending on the manner in which 
GABAergic cells fire. Brief firing in PGN cells produces fast GABAa receptor 
mediated IPSPs in thalamocortical cells which sets the spindle wave frequency to 10 
Hz. However, strong firing in PGN cells produces slow GABAb receptor mediated 
IPSPs in thalamocortical cells which changes the oscillation frequency to 3-4 Hz 
(Kim et al, 1997). Hence, GABAb receptors seem to play a key role in setting the 
oscillatory rhythm of the thalamocortical circuitry in absence seizures, and it is 
enhanced firing that causes the transition from sleep spindles to spike-and-wave 
discharges. How does this occur? It has been hypothesized that increased firing in 
the cortex causes increased firing in thalamic GABAergic cells, leading to increased 
GABA release and activation of GABAb receptors.
1.15 Are other receptors altered in TLE?
Several other receptor types are altered in the epileptic brain.
1.15.1 Metabotropic glutamate receptors (mGluRs)
It is likely that altered mGluR function plays a role in epileptogenesis (Doherty and 
Dingledine, 2001). Alterations in mGluR expression are observed both in
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experimental epilepsy models and tissue from TLE patients. MGluR mRNA levels 
are altered in the hippocampus after kainic acid induced SE and results vary 
depending on the subunit studied and the cell type (Aronica et al, 1997). There was a 
downregulation of mGluR2 mRNA in dentate granule cells. Klapstein et al (1999) 
observed reduced perforant path sensitivity to mGluR group III agonists in kindled 
rats although Friedl et al (1999) found no significant change in the same model. 
Neugebauer et al (1997) reported an enhancement in group II sensitivity in the 
epileptic amygdala which was consistent with the findings of Doherty and 
Dingledine (2001) who demonstrated an increase in sensitivity to mGluR agonists in 
the SE-experienced dentate gyrus. Similarly, in epileptic human tissue mGluR la 
(Blumcke et al, 2000) and mGluR4 (Lie et al, 2000) immunoreactivity is increased 
in the dentate gyms.
1.15.2 Other receptor types
Several other receptor and ion channel abnormalities are associated with epilepsies. 
These include observations of altered expression or function in models and humans, 
and mutations in genes encoding for certain channels or receptors. There is some 
evidence that NMDA receptor expression and function is altered in epilepsy. 
Mathem et al (1998) found that NMDAR2b mRNA was upregulated in the dentate 
gyms of rats after self-sustaining limbic SE and human TLE patients. Behr et al 
(2001) showed a transient NMDA receptor mediated facilitation of high frequency 
input in the rat dentate gyrus after kindling. Altered expression of NMDA subunits 
was also recently reported in pentylenetetrazol-kindled animals (Zhu et al, 2004).
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Skyers et al (2003) observed an increase in opioid receptor labelling in the dentate 
gyrus following seizures. Also, changes in editing of mRNA encoding for AMPA 
receptor subunit GluR2 has been observed in hippocampi from epileptic humans 
(Vollmar et al, 2004). Enhanced expression of GluRl flip AMPA receptor subunits 
has been observed in hippocampal astrocytes from epilepsy patients (Seifert et al, 
2004). Recently, mutations in genes encoding for receptors and ion channels are 
being associated with naturally occurring human epilepsies. These include subunits 
of the GABAa receptor (Baulac et al, 2001), sodium channel (Wallace et al, 2001b), 
chloride channel (Haug et al, 2003), potassium channels (Eunson et al, 2000), 
calcium channels (Jouvenceau et al, 2001) and nicotinic acetylcholine receptors (De 
Fusco, 2000).
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1.16 Are GABAb receptors a useful target for antiepileptic drugs?
Enhancing GABAergic inhibition is an effective way of treating epilepsy. This has 
been evident with treatments that act at GABAa receptors such as barbiturates and 
benzodiazepines. An alternative way of enhancing GABAergic inhibition and 
stopping seizures could be via GABAb receptors.
There has been suggestion that some antiepileptic drugs may exert their effect via 
GABAb receptors. Ng et al (2001) proposed that the antiepileptic drug gabapentin 
was a GABAb receptor agonist but this was subsequently disputed by Lanneau et al 
(2001) who were unable to replicate their results. Karlsson (1992) showed that 
GABAb agonists retarded amygdala kindling but antagonists accelerated it. It has 
also been suggested that CGP 36742, a GABAb receptor antagonist, may prove to be 
useful in the management of primary generalised absence seizures (Czuczwar and 
Patsalos, 2001). I asked if activation of GABAb receptors by the GABAb agonist 
baclofen could inhibit excitatory transmission and stop seizures. NB drugs that act at 
the GABAb receptor may have complex network effects because they are present 
both pre- and post-synaptically at the mossy fibre synapse and inhibit transmitter 
release at both inhibitory and excitatory synapses.
Another way of increasing GABAb receptor activation is by blocking GABA uptake 
and increasing ambient GABA concentration. I asked if the antiepileptic activity of 
the GABA uptake blocker tiagabine was due to increased GABA acting on GABAb 
receptors.
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1.17 Tiagabine
This new antiepileptic drug was developed from the GABA uptake inhibitor 
nipecotic acid. Unlike nipecotic acid it can pass through the blood brain barrier 
because it is more lipid soluble than its parent compound. It is a potent selective 
inhibitor of the GABA transporter GAT-1. Its mode of action as an antiepileptic 
drug is not fully understood, but it is suspected that it may enhance inhibition via an 
increase in GABAa receptor mediated tonic inhibition and by increasing GABAa 
receptor mediated currents (Suzdak and Jansen, 1995). In addition, increased 
ambient GABA could activate GABAb receptors. Post-synaptic GABAb receptors 
are often positioned extrasynaptically and are only activated when GABA is 
simultaneously released from multiple synapses which leads to GABA spillover 
(Scanziani, 2000). Four GABA transporter (GAT) proteins have been cloned in both 
rats and humans: GAT-1, GAT-2, GAT-3 and BGT-1 (Borden, 1996). GAT-1 is the 
most prevalent GABA transporter in the rat forebrain and is predominantly found on 
presynaptic GABAergic terminals and glia. A decrease in clearance of synaptically 
released extracellular GABA has been observed in epilepsy, possibly due to reduced 
expression or function of GABA transporters (During et al, 1995; Patrylo et al, 
2001). Tiagabine’s anti-epileptic action is usually suggested to be due to an increase 
in extracellular GABA concentration. However, the time-course of the GABA 
transient in the synaptic cleft will also be affected, and by decreasing GABA uptake 
there is greater spillover of GABA on to extra-synaptic receptors. Increasing 
extracellular GABA does not necessarily increase GABAergic inhibition. Increasing
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extracellular GABA can desensitize synaptic GABAa receptors which will result in 
reduced amplitude of GABAa receptor mediated currents (Overstreet et al, 2000). 
However, an increase in extracellular GABA can lead to an increase in tonic 
inhibition which is mediated by high affinity extrasynaptic GABAa receptors. 
Spillover of GABA may also enhance GABAb receptor mediated inhibition. 
Scanziani (2000) reported that blocking GABA uptake can result in activation of 
GABAb receptors by GABA released from a single intemeuron which does not 
occur under baseline conditions. Activation of post-synaptic GABAb receptors may 
decrease excitability by hyperpolarising the post-synaptic neuron but there is also 
evidence that GABAb receptor activation can modulate oscillation frequency 
(Scanziani, 2000). Also, activation of post-synaptic GABAb receptors in the 
thalamus has been implicated in the generation of absence seizures (von Krosigk et 
al, 1993). A defect in GABA uptake was implicated in the pathogenesis of genetic 
absence epilepsy in a rat model (Richards et al, 1995; Sutch et al, 1999). Tiagabine 
can actually exacerbate absence seizures and induce absence status epilepticus 
(Coenen et al, 1995; Hosford and Wang, 1997). Tiagabine is an effective 
antiepileptic drug in several animal models. It stops status epilepticus in our self­
sustained SE model. I asked if its antiepileptic action was partly due to GABAb 
receptor activation.
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1.18 Summary of introduction
I investigated the role of GABAb receptors in temporal lobe epilepsy in two rodent
models.
I asked the following questions:
1. Is GABAb receptor mediated heterosynaptic depression present at the adult rat 
mossy fibre -CA3 synapse?
2. Is it altered after status epilepticus?
3. Via what mechanisms is heterosynaptic depression altered after status 
epilepticus?
4. What is the source of GABA that mediates heterosynaptic depression?
5. Is baclofen antiepileptic in our models of status epilepticus?
6. Is the action of the antiepileptic drug tiagabine mainly mediated by GABAb 
receptors?
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Chapter 2: General Methods
2.1 Epilepsy Models
I used adult male Sprague Dawley rats in all experiments. They were kept under a 12 
hour light-dark cycle with free access to water and a normal laboratory diet (SDS R 
and M number 1 expanded, Scientific Dietary Services, Witham, Essex, UK). All 
animal procedures followed the Animal (Scientific Procedures) Act, 1986.
2.1.1 Perforant path stimulation
I selected this model for several reasons. First, the induction of self-sustaining status 
epilepticus is highly reproducible (Holtkamp et al, 2001). Second, in our laboratory, 
the seizure severity is similar in each animal and there is a minimal mortality rate. 
Third, the EEG can be recorded during and after stimulation via the implanted 
electrodes. Thus status epilepticus can be confirmed electrographically and 
monitored during administration of antiepileptic drugs.
2.1.1.1 Electrode preparation
Bipolar stimulating electrodes were made by twisting two 125 pm Teflon coated 
stainless steel wires together. The tips of the electrodes were separated by 
approximately 0.5mm. A single 250pm stainless steel wire was used as the 
recording electrode and a silver wire was used for the earth electrode.
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2.1.1.2 Anaesthesia
Male Sprague-Dawley rats (270-330 g) were placed in an induction chamber and 
administered 4% halothane in O2. When they became laterally recumbent and 
unresponsive to a foot pinch they were removed from the chamber, and placed in a 
stereotaxic frame where anaesthesia was maintained with 1-2% halothane in O2 at a 
flow rate of 2 litres / minute.
2.1.1.3 Electrode placement
Two full-thickness holes were drilled into the skull using a drill mounted on a 
stereotaxic frame for placement of the recording (coordinates 2.5 mm lateral, 4 mm 
caudal from bregma) and stimulating (coordinates 4.4 mm lateral, 8.1 mm caudal 
from bregma) electrodes. Three further holes were then drilled for placement of 
skull screws that would be used for anchoring of the headstage later. A bent 
hypodermic needle was used to tear the dura if it had not been penetrated by the 
burr. Three screws were placed in the anchoring holes. The silver wire earth 
electrode was wound around one of the screws to anchor it, and then positioned 
subcutaneously. The bipolar stimulating electrode was implanted in the right 
hemisphere, and advanced to a depth of 4 mm into the angular bundle to stimulate 
the perforant path. The monopolar recording electrode was implanted stereotaxically 
into the right hippocampus and lowered through the skull hole until it touched the 
brain parenchyma. It was then slowly lowered into the parenchyma while test shocks 
were applied to the stimulating electrode and any response observed on the 
oscilloscope. It was lowered until the slope of the population excitatory post
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synaptic potential (EPSP) was maximal as described by Errington et al (1987). Once 
all the electrodes were in place and a fEPSP could be recorded, dental cement was 
applied around the electrodes and screws to anchor them in place. The gold 
connectors of the three electrodes were then placed into a plastic headstage. The 
headstage itself was also held in place by more dental cement. A piece of tape was 
placed over the holes of the headstage as a protective barrier. The animals were 
allowed to recover from anaesthesia. Seven days later the perforant path was 
electrically stimulated with 4-5 mA, 50 fis monopolar pulses at 20 Hz for two hours; 
this induced self-sustaining SE that was terminated after 2 hours with propofol (50 
mg/kg i/p) or diazepam (10 mg/kg i/p). In some experiments baclofen (5-10 mg/kg) 
(Tocris Cookson), tiagabine (80 mg/kg) (gift from Novo Nordisk) or SCH50911 (40 
mg/kg) (Tocris Cookson) were given.
Animals were killed 24 hours after SE with an overdose of pentobarbitone (500 
mg/kg i/p).
2.1.2 The pilocarpine model
The perforant path model of status epilepticus was already in use in the laboratory. 
Stimulation of the perforant path evokes population spikes in granule cells and 
epileptiform discharges and is likely to cause excessive glutamate release. This leads 
to hippocampal damage which is similar to that seen in human patients with 
epilepsy. There are many different models of epilepsy available and changes in these 
models are sometimes model specific. It can therefore be difficult to know the 
relevance of some of these changes to human epilepsies. I therefore decided to 
compare two different models of status epilepticus to ensure that any changes
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observed were not model specific. The pilocarpine model of seizures and epilepsy is 
one of the most commonly used chemical models. Pilocarpine is a muscarinic 
agonist and causes seizures via activation of the Ml muscarinic acetylcholine 
receptor (Hamilton et al, 1997; Berkeley et al, 2002). The pilocarpine model has 
both clinical and neuropathological features similar to human temporal lobe epilepsy 
(Turski et al, 1987; Cavalheiro, 1995) and is widely used by several different groups. 
This means that my data can be put into the context of the work of others.
Muscarinic agonists suppress a voltage dependent tonically active potassium current 
known as the M current (Brown and Adams, 1980). Blocking the M current causes 
membane depolarisation and increases the probability of firing (Hamilton et al, 
1997). During pilocarpine-induced seizures excessive glutamate is released which 
stimulates continuous release of acetylcholine and neuronal damage induced by 
NMDA receptor activation (Smolders et al, 1997). Since this method of seizure 
induction is different from that of perforant path stimulation but still results in 
histopathological changes similar to humans with temporal lobe epilepsy, I set out to 
develop this method in our laboratory.
2.1.2.1 Development of the pilocarpine model in our laboratory
Slight variations in methodologies have been used. The dose of pilocarpine used is 
variable but is usually in the range of 310-380 mg/kg (Chum et al, 2000; Brooks- 
Kayal et al, 1998; Mello et al, 1993; Covolan and Mello, 2000a,b; Kobayashi and 
Buckmaster, 2003). In most studies a peripheral muscarinic antagonist such as 
scopolamine methyl nitrate (or bromide) or atropine is given 30 minutes prior to
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pilocarpine injection. This is claimed to reduce mortality because it reduces 
peripheral cholinergic side effects such as hypersalivation, increased secretions in 
the respiratory tract and hypermotility of the gastro-intestinal tract. A protocol of 
repeated low-dose pilocarpine injections has also been tried (Glien et al, 2001).
Also, lithium can be given prior to pilocarpine adminstration which markedly 
reduces the dose of pilocarpine necessary to induce SE (Clifford et al, 1987;
Honchar et al, 1983). Lithium may alter the response to pilocarpine by several 
mechanisms: decreasing noradrenaline or dopamine release, increasing acetylcholine 
release, altering muscarinic binding, or altering inositol phospholipid second 
messenger systems. I decided to use pilocarpine without the addition of lithium to 
reduce the complexity of any pathological effects of the drugs themselves. I selected 
my initial protocol by reviewing the literature and selecting the methods used most 
commonly (Chum et al, 2000; Covolan et al, 2000a,b; Brooks-Kayal et al, 1998; 
Arida et al, 1999; Kobayashi and Buckmaster, 2003). I defined the onset of status 
epilepticus as the appearance of Stage 3 (Racine, 1972) seizures (see General 
Introduction) followed by continuous clinically detectable seizure activity. Dmgs 
were dissolved in 0.9 % sterile saline and were administered via the intraperitoneal 
route unless stated otherwise. I modified the initial protocol to reduce the mortality 
rate while maintaining a high percentage of status epilepticus induction.
My initial protocol consisted of the following:
Scopolamine methyl nitrate (Sigma) was given intraperitoneally at 1 mg/kg. Thirty 
minutes later, I administered pilocarpine at 350mg/kg intraperitoneally. I monitored
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the evolution and severity of the seizures. Pilocarpine at 350mg/kg resulted in 
prolonged generalised seizures in the first animal tested. I therefore reduced the 
pilocarpine dose to 325mg/kg which was still sufficient to induce seizures in all 
animals.
The following modifications were used to reduce the mortality rate:
Each rat was given two injections of scopolamine : one half an hour before the 
pilocarpine injection and one half an hour afterwards. This reduced overt signs of 
peripheral muscarinic effects such as piloerection, excessive salivation and increased 
intestinal activity (frequent defaecation or diarrhoea). The animals were given 5 ml 
of saline subcutaneously immediately after SE and offered fluid gel when they were 
able to swallow and sufficiently recovered to take fluids per os. Later they were 
offered soaked food pellets. 1 used minimal restraint when handling the rats and used 
insulin syringes to administer drugs which reduced the trauma of injection. I allowed 
them to adjust to their new environment for a minimum of twenty minutes before 
starting each experiment. Paper linings were placed in the cages to prevent 
inhalation or choking on sawdust which sometimes appeared to cause respiratory 
distress.
After these modifications had been made, the mortality rate was approximately 10%. 
I therefore used the final protocol below:
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Table 2.1 F inal protocol for pilocarpine model
Time (mins) Drug Dose Concentration (mg/ml)
0 Scopolamine methyl nitrate 
(Sigma)
1 mg/kg 1
30 Pilocarpine hydrochloride 
(Sigma)
320
mg/kg
320
60 Scopolamine methyl nitrate 
(Sigma)
1 mg/kg 1
90 mins after start 
of SE
Diazepam (Phoenix Pharma) 10 mg/kg 5
90 mins after start 
of SE
0.9 % sterile saline (s/c) 5 ml
2.2 Slice preparation
In all experiments, rats were killed with an overdose of pentobarbitone (500 mg/kg) 
i/p. Epileptic animals were killed either 24 hours or three weeks after status 
epilepticus. The brain was removed in < 1 minute and immersed in oxygenated ice- 
cold sucrose solution which contained (in mM), NaCl 87, KC1 2.5, MgCl2 7, sucrose 
75, CaCl2 0.5, NaH2P 04 1.25 and glucose 25. This was used because the tissue 
preservation appeared to improve when compared to other slicing solutions such as 
Ringer or choline based solution (personal communication from other laboratory 
members). In order to perform many of the in vitro experiments, two separate groups 
of mossy fibre axons needed to be stimulated and recorded from simultaneously in 
each slice. Mossy fibres run transversely through the hippocampus. The angle of 
slice preparation has to be precise; otherwise mossy fibre axons will be transected, 
making identification of two pathways from granule cells to CA3 unfeasible. 
Therefore, slice preparation at the correct angle is imperative for these experiments.
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Two methods of hippocampal slice preparation were tried. The aim was to prepare 
transverse hippocampal slices with as many intact mossy fibres as possible.
Figure 2.1: Whole brain slicing method (D = dorsal, L = lateral, M-medial, 
V=ventral), adapted from web resource: http://synapses.mcg.edu/index.asp
M
V
In the first method (Fig. 2.1), each hemisphere was removed from the sucrose 
solution and a cut (a, red line) was made as illustrated with a scalpel blade. The cut 
surface of the hemisphere was glued onto the cutting stage. Slices o f400 pm were 
prepared using a Leica vibratome. Slices were cut along the plane of the line, b. The 
slices collected in the middle of the hippocampus are transverse. As each slice was 
prepared, the hippocampus was dissected using two hypodermic needles. With this 
slicing method, I frequently obtained slices in which two mossy fibre pathways 
could not be identified. In this situation fEPSPs could be recorded if the axons were 
stimulated in s. lucidum, but not in the dentate granule cell layer. This suggested that
hippocampus
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the axons had been severed during the slicing procedure. I therefore changed to the 
following method.
After the whole brain had been removed and placed into ice-cold sucrose solution, 
each hippocampus was removed from its hemisphere using spatulas to peel it away 
from the rest of the temporal cortex. It was gently straightened and placed in a 
previously prepared agar block that had had two grooves which were cut slightly 
wider than the width of the hippocampi. Transverse slices at 400 pm were then 
obtained using the Leica vibratome. This technique yielded slices with two mossy 
fibre pathways more frequently.
2 3  Electrophysiology
Transverse hippocampal slices (400 pm thick) were obtained from control rats and 
rats following SE as described above. They were stored in an interface chamber 
containing Ringer solution for at least 1 hour prior to transfer to a submersion 
recording chamber. The storage and perfusion solution contained (in mM) NaCl 
(119), KC1 (2.5), MgS04 (4), CaCl2 (4), NaHC03 (26.2), NaH2P 04 (1), and glucose 
(11), and was gassed with 95% 0 2/5% C 02 (23-25 °C). The CA3 region, which is 
where I was recording, is prone to spontaneous epileptiform activity in vitro, and 
thus I used high concentrations of divalent cations to increase the “charge screening” 
of axons (Guth and Drescher, 1990). This high concentration of cations was used in 
both control and epileptic slices.
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2.3.1 Field potentials
Extracellular changes in potential that arise due to synaptic activity (field potentials) 
can be recorded in vivo and also in slice preparations. I recorded field potentials in 
acute hippocampal slices in order to measure synaptic activity at the mossy fibre to 
CA3 pyramidal cell synapse. Field potentials consist of a presynaptic component 
(the fibre volley) and a post-synaptic component (the field excitatory post synaptic 
potential (fEPSP). If mossy fibres are stimulated in the dentate granule cell layer by 
applying a current across a bipolar electrode and extracellular potential is measured 
in s.lucidum of CA3 (i.e. the dendritic layer where mossy fibres terminate on the 
proximal dendrites of CA3 pyramidal neurons), then the fEPSP is recorded as a 
negative potential (Fig. 2.1). Mossy fibres often have a large complex fibre volley 
(reflecting depolarization of presynaptic axons) that contaminates the initial part of 
the fEPSP. For this reason, I measured amplitude of the field potential rather than 
the slope; measurement of the fEPSP slope is often used, as the initial slope is not 
contaminated by population spikes or IPSPs. I also, at the end of all experiments, 
applied the AMPA/kainate receptor antagonist NBQX to abolish the fEPSP, leaving 
the fibre volley. I was then able post-hoc to subtract the fibre volley from the 
recorded field potentials before analysis, giving me a more accurate measure of 
fEPSP amplitude.
Field potentials were recorded using glass microelectrodes (resistance ~1 MQ ) 
filled with perfusing solution. A Digitimer DS3 isolated constant current stimulator
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was used to apply electrical stimuli to the slice through a bipolar stimulating 
electrode. I constructed the electrodes by positioning two tungsten electrodes (8-10 
MOhm resistance) (FHC) at approximately 30° to each other with the tips as close 
together as possible without touching, which was achieved under a dissecting 
microscope. They were then glued together using dental cement which was arranged 
in such a way so that the finished bipolar electrode could be inserted into the 
electrode holder.
The following drugs were used to block GABAb, AMPA/kainate and group II 
metabotropic glutamate receptors (mGluRs); CGP52432 (5 fiM) or SCH50911 (20 
pM), NBQX (50 pM), and LY341495 (500 nM). N 0711 (20 pM) was used to block 
GABA uptake. The GABAb receptor agonist baclofen (0.1 -10 pM) was used to 
determine GABAb receptor sensitivity. (2S,2'R,3'R)-2-(2,,3,-dicarboxycyclopropyl)- 
glycine (DCG-IV) was used to activate group II metabotropic glutamate receptors. 
All drugs were obtained from Tocris, except for DCG-IV and NO-711 (Sigma).
2.4 Immunogold labelling
Animals used for immunogold labelling were perfused over 20 minutes with 4% 
paraformaldehyde while under deep pentobarbitone anaesthesia. Immunogold 
labelling of GABA was examined at the ultrastructural level using electron 
microscopy to measure GABA within the mossy fibre terminals. This is much more 
specific than using other immunocytochemical methods at light microscopic level as
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the mossy fibre terminals can be precisely identified. Light microscopy cannot easily 
distinguish between labelled GABA in mossy fibres from that in the extracellular 
space and/or in other terminals. A modified Timms stain was used to confirm the 
identity of mossy fibres. Samples were incubated with a primary rabbit antibody 
raised to GABA (Sigma). The sample was then incubated with a secondary antibody 
which was goat anti-rabbit IgG coupled to 10 nm gold particles (Sigma). Electron 
microscopy was used to reveal the localization of the gold particles. The electron 
microscopy and results described in this part of the thesis were obtained by Ruth 
Fabian-Fine. The methods that she used are described in more detail in Chapter 5.
2.5 Theory of autoradiography
How can we analyse receptors by radioligand binding?
Drug + Receptor — drug-receptor complex — active drug receptor complex
affinity efficacy H
Response
As can be seen from the reaction scheme above, the binding of a drug to a receptor is 
the first step in the pathway that allows transduction of a signal from the outside to 
the inside of a cell. In autoradiography, a radioactive ligand can be used to measure 
binding to a receptor. How was a suitable ligand selected? Antagonists tend to be 
used more commonly than agonists because they provide the basis for a more robust 
assay. This is because agonist binding can be influenced profoundly by local 
concentrations of GTP and other nucleotides, and by mono- or di-valent cations and
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pH (Wharton and Polak, 1993). Often, antagonists of higher affinity than their 
corresponding agonists have been synthesized by the pharmaceutical industry. Care 
should be taken to select a ligand with an appropriate affinity. The off-rate should 
not be so slow that problems are encountered with equilibrium binding, or so fast 
that the ligand-receptor complex dissociates before the complex can be measured. 
The equilibrium dissociation constant (K d) should be in the range 50 pM to 25nM. 
The ligand selected was [3H]-CGP 62349 , a GABAb receptor antagonist that had 
been used successfully in Professor Bowery’s laboratory previously and its use is 
described in detail in Chapter 7. The choice of radioisotope depends on such factors 
as half life of decay, chemical stability, solubility and cost. 3H and 125I are the most 
commonly used isotopes.
The concept of specific and non-specific binding is important. We measured specific 
binding as follows: the preparation was incubated with radioligand alone. This 
yielded a measurement of total binding. Similar incubations were performed in 
parallel with the same concentration of radioligand but also in the presence of a 
saturating concentration of an unlabelled competing ligand. This yielded a 
measurement of non-specific binding. Total minus non-specific binding was then 
calculated which provided specific binding for GABAb receptors. For the 
displaceable binding to equate with binding to a specific receptor, the displacing 
agent needs to have binding specificity for the receptor in question. Once the 
radioligand had bound to the receptors, how was the bound ligand detected? A 
radiosensitive film was exposed to the preparation, and the energy of radioactive
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decay converted silver halide crystals to free silver. Tritium is a very weak P emitter. 
The film that I used, Hyperfilm 3H, consists of a clear plastic sheet, with emulsion 
on one side, with no protective antiscratch layer. This allowed the weak emission to 
be detected. The images obtained using radiosensitive films could then be used to 
obtain quantitative data regarding the receptor binding. The concept behind this is 
that the film optical density can be measured in terms of known concentrations of 
tissue radioactivity. Darker areas on the film have higher binding than lighter areas. 
The specific methods used will be described in Chapter 7.
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Chapter 3: Is GABAb receptor mediated heterosynaptic 
depression present at the adult rat mossy fibre -  CA3 
synapse?
3.1 Introduction
Hippocampal mossy fibres are sensitive to several neurotransmitters that depress 
transmitter release via action on their presynaptic receptors, including glutamate 
acting on metabotropic glutamate receptors (Kamiya et al, 1996), GABA acting at 
GABAb receptors (Min et al, 1998; Vogt andNicoll, 1999), and endogenous opioids 
acting at opioid receptors (Weisskopf et al, 1993). What is the adaptive significance 
of the profound modulation exhibited at the mossy fibre synapse? Hippocampal 
principal cells are highly vulnerable to excitotoxicity (Meldrum, 1993). Prolonged 
seizure activity such as that induced by pilocarpine or kainate injection, causes 
damage to pyramidal neurons in both CA1 and CA3 (Covolan and Mello, 2000). 
Humans with temporal lobe epilepsy lose hippocampal principal cells (Foldvary et 
al, 1999) as part of the pattern of cell loss known as hippocampal sclerosis. 
Presynaptic inhibitory phenomena acting at the mossy fibre synapse could 
potentially reduce excitatory input into CA3 and minimise damage to these cells. 
Presynaptic inhibition at this synapse provides dynamic control of this strong input 
which could be very important in gating seizure activity into the hippocampus 
proper.
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Second, profound modulation at the mossy fibre synapse could result in a sparse 
dynamic input to CA3 pyramidal neurons. Why might CA3 require a sparse input? It 
has been proposed that CA3 acts as an auto-associative memory. This is a way of 
storing memories that are represented by a pattern of neural activity. Stored 
memories can then be retrieved when the network is presented with a fragment of 
one of the memories by a process known as completion (Treves and Rolls, 1992). 
What properties would CA3 need to provide this function? A sparse but strong input 
is required to force CA3 cells into a pattern of activity that is relatively independent 
from information from the many collateral inputs within CA3 (Treves and Rolls,
1992). Mossy fibres potentially have the properties necessary to provide this strong 
and sparse input. Characteristics suggesting that they provide a strong input are: they 
have large synaptic terminals, form synapses on CA3 cell proximal dendrites, 
express marked frequency facilitation and large mean EPSP size. These properties 
suggest that mossy fibre synapses have a higher release probability than most other 
cortical synapses (Henze et al, 2000) and hence provide the strong input that would 
be required. They have also been described as conditional detonators by Henze et al 
(2002) meaning that they are capable of causing CA3 cells to fire depending on their 
firing frequency. The profound presynaptic modulation of mossy fibres could 
provide the sparseness required for CA3 to exhibit this form of memory.
One form of presynaptic modulation that occurs at the mossy fibre synapse is 
heterosynaptic depression. This arises when transmitter is released from one 
pathway and depresses transmission in an adjacent pathway. Studies in juvenile 
guinea-pigs have shown that this phenomenon is mediated both by group II
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metabotropic glutamate receptors and by GABAb receptors (Min et al, 1998; Vogt 
and Nicoll). It is potentially an extremely important phenomenon because it provides 
a gate to excitatory input into the hippocampus proper. It could thus potentially 
prevent damage to the vulnerable hippocampal principal cells by halting propagation 
of seizure activity through the hippocampus proper. I therefore asked: is 
heterosynaptic depression present at the adult rat mossy fibre synapse, and is it 
mediated by the same receptor types as in the guinea-pig?
3.2 Methods
Acute hippocampal slices were prepared from adult control Sprague-Dawley rats, as 
described in Chapter 2. A recording electrode, with resistance of approximately 
1MQ, filled with Ringer solution identical to the extracellular recording solution 
(see Chapter 2: General Methods), was placed in stratum lucidum, which could be 
visualised as a pale band between stratum pyramidale and stratum radiatum of CA3 
(Fig. 3.1).
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Stratum htcidum
Stratum pyramidal*'
Figure 3.1: Low power photomicrograph (x 30 magnification) o f hippocampal slice, 
demonstrating the different strata.
Two bipolar tungsten stimulating electrodes were positioned in the dentate granule 
cell layer and 0.5-1 mA pulses (80 p.s duration) were applied with constant current 
stimulators. Stimuli were applied to one electrode at 0.2 Hz when searching for 
mossy fibre fEPSPs. If no response was observed, the depth and position of the 
recording electrode within s.lucidum was altered, and the stimulating electrode was 
systematically positioned along s.granulosum of the dentate gyrus until a response 
was found (Fig. 3.2).
74
Extracellular 
recording electrode
Stimulating electrode
Dentate gyrus
CA3 pyramidal neurons
Mossy fibres
Figure 3.2: Mossy fibre field potentials were recorded in acute hippocampal slices 
in s.lucidum using this electrode arrangement. Stimulating electrodes were 
positioned systematically at different points in s.granulosum until fEPSPs could be 
elicited from each o f them. The recording electrode was placed in stratum lucidum.
Once a putative mossy fibre fEPSP was found the stimulus intensity was increased 
(within a range of 0.5-1 mA) until the amplitude did not increase further. The 
stimulation was then reduced to the minimum necessary to achieve the maximal 
field potential amplitude. Typically, mossy fibre synapses exhibit marked frequency 
facilitation (Salin et al, 1996) and responses show a marked reduction in amplitude 
in the presence of (2S,2'R,3’R)-2-(2',3'-dicarboxycyclopropyl)-glycine (DCG-IV) 
(Kamiya et al, 1996). I measured frequency facilitation and sensitivity to DCG-IV (1 
j l iM ) , to test whether the response had characteristics of mossy fibre synapses. Once 
I had identified one putative mossy fibre pathway, I positioned a second stimulating 
electrode in stratum granulosum of the dentate gyrus, as far as way as possible from 
the first stimulating electrode. I then systematically moved the electrode through 
s.granulosum until another putative mossy fibre fEPSP emerged. Sensitivity to 
DCG-IV was measured in both pathways at the end of each experiment to ensure
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they both had characteristics typical of mossy fibres. I then used a two pathway 
stimulation protocol to investigate whether heterosynaptic depression could be 
induced.
3.3 Results
In 8 slices from different control animals fEPSPs showed marked short-term 
frequency-dependent facilitation which was observed as an increase in amplitude of 
at least twice baseline when the stimulation frequency was increased from 0.05 Hz 
to 1 Hz (Fig. 3.3 A,B,C,D). In all experiments, I also confirmed that they showed a 
reduction to less than 30% of the baseline amplitude in the presence of DCG-IV (1 
pM) (Fig. 3.3 A,B,C,D). Responses were rejected if they did not exhibit these two 
criteria, however it was extremely rare to record a fEPSP that did not show these two 
properties.
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Figure 3.3: Identification o f mossy fibre field potentials. I  identified mossy fibre 
fEPSPs by demonstrating markedfrequency facilitation and sensitivity to the Group 
II metabotropic glutamate receptor agonist DCG-IV. A, fEPSPs (traces = averages 
o f 5 trials, taken from experiment shown in B) recorded in stratum lucidum whilst 
stimulating in stratum granulosum o f the dentate gyrus at a baseline frequency o f  
0.05 Hz, 1 Hz and at 0.05 Hz in the presence o f the group II metabotropic glutamate 
receptor DCG-IV (lpM). B, example o f an experiment demonstrating the 
identification o f mossy fibre fEPSPS by frequency facilitation (arrows show change 
in stimulation frequency from 0.05 Hz to I Hz) and DCG-IV sensitivity. C: same 
experiment as shown in B showing effect o f increase in frequency plotted against 
stimulus number. D, Summary data (n = 8). The fEPSP amplitude increased to at 
least 200 % o f baseline (20th /  1st response) when the stimulus frequency was 
increased from 0.05 Hz to 1 Hz, and the metabotropic glutamate receptor agonist 
DCG-IV (I pM) decreased fEPSP amplitude to less than 30% o f baseline.
Mossy fibre responses typically show paired pulse facilitation when two stimuli are
applied to the same mossy fibre pathway (Salin et al, 1996). I used this property to
confirm that the two pathways that I had identified were separate. Once I had found
two mossy fibre fEPSPs I tested whether the fEPSP elicited in one pathway was
facilitated by a preceding stimulus to the other pathway (Fig. 3.4). If I observed any
facilitation I re-positioned the stimulating electrodes until no facilitation was
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observed (mean cross-facilitation of 4 ± 3 % n = 6).
20 ms
2 mV
B
Y V C
 1 °
20 ms
2 mV
Figure 3.4: Mossy fibre fEPSPs exhibit paired pulse facilitation when two 
consecutive stimuli are applied to the same pathway but not when two different 
pathways are stimulated 40 ms apart. A, Two consecutive fEPSPs induced by 
stimulating the same mossy fibre pathway 50 ms apart, demonstrating marked 
facilitation o f the fEPSP. B, The left trace is a mossy fibre fEPSP induced by a single 
stimulus applied in stratum granulosum o f the dentate gyrus. The right trace shows 
the response from the same group o f mossy fibres, preceded by a separate mossy 
fibre fEPSP induced by stimulating a different region o f the dentate gyrus in the 
same slice 40 ms previously. The preceding fEPSP does not cause an increase in 
amplitude o f the original response, demonstrating an absence offacilitation.
After I had identified two separate mossy fibre pathways, I used the following
stimulation protocol to induce heterosynaptic depression. Single stimuli were
applied to the “test” pathway at a frequency of 0.05Hz. Three hundred milliseconds
before every 10th stimulus a train of 5 stimuli at 50Hz was applied to the
“conditioning” pathway (Fig. 3.5).
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Figure 3.5: A schematic to show the stimulation protocol.
The black lines represent a cycle o f stimulations at a frequency o f 0.05 Hz applied to 
the test pathway. The red lines represent the conditioning train (5 pulses at 50 Hz) 
applied to the conditioning pathway which precedes every 10th low frequency 
stimulus.
I used a train of this frequency and duration because first, dentate granule cells fire 
in short bursts at high frequencies in vivo (Jung and McNaughton, 1993) and so this 
is a physiologically relevant stimulus. For example, Henze et al (2002) recorded 
trains of 26 Hz in dentate granule cells of awake mice. Second, Vogt and Nicoll 
(1999) could induce a heterosynaptic depression with a train of the same length and 
frequency in slices from guinea-pigs and Min et al (1998) observed a depression 
when using a train of only 20 Hz. When the train was applied, a marked facilitation 
of the induced response was seen (Fig. 3.6). This indicates that a large amount of 
transmitter is likely to be released during this stimulus.
Figure 3.6: Mossy fibre fEPSPs recorded during application o f a train o f 5 stimuli 
at a frequency o f 50 Hz. Marked facilitation was observed during the train.
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I measured the amplitudes of the fEPSPs elicited by application of the test stimuli. 
The magnitude of heterosynaptic depression was calculated by comparing the 
amplitude of every 10th fEPSP recorded (conditioned fEPSPs or fEPSPc) to the 
average amplitude of the nine preceding fEPSPs (unconditioned fEPSPs or fEPSPu). 
The fEPSP ratio was calculated as fEPSPc/fEPSPu-
At the end of each experiment, I applied the AMPA/kainate receptor antagonist 
NBQX (50 (iM) in order to record the remaining presynaptic fibre volley, which was 
then subtracted from the fEPSP prior to analysis of the results (Fig. 3.7). A high 
concentration of NBQX was used to ensure that all AMP A and kainate receptors 
were blocked (Bortolotto et al, 1999; Bureau et al, 2000).
Figure 3.7: At the end o f each experiment I  applied the AMPA/kainate receptor 
antagonist NBQX (50 juM) in order to record the remaining presynaptic fibre volley. 
The trace on the left is a mossy fibre fEPSP recorded in naloxone only and the trace 
on the right shows the remaining stimulus artefact and presynaptic fibre volley in 
the presence o f  NBQX. ( Each trace is an average o f 5 trials stimulated at 0.05 Hz ).
Once two separate pathways had been identified, I used the two pathway stimulation
protocol (Fig. 3.5) to induce heterosynaptic depression as described in the methods.
Heterosynaptic depression, expressed as (1-fEPSP ratio) x 100 %, was observed in
0.1 mV
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all slices from adult control rats (20 ± 7 % depression, n = 8 slices from different 
animals, Fig. 3.8).
What mediates this heterosynaptic depression ?
Weisskopf et al (1993) described a heterosynaptic depression mediated by 
endogenous opioids released from mossy fibres although the frequency of 
stimulation required to induce the release of opioids was much higher than that used 
in my protocol. Nevertheless, I applied the opioid antagonist naloxone (10 pM) 
during the same stimulus protocol and calculated the magnitude of depression, to 
determine if there was an opioid mediated component to the depression. Naloxone 
did not significantly change the magnitude of depression (depression without 
naloxone 20 ± 7 %-, depression with naloxone 21 ± 7 %, n = 8, p = 0.9 paired t test 
Fig. 3.8A,B), suggesting that opioids are not involved in the depression that I 
observed. I subsequently did all two pathway experiments in the presence of 
naloxone to ensure that opioid receptors were blocked. I then applied the GABAb 
receptor antagonists, SCH50911 (Bolser et al, 1995) or CGP52432 (Lanza et al,
1993) while applying the same stimulation protocol. Bath perfusion of GABAb 
receptor antagonists (20 pM SCH50911, n = 6, or 5 pM CGP52432, n = 2) 
completely abolished heterosynaptic depression in all cases (0 ± 6 % depression, p < 
0.001 for comparison with baseline, Fig. 3.8A,B).
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Figure 3.8: Heterosynaptic depression evoked in control slices is mediated by 
GAB A b receptors. A conditioning train was applied to the “conditioning” pathway 
preceding every 10th stimulus delivered to the “test” pathway. A, An example o f  one 
experiment from a control slice. Heterosynaptic depression was observed as a 
reduction in amplitude o f the fEPSPs that were preceded by a train (open circles) 
compared to fEPSPs not preceded by a train (each filled circle represents average 
o f the nine unconditionedfEPSPs in each cycle). The opioid antagonist naloxone (10 
juM) had no effect on the magnitude o f depression. The GABAb receptor antagonist 
SCH50911 (20 pM) abolished the depression. fEPSPs (averages o f 5 trials each) 
are shown in the absence and presence o f SCH50911. B, Summary o f the ratio o f  
conditioned/unconditioned fEPSP amplitudes in 8 control slices, showing the 
abolition o f heterosynaptic depression by blocking GABAb receptors.
Thus, in slices from control adult rats, heterosynaptic depression evoked with this 
protocol was entirely mediated by GABAb receptors (Min et al, 1998; Vogt and
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Nicoll, 1999). To confirm that there was no contribution from metabotropic 
glutamate receptors, I applied SCH 50911 to one slice as in previous experiments, 
and then added the broad spectrum (group I and group II) (Eaton et al, 1993) 
metabotropic glutamate receptor antagonist (RS)-a-methyl-4-carboxyphenylglycine 
(MCPG) (500 pM). This is a concentration that was effective in reducing 
heterosynaptic depression in similar experiments by Min et al (1998). It had no 
significant effect on the fEPSP ratio, confirming that group I/II metabotropic 
glutamate receptors are not involved in this phenomenon (fEPSP ratio in naloxone 
only = 0.78, SCH 50911 = 0.93, SCH 50911 + MCPG = 0.90). This differs from the 
results in guinea-pigs observed by Min et al (1998) and Vogt and Nicoll (1999)
Heterosynaptic interactions mediated by spillover of glutamate are temperature 
dependent in that spillover is decreased at higher temperatures (Asztely et al, 1997). 
This may be due to the high Qio of transporters, to a larger fraction of the glutamate 
transporters being exposed to the extracellular space as temperature increases, or to 
temperature-dependent modulation of transporter function. I asked if this was also 
true of GABA mediated depression. I measured heterosynaptic depression at 34°C, 
using the same stimulation protocol. GABAb receptor mediated heterosynaptic 
depression was identical to that recorded at room temperature (21 ± 8 % depression, 
n = 3 slices from different animals, p = 0.9, unpaired t test when compared to 
depression at room temperature, Fig. 3.9).
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Figure 3.9: GABAb receptor mediated heterosynaptic depression is still present at 
physiological temperature (32-34°C), and o f the same magnitude as that recorded at 
room temperature (see Fig. 3.8B).
Finally, I asked if there was any GABAb receptor mediated tonic inhibition.
Blocking GABAb receptors caused a small increase in the size of the unconditioned 
fEPSPs in 2/8 control slices (Fig. 3.8 A). There was no significant effect of the 
GABAb receptor antagonists on the unconditioned fEPSP when all results were 
averaged (base-line fEPSP amplitude = 0.21 ± 0.07 mV, fEPSP amplitude in 
presence of GABAb antagonist=0.22 ± 0.06 mV, p = 0.45 paired t test, n = 8).
Hence, tonic GABAb receptor mediated inhibition was not a consistent finding in 
these experiments.
I performed all of the previous experiments in 4 mM Ca2+ and 4 mM Mg2+ to 
prevent any epileptiform bursting in CA3 (see Chapter 2: General Methods, 
“Electrophysiology”). To verify that the phenomenon of heterosynaptic depression is 
present at more physiological concentrations of divalent cations, I repeated the 
experiments with a perfusion solution containing 2.5 mM Ca2+ and 1.3 mM Mg2+. In
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two slices this yielded heterosynaptic depression of 33 ± 4 %, which was reduced to 
4 ± 2 % with GABAb receptor antagonists.
Although GABAb receptors profoundly depress transmitter release, a potentially 
confounding effect is efflux of K+ from neurons secondary to activation of G protein 
coupled potassium channels (Sodickson and Bean, 1996), which could alter axon 
recruitment and/or action potential propagation. An increase in extracellular 
potassium has previously been shown to decrease the presynaptic fibre volley at 
CA3-CA1 synapses (Frerking et al, 2001). I therefore compared the presynaptic 
fibre volleys (recorded in the presence of NBQX to abolish the fEPSP) with and 
without the 50 Hz train in the conditioning pathway. Neither the amplitude (fibre 
volley without train = 0.08 ± 0.04 mV, fibre volley in presence of train = 0.08 ± 0.04 
mV; p = 0.69, paired t test, n = 8) nor the shape of the fibre volley was significantly 
affected (Fig. 3.10), implying that heterosynaptic depression is not mediated by an 
increase in extracellular K+.
u c
Figure 3.10: The fibre volley was unchanged in both shape and amplitude in the 
presence o f the conditioning train. Example ofpresynaptic fibre volleys from one 
experiment showing that the conditioned presynaptic fibre volley (preceded by a 
conditioning train, c) is not different in amplitude or shape from the unconditioned 
fibre volley (not preceded by a train, u). Traces are averages o f responses in the
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presence o f  50pM  NBQXfrom two cycles o f 9 unconditioned stimuli and one 
conditioned stimulus. The intensity o f the stimuli was unchangedfrom that used to 
evoke heterosynaptic depression prior to addition o f  NBQX.
3.4 Discussion
In this study I have shown that GABAb receptor mediated heterosynaptic depression 
can be induced at the hippocampal mossy fibre synapse in slices taken from adult 
control rats.
In order to identify mossy fibre responses, I measured frequency facilitation and 
sensitivity to DCG-IV; the responses that I recorded showed a facilitation of at least 
200% increase in amplitude and a decrease to at least 30% of baseline, respectively.
I chose these criteria to define mossy fibre responses because others have shown that 
they are specific for mossy fibre synapses and have used them to confirm that 
responses are of mossy fibre origin. Kamiya et al (1996) showed that DCG-IV 
reduced the amplitude of putative mossy fibre responses but did not affect 
commissural/associational inputs onto CA3, or Schaffer collateral synapses between 
CA3 and CA1. They also showed that frequency facilitation was enhanced by DCG- 
IV and that responses evoked by pressure application of glutamate in stratum 
lucidum were not affected by it. These lines of evidence strongly support that DCG- 
IV acts on presynaptic receptors on mossy fibre terminals to reduce transmitter 
release at the mossy fibre synapse. Presynaptic group II metabotropic glutamate 
receptors also inhibit transmitter release at synapses between medial perforant path 
and dentate granule cells (Macek et al, 1996).The perforant path also projects 
directly to CA3 (Berzhanskaya et al, 1998). Contamination of my putative mossy
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fibre responses by perforant path input will thus not be detected by sensitivity to 
DCG-IV. I therefore used frequency facilitation as an additional criterion to confirm 
that responses were of mossy fibre origin which was a mossy fibre characteristic 
reported by Salin et al (1996). This characteristic is unlikely to be exhibited by the 
perforant path since the lateral and medial perforant path exhibit short-term 
depression at dentate granule cell synapses (White et al, 1979; Kilbride et al, 2001; 
Rush et al, 2002) and have similar physiological properties at the CA3 synapses 
(Berzhanskaya et al, 1998)
I could elicit heterosynaptic depression in the adult rat hippocampus using the 
stimulation protocol described by Vogt and Nicoll (1999) and similar to that 
described by Min et al (1998). However in adult control rats I have shown that it is 
mediated solely by GABAb receptors without a contribution from metabotropic 
glutamate receptors. This contrasts with the phenomenon in guinea-pigs which did 
have a metabotropic glutamate receptor mediated component. Possible explanations 
for this are: different expression of metabotropic glutamate receptors on mossy fibre 
terminals in adult rats compared to juvenile guinea-pigs or less glutamate spillover, 
more glutamate uptake or reduced diffusion due to more tortuous extracellular space 
in this age and species.
Although Weisskopf et al (1993) have observed an opioid mediated heterosynaptic 
depression at the mossy fibre synapse, I showed that the opioid antagonist naloxone 
did not affect the magnitude of heterosynaptic depression. This can be explained by
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the fact that they used a much higher frequency of stimulation to induce depression, 
which may be necessary to release opioids from mossy fibres (Wagner et al, 1990). 
Heterosynaptic depression is present in physiological conditions and does not appear 
to be due to an increase in extracellular potassium. How does activation of GABAb 
receptors cause heterosynaptic depression? G-protein-mediated signalling through 
presynaptic GABAb receptors can depress transmission in two ways. First, GABAb 
receptor activation reduces calcium influx (Takahashi et al, 1998; Isaacson and 
Hille, 1997) via inhibition of P/Q-(Barral et al, 2000; Mintz and Bean, 1993) and N- 
type (Easter and Spruce, 2002) calcium channels. This reduction in intraterminal 
calcium reduces vesicle recruitment. However, Scanziani et al (1992) showed that 
inhibition of presynaptic calcium currents was not necessary for inhibition of 
spontaneous action potential independent miniature excitatory synaptic currents by 
baclofen. This implies the existence of additional mechanisms linking GABAb 
receptors to exocytosis. In fact it has been recently shown that GABAb receptor 
agonists retard the recruitment of synaptic vesicles during sustained activity at the 
calyx of Held synapse (Sakaba and Neher, 2003). The retardation occurs through a 
lowering of cyclic AMP which blocks the stimulatory effect of increased calcium 
concentration on vesicle recruitment. One or a combination of these mechanisms can 
explain how GABAb receptors mediate the depression of transmission at mossy 
fibre synapses that I observed here.
GABAb receptors are present both pre- and postsynaptically at the mossy fibre 
synapse. Heterosynaptic depression has previously been attributed to presynaptic
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receptors only. Could post-synaptic GABAb receptors also play a role? Takigawa 
and Alzheimer (2002) have shown that the GABAb receptor agonist baclofen 
attenuates EPSPs recorded at the soma by whole cell patch-clamp in cultured CA1 
neurons by approximately one-third via activation of G-protein-activated inwardly 
rectifying potassium channels (GIRKs) on post-synaptic cells. It is therefore possible 
that post-synaptic GABAb receptors could play a role. However this is difficult to 
put into the context of my study because I was recording extracellular fEPSPs in the 
dendrites of CA3 pyramidal neurons.
I also demonstrated that the phenomenon was unaffected by temperature. This is in 
contrast to glutamate spillover phenomena (Asztely et al, 1997). Why should this be 
the case? Glutamate transporters are less active at lower temperatures (Wadiche and 
Kavanaugh, 1998; Diamond and Jahr, 2000). This may not necessarily be the case 
for GAB A transporters in this region of the hippocampus although there is some 
evidence that GABA uptake is increased at higher temperatures (Binda et al, 2002). 
If however GABA transporter function is upregulated at higher temperatures, my 
results could be explained by greater GABA release at higher temperatures. This is 
in keeping with the finding that tonic GABAa receptor activation is unaffected by 
temperature (Semyanov et al. 2003).
Since modulatory phenomena at the mossy fibre synapse can potentially gate limbic 
seizure propagation, I studied this phenomenon in rodent seizure models to 
determine whether a change in heterosynaptic depression could play a role in
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epilepsy. An additional question is whether the GABA that causes heterosynaptic 
depression is released from mossy fibres or intemeurons. This question is addressed 
in Chapters 4 and 5 respectively.
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Chapter 4: Is heterosynaptic depression altered after status 
epilepticus?
4.1 Introduction
Most naturally occurring seizures only last a maximum of a few minutes but 
occasionally seizure activity develops into a self-sustaining seizure state, which is 
termed status epilepticus (Hopkins et al, 1995). The intrinsic mechanisms that stop 
most naturally occurring seizures and the changes that allow status epilepticus to 
develop are not understood (Dragunow, 1986; Young and Dragunow, 1994). 
Following a period of status epilepticus, both humans and animals frequently 
develop spontaneous seizures (Leite et al, 2002; Herman, 2002). There are several 
changes including axonal reorganisation (Represa et al, 1990) and altered receptor 
expression that occur during the latent period between status epilepticus and the 
emergence of spontaneous seizures (see Chapter 1: General Introduction). Could the 
phenomenon that I described in the previous chapter, heterosynaptic depression, be 
involved in these phenomena; the development of status epilepticus, and the later 
emergence of spontaneous seizures? I first asked if heterosynaptic depression was 
changed following experimentally induced status epilepticus.
4.2 Methods
Acute hippocampal slices were prepared from adult rats 24 hours after 90-120 
minutes of status epilepticus induced by pilocarpine administration or perforant path 
stimulation (see Chapter 2: General Methods). Mossy fibre fEPSPs were identified
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using identical methods to those used in the previous chapter. The same two 
pathway stimulation protocol was used to study heterosynaptic depression as 
previously described.
4.3 Results
I identified two mossy fibre pathways in slices from animals after pilocarpine- 
induced status epilepticus using the same protocol as in chapter 4.
To determine if mossy fibre responses had the same properties in control and post­
status epilepticus slices, I compared the degree of frequency facilitation and 
sensitivity to DCG-IV in controls and post-status epilepticus slices. Frequency- 
dependent facilitation was not significantly different from that measured in control 
slices (post-SE: 232 ± 25 % of baseline, n = 12; control: 358 ± 67 %, n = 8; 
measured as 20th fEPSP / 1st fEPSP amplitude when stimulation was increased from 
0.05Hz to 1Hz, p = 0.1, Fig. 5.1).
Figure 4.1: Mossy fibre fEPSPs in slices after pilocarpine-induced SE (n = 12) 
showed frequency facilitation and DCG-IV sensitivity which were not significantly 
different from that observed in control slices.
p = 0.1
G
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It has been well described that sprouting of mossy fibre axons into the inner 
molecular layer occurs following status epilepticus (Okazaki et al, 1995; Buckmaster 
et al, 2002; Zhang and Houser, 1999) and this could potentially have made 
identification of separate mossy fibre pathways difficult. However, this was not a 
problem because these slices were taken 24 hours following status epilepticus. 
Sprouting takes several days to develop (Mello et al, 1993). I used the same criteria 
to confirm that the two pathways were separate (cross-facilitation = 0 ± 6 % n = 11). 
Moreover, in post-SE slices, DCG-IV perfusion reduced the fEPSPs to 22 ± 5 % of 
baseline. This depression was also indistinguishable from that seen in control slices 
(19±8% , p = 0.8, Fig. 4.1). I then used the same protocol as used in chapter 4 to 
stimulate the two pathways in order to induce heterosynaptic depression. However, 
in contrast to control animals, heterosynaptic depression was not detected after 
pilocarpine induced SE (1 ± 4 % depression, n = 12, p = 0.75, paired t test 
comparing conditioned to unconditioned fEPSPs, Fig. 4.2).
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Figure 4.2: GABAb receptor mediated heterosynaptic depression is absent after SE. 
Heterosynaptic depression was absent after pilocarpine-induced SE: example o f one 
experiment. fEPSPs are shown in the absence and presence o f SCH50911. (Each 
trace is the average o f 5 trials; conditioned: filled circles, unconditioned: open 
circles). The GABAb receptor antagonist SCH50911 had no significant effect.
Thus in slices from SE experienced animals, in spite of the apparently normal short­
term plasticity and metabotropic glutamate receptor sensitivity of mossy fibre 
synapses, they were unaffected by trains of stimuli delivered to neighbouring axons.
These results do not distinguish between a generic effect of limbic seizures and a 
specific result of the chemoconvulsant used to evoke SE. I therefore asked whether a 
different model of SE, which does not involve the use of an exogenous convulsant, 
also interfered with GABAb receptor-mediated modulation of mossy fibre 
transmission. I examined hippocampal slices taken from six animals 24 hours after
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SE evoked by perforant path stimulation (see Chapter 2: General Methods). 
Heterosynaptic depression was again absent in slices from all six animals (-2 ± 5 % 
depression, n = 6, Fig. 4.3A).
B
Cl.
onCL
m
1.2
1
0.8
0.6
0.4
0.2
p = 0.03
r
p = 0.02
I
-o<D4-»
03
■3
25
£ 2 0
*r c 15 Oi o 
“ ' 3  10<DQ
<
o
aO,<UTJ
p= 0.026
I 1
l
Con Pilo PP Control Post-SE
Figure 4.3: A There was no significant heterosynaptic depression in animals after 
pilocarpine-induced or perforant path stimulation-induced SE in contrast to the 
marked depression seen in control animals. B Size o f GABAb receptor mediated 
heterosynaptic depression, estimatedfrom the effect o f the GABAb antagonists 
SCH50911 or CGP52432 on the fEPSP ratio. SE: both models combined (n = 18).
I also examined slices from two animals treated with pilocarpine that had not 
developed SE. Both animals received diazepam injections identical to those 
administered to the animals that experienced SE. Heterosynaptic depression was 
observed in slices from these animals (45 ± 4 %  depression). Thus, the loss of 
heterosynaptic depression is related to SE per se, rather than to the stimulus used to 
evoke it.
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To test whether the loss of heterosynaptic depression post-SE was due to the 
emergence of a compensatory heterosynaptic facilitation, I applied the GABAb 
receptor antagonists SCH50911 (20 pM) or CGP52432 (5pM) during the two 
pathway protocol in slices post-SE. This had no significant effect on the fEPSP ratio 
in slices from the post-SE animals (5 ± 4 % change in the fEPSP ratio, n = 18, Fig. 
4.3B). This was significantly different from controls (22 ± 3 %  change in the fEPSP 
ratio, n = 8) when GABAb receptor antagonists were applied (p = 0.026 unpaired t 
test for difference between SE and control animals). This result implies that loss of 
heterosynaptic depression post-SE was not due to the emergence of a compensatory 
heterosynaptic facilitation, but because of failure of GABAb receptor-mediated 
depression.
4.4 Discussion
I have demonstrated that GABAb receptor-mediated heterosynaptic depression at the 
rat mossy fibre synapse is lost after SE. This is observed in animals after both 
pilocarpine and perforant path stimulation induced status epilepticus. This loss is not 
due to a compensatory heterosynaptic facilitation, as shown by the application of 
GABAb antagonists. The mossy fibre responses in the epileptic animals had 
frequency facilitation and sensitivity to DCG-IV that were not significantly different 
from controls.
The non-significant trend for less frequency facilitation in the post-SE animals is 
consistent with the findings of Goussakov et al (2000), who showed a significant
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loss of facilitation after kainic acid induced SE. The more marked changes observed 
by Goussakov et al. (2000) may be due to differences in (i) the method used to 
induce SE (kainic acid vs. pilocarpine), (ii) stimulation frequency (100 Hz instead of 
1 Hz) and/or (iii) a longer interval from SE to sacrifice of the animals (several weeks 
instead of 24 hours). I selected mossy fibre responses on the basis of their frequency 
facilitation and DCG-IV sensitivity. I accepted fEPSPs that showed a 200 % 
increase in amplitude. This means that responses were rejected if they did not show 
sufficient facilitation and could have led to a skew in the selection process. If I 
rejected some responses that were indeed mossy fibres but had less facilitation this 
might also explain the discrepancy between mine and the results of Goussakov 
(2000).
This loss of a GABAb receptor mediated phenomenon could have important 
implications for the use of antiepileptic drugs that act via GABAb receptors. 
Although there are no GABAb receptor agonists currently used as antiepileptic 
drugs, several in vitro studies have shown that they have antiepileptic properties 
(Ault et al, 1986; Swartzwelder, 1986a,b). Does the downregulation of a GABAb 
receptor mediated phenomenon affect the efficacy of GABAb receptor agonists in 
these models? I address this question in later chapters. Why else could the loss of 
GABAb receptor mediated heterosynaptic depression be important? First it could be 
a mechanism by which self-sustaining status epilepticus develops. Second it could 
be one phenomenon that increases hippocampal excitability and allows spontaneous 
seizures to occur.
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Two important questions arise from this finding. First, from where is the GABA that 
mediates heterosynaptic depression released? Is it from the mossy fibres themselves, 
or intemeurons that are recruited by mossy fibres? Second, what mechanisms lead to 
loss of heterosynaptic depression after status epilepticus? This could be due to 
reduced GABA release from mossy fibres or inhibitory intemeurons, loss of 
GABAergic cells or reduced recruitment of GABAergic cells, increased GABA 
uptake, altered extracellular space or loss of functional GABAb receptors. These 
questions will be addressed in the following chapters.
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Chapter 5: Is the GABA that causes heterosynaptic 
depression in control slices released from interneurons or 
mossy fibres?
5.1 Introduction
The stimulation protocol that I used to induce heterosynaptic depression consisted of 
a train of stimuli applied to one mossy fibre pathway which inhibited transmission in 
an adjacent mossy fibre pathway. In previous experiments I have shown that this 
depression of transmission is mediated via GABAb receptors. Which cell types 
release the GABA that mediates this heterosynaptic depression? Vogt and Nicoll 
(1999) did not directly address the question of the source of GABA experimentally 
but they suggested that the main source was local inhibitory intemeurons and that 
perhaps mossy fibres also contributed to the GABA release. Could mossy fibres be 
the source of GABA for heterosynaptic depression? This is paradoxical because 
mossy fibres are usually considered to form excitatory synapses. They contain high 
concentrations of glutamate (Storm-Mathisen et al, 1983; Bramham et al, 1990) 
express the vesicular glutamate transporter VGLUT1 (Fremeau et al, 2001) and 
release glutamate at their synapses onto CA3 pyramidal neurons (Jonas et al, 1993 ). 
However, as well as containing glutamate, mossy fibres also contain the GABA 
synthesizing enzyme GAD67 (Dupuy et al, 1996; Schwarzer and Sperk, 1995a) and 
GABA itself (Sloviter et al, 1996; Woodson et al, 1989; Taupin et al, 1994). In 
addition, recent reports have shown that a GABAergic response with mossy fibre­
like properties can be recorded in CA3 pyramidal neurons when mossy fibres are
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stimulated (Walker et al, 2001; Bergersen et al, 2003;Gutierrez, 2000;Gutierrez and 
Heinemann, 2001). When electrical or chemical stimuli designed to recruit mossy 
fibres were applied to a slice, monosynaptic GABAergic responses were recorded in 
CA3 pyramidal neurons which remained when glutamate receptors were blocked 
(Walker et al, 2001). This GABAa receptor mediated response exhibits the same 
frequency facilitation, NMDA receptor independent long-term potentiation and 
metabotropic glutamate receptor agonist sensitivity as the glutamatergic component, 
providing compelling albeit circumstantial evidence that mossy fibres do indeed 
release GAB A. Gutierrez (2000) and Gutierrez and Heinemann (2001) reported that 
following seizures, a GABAergic potential can be recorded in CA3 pyramidal 
neurons when mossy fibres are stimulated, that is not present in control slices. A 
similar phenomenon was observed in juvenile rat tissue (Gutierrez et al, 2003). 
These studies strongly suggest that mossy fibres release GAB A and that the 
GABAergic component of the postsynaptic component increases after seizures. It is 
therefore possible that stimulation of the conditioning pathway in my protocol 
induces GAB A release from mossy fibres. If this spills over to adjacent synapses it 
could induce GABAb receptor mediated heterosynaptic depression.
An alternative possible source of GABA is intemeurons recmited by mossy fibres. 
Although the stimulating electrode that delivered the train of 5 stimuli to the 
conditioning pathway was positioned in the dentate granule cell layer where it 
recmited mossy fibres, these in turn may recruit other cells. Indeed, one dentate 
granule cell provides input to only 11-18 CA3 pyramidal neurons (Acsady et al,
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1998) and ~150 hilar cells (Henze et al, 2000), most of which are inhibitory 
intemeurons. However, direct stimulation of intemeurons projecting to CA3 is likely 
to be minimal with a stimulating electrode positioned in stratum granulosum 
(Walker et al, 2001). Since mossy fibres make many more synapses with inhibitory 
intemeurons than with CA3 pyramidal neurons, the stimulation of mossy fibres is 
likely to recruit large numbers of intemeurons. There are many intemeuronal 
subtypes in the hippocampus (Freund and Buzsaki, 1996). Which of these are most 
likely to be involved in release of GABA that mediates heterosynaptic depression? 
Mossy fibres provide a robust innervation to all types of intemeurons that have 
dendrites in stratum lucidum (Henze et al, 2000) and to basket cells in CA3 
(Frotscher, 1985). They also make connections with mossy fibre-associated 
intemeurons in stratum lucidum which then synapse onto the proximal dendritic 
shafts and somata of pyramidal neurons and onto inhibitory intemeurons (Vida and 
Frotscher, 2000). Since these mossy-fibre associated intemeurons are GABAergic 
cells that reside in stratum lucidum they could contribute to the GABA that mediates 
heterosynaptic depression. However, none of these intemeurons are known to form 
GABAergic synapses in stratum lucidum.
If mossy fibres release the GABA that mediates heterosynaptic depression, why is 
the depression lost following status epilepticus? One possible explanation is that 
GABA is depleted in mossy fibres following prolonged seizures. However, an 
increase in GABA has been reported after prolonged perforant path stimulation 
(Sloviter et al, 1996) and kindling (Lehmann et al, 1996; Gomez-Lira et al, 2002)
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and the GABA synthesizing enzyme GAD67 is increased after kainic acid induced 
seizures (Schwarzer and Sperk, 1995). I asked if GABA was depleted in mossy 
fibres after status epilepticus induced by pilocarpine by using immunogold labelling 
of GABA. This method was used so that I could confirm that the GABA measured 
was within the mossy fibre terminals themselves and not in other surrounding 
GABAergic cells.
If, alternatively, the GABA is released from intemeurons, then preventing GABA 
release from intemeurons should abolish depression. Endogenous cannabinoids can 
depress GABA release from specific intemeurons during a process known as 
depolarization-induced suppression of inhibition (DSI) (Wilson and Nicoll, 2001). 
When hippocampal pyramidal neurons are depolarized they release the endogenous 
cannabinoids anandamide and 2-arachidonylglycerol which act at the G protein- 
coupled cannabinoid receptor-1 (CB1). They transiently suppress GABA-mediated 
transmission via these receptors. Since endocannabinoids reduce GABA release 
from intemeurons, I asked if application of an endocannabinoid agonist reduced 
heterosynaptic depression in control slices.
Finally, if the GABA is released from mossy fibres, I hypothesized that increasing 
the release probability in the conditioning train will increase mossy fibre GABA 
release and hence, an increase in the magnitude of heterosynaptic depression. I did 
this by inducing long-term potentiation (LTP) in the conditioning train. Mossy fibres 
exhibit an unusual form of LTP distinct from that seen at other synapses in that it is
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independent of NMD A receptor activation (Harris and Cotman, 1986; Zalutsky and 
Nicoll, 1990). This is in contrast to the NMDA receptor dependent form seen at the 
Schaffer collateral synapse in CA1 (Bliss and Collingridge, 1993). I used this 
property to induce LTP in a mossy fibre pathway while blocking NMDA receptors, 
thus preventing LTP induction at commissural-associational synapses. This protocol 
should not induce LTP at mossy fibre -  intemeuron synapses because mossy fibre -  
intemeuron synapses exhibit long-term depression or no change when stimulated at 
high frequency (Toth et al, 2000; although see Alle (2001). However, it may result 
in an increase in GABA release from mossy fibre synapses onto CA3 pyramidal 
cells (Walker et al, 2001). I asked if increasing release probability by inducing LTP 
in the conditioning mossy fibre pathway increases the magnitude of depression.
5.2 Methods
5.2.1 Immunogold labelling for GABA
The GABA immunogold experiments were carried out by Dr. Ruth Fabian-Fine of 
Dalhousie University, Canada. I prepared the pilocarpine treated animals (see General 
Methods) and she performed the electron microscopic studies. For electron 
microscopy (EM) postembedding immunogold labelling, brain sections were obtained 
from adult male Sprague-Dawley rats (2 controls and 2 post-status epilepticus, 
induced by pilocarpine that were killed 24 hours after status epilepticus). The rats 
were perfused over 20 minutes with 4% paraformaldehyde while under 
deep pentobarbitone anaesthesia. Ultrathin sections (50 nm) were cut with a 
Reichert Ultracut and collected on pioloform-coated single-slot nickel grids. Grids
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were then mounted in a grid support plate, soaked in phosphate buffer (PB) for 30 
min and preincubated in an incubation medium (IM) consisting of PB with 1% 
bovine serum albumin (A4503, Sigma) and 5% foetal calf serum for 30 min at room 
temperature. Sections were then incubated with a rabbit anti-GABA antibody 
(1:4000 in IM; A2052; Sigma) overnight at 4°C. After thorough washing (4x10 min 
in PB) and preincubation in IM (30 min), the secondary antibody (goat anti-rabbit 
IgG coupled to 10 nm gold particles; Sigma) was applied at a dilution of 1:100 in IM 
for 4 h at 37°C. Preparations were washed subsequently in PB (5x10 min) before 
final rinsing in double-distilled water. The sections were contrasted with uranyl 
acetate (4 min) and Reynold’s lead citrate (50 sec) according to standard EM 
methods. Preparations were examined using a Philips 201C electron microscope. 
Control preparation from which the primary antibody was omitted showed no 
immunolabelling.
Mossy fibres contain high concentrations of zinc. This property is used to label 
mossy fibres at light microscopic level using a stain for zinc developed by Timm 
(1958). In this method sodium sulphide is used to precipitate any zinc contained in 
the mossy fibres. Metallic silver is then used to enlarge the resulting zinc sulphide 
grains by means of the Liesegang's physical developer containing gum arabic as 
protective colloid. This method is not suitable for labelling zinc when examining at 
the ultrastructural level, because the silver grains are large and the ultrastructure is 
not sufficiently preserved. The Timm’s stain was therefore modified by Seress and 
Galiyas (2000) to make it suitable for use at electron microscopic level. This method
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uses sodium tungstate as a protective colloid. This developer ensures that the 
ultrastructure is preserved and that small silver grains are produced. The modified 
Timm’s stain was used in this study to confirm the identity of mossy fibre terminals. 
This method was used in two additional animals: one control and one post-SE. Since 
a different fixation method was used for these two animals, they were not included 
in the quantitative analysis. The animals were perfused over 1 min with a buffered 
Na2S solution followed by 3% glutaraldehyde in 0.1% phosphate-buffered saline 
(PBS, pH 7.4,20 min) and again with Na2S solution (15 min). After 
dissection, brains were postfixed in 3% glutaraldehyde for 2 h on ice.
Vibratome sections (50 pm) were washed in Tris buffer (pH) 7.4 and placed 
in tungstate physical developer (pH 5.5,15 min) at room temperature. The 
reaction was stopped by placing the sections into 1% sodium thiosulphate (1 
min). After final rinsing in Tris buffer, sections were osmicated (0.5% for 
15 min), dehydrated, and embedded in Araldite according to standard 
protocols. For EM immunogold labeling, ultrathin sections (50 nm) were 
collected on pioloform-coated single-slot nickel grids. Grids were then 
mounted in a grid support plate and etched for 25 min in 1% periodic acid 
in distilled water. After washing in distilled water ( 3x5  min) grids were 
exposed to 2% sodium metaperiodate (25 min), rinsed in distilled water, and 
preincubated in incubation medium (IM) consisting of 1% bovine serum 
albumin and 10% fetal calf serum in PBS (30 min). Sections were then incubated in 
the primary and then secondary antibody as described for the previous animals.
105
5.2.3 Effect of WIN 55,212-22 on heterosynaptic depression
I compared the magnitude of heterosynaptic depression in the absence and presence of 
WIN 55,212-22 (800nM, dissolved in DMSO) while recording two pathway 
experiments in control slices.
5.2.2 Induction of long-term potentiation
LTP was induced by applying 3 trains of 100 pulses at 100 Hz with an inter-train 
interval of 10s. LTP was defined as an increase in fEPSP amplitude to at least 150% 
of base-line at 10 minutes after induction, persisting to the end of the experiment. 
Slices were rejected if this was not achieved. Heterosynaptic depression was 
measured 10 minutes following induction of LTP. LTP was induced in the presence 
of the NMDA receptor antagonist D-APV (50 pM) to ensure that only mossy fibres 
were potentiated.
5.3 Results
Immunogold electron microscopy was used to detect GABA-like immunoreactivity 
in mossy fibre terminals, in control tissue and tissue from rats 24 hours after 
pilocarpine induced status epilepticus. Figure 5.1 shows examples of electron 
micrographs taken from stratum lucidum. Mossy fibre terminals were identified by 
their large size, multiple active zones and numerous vesicle profiles. In addition, the 
modified Timm’s reaction was used in one control and one post-SE animal to 
confirm the identity of the mossy fibre terminals on the basis of their high zinc 
content (Seress and Galiyas, 2000). I did not use the Timm’s stained preparations for 
quantitative analysis because of the different fixation method used. Immunogold 
particles in mossy terminals of control animals (Figure 5.1C,D) were present at a 
density of 12 ± 1 per pm (56 terminals from two animals). This was significantly 
greater than the background density of 4 ± 1 per pm2 (p < 0.001). The measurements 
were repeated in 2 post-SE animals (Fig. 5.1A,B). The GABA immunogold particle
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density in mossy fibre terminals was doubled 24 hours after SE induced by 
pilocarpine to 24 ± 2 per pm2 (45 terminals from two animals, p < 0.001 compared 
to controls). Thus, the immunolabelling, while confirming more indirect evidence 
for GABA in mossy fibres, lends no support to the hypothesis that the amount 
available to be released is decreased following SE. On the contrary, there is more 
GABA in mossy fibres following SE, in keeping with previous reports that seizure- 
like activity is followed by the emergence of an upregulation of GABA in mossy 
fibres (Sloviter et al, 1996) and a monosynaptic GABAergic signal in CA3 
pyramidal neurons (Gutierrez and Heinemann, 2001).
Cannabinoid agonists reduce GABA release from intemeurons via activation of CB1 
receptors (Wilson and Nicoll, 2001). I applied the endocannabinoid agonist WIN 
55,212-22 (800nM) while recording two pathway experiments in control slices. This 
concentration was used because Wilson and Nicoll (2001) showed that this was 
sufficient to depress IPSC amplitudes in slice preparations. The heterosynaptic 
depression did not significantly change in the presence of WIN55,212-22 when 
compared to depression in base-line conditions (n = 3, p = 0.49, paired t test, Fig. 5.2 
). In these three experiments the mean fEPSP ratio in the presence of naloxone only, 
was 0.80 ± 0.08. This was abolished (0.0 ± 0.1 % depression) by the GABAb 
receptor antagonist.
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Figure 5.1: Sections through GABA immunogold-labelled mossy fibre terminals in 
SE (A, B) and control (C, D) animals. Tissue from animals after SE have 
significantly higher density o f immunogold particles (arrows). Arrowheads, 
synaptic sites; mft, mossy fibre terminal; s, spine. Scale bar: 100 nm (A,B), 120 nm 
(C), 60nm (D).
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Figure 5.2: The endocannabinoid agonist WIN 55,212-22 did not significantly 
change the magnitude o f heterosynaptic depression in control slices (baseline fEPSP  
ratio = 0.80 ±0.08, WIN fEPSP ratio = 0.88 ±0.18).(con = conditioned, uncon = 
unconditioned).
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I then asked if induction of LTP in the conditioning mossy fibre pathway leads to 
increased heterosynaptic depression. If the GABA that mediates heterosynaptic 
depression is released from mossy fibres I would expect to see an increase in 
depression after the induction of LTP in the mossy fibre conditioning train, because 
this should increase mossy fibre GABA release. In the presence of D-APV (50 pM),
I induced LTP in the conditioning train in 5 slices from control animals. I used 3 
trains of 100 Hz stimuli, of duration 1 s, which were applied every 10 seconds 
(Urban and Barrionuevo, 1996). Slices were rejected if the increase in amplitude was 
to less than 150 % of base-line (measured 10 minutes after applying the trains) or if 
the increase was not persistent throughout the experiment. The mean amplitude after 
induction was 248 ± 43 % of base-line at 10 minutes after induction (n = 5) (Fig.
5.3).
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Figure 5.3:1 applied 3 trains o f 100 pulses at 100 Hz at 10 s intervals (arrow) to 
induce LTP in the conditioning train. This graph demonstrates the amplitude o f the 
first fEPSP in each 50 Hz conditioning train before and after LTP induction. In this 
experiment the amplitude increased to 265 % o f  base-line when measured 10 
minutes after LTP induction. DCG-TV(1 juM) was applied at the end o f the 
experiment to confirm that responses were mossy fibre in origin.
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I applied the two pathway protocol both before and after the induction of LTP. I 
compared the fEPSP ratio under base-line conditions and ten minutes after LTP 
induction. After LTP induction there was a trend for increased depression but it did 
not reach significance. The pre-LTP fEPSP ratio was 0.59 ± 0.05 and the post-LTP 
fEPSP ratio was 0.48 ± 0.05 (Fig. 5.4, n = 5, p = 0.15 paired t test).
Figure 5.4: The fEPSP ratio during the two pathway protocol was measured before 
and ten minutes after the induction o f  LTP in the conditioning train. Although there 
was a trend towards a lower fEPSP ratio, the post-LTP ratio was not significantly 
different from the pre-LTP ratio. Heterosynaptic depression was therefore not 
significantly increased after induction o f LTP in the conditioning train.
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5.4 Discussion
In this chapter I explored the question: what is the source of GABA that mediates 
heterosynaptic depression? First, we demonstrated that there is an increase rather 
than a decrease in GABA concentration in mossy fibres after status epilepticus 
which means that they are unlikely to be the source of GABA. However I failed to 
abolish depression by the application of endocannabinoids, and was unable to 
increase significantly depression by increasing release probability in the 
conditioning train. No hard conclusions can be drawn from these data, and I have 
been unable to demonstrate a definite role for intemeurons in the phenomenon of 
heterosynaptic depression.
The electron microscopic data are consistent with the work of others. Sloviter et al 
(1996) showed that immunolabelling for GABA and glutamic acid decarboxylase 
increase after seizure-like activity. This is accompanied by the emergence of a 
monosynaptic GABAergic signal (Gutierrez and Heinemann, 2001). Sloviter et al
(1996) also found that GAD67-like immunoreactivity was present in the mossy 
fibres of rats, mice, and the monkey Macaca nemestrina. Perforant path stimulation 
for 24 hours, which evoked population spikes and epileptiform discharges, induced 
GAD65-, GAD67-, and GABA-like immunoreactivity in granule cells and pre­
embedding immunocytochemical electron microscopy confirmed that GAD67- and 
GABA-like immunoreactivity were induced selectively within granule cells. I used a 
much shorter period of seizure activity in my models. I therefore wanted to confirm 
that there was an increase in GABA in the models that I was using and that the
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increase is specifically in mossy fibres. The possibility cannot be excluded however, 
that mossy fibres are not able to release GABA following SE, perhaps due to a 
failure in the release mechanisms. This might lead to a build-up of GABA in the 
terminals. This seems unlikely however in the light of the findings of others who 
observed that a GABAergic signal emerges after seizures which was not present in 
controls (Gutierrez, 2000). In fact, this suggests the opposite, that GABA release 
from mossy fibres is increased after seizures.
I also explored the possibility that it is the intemeurons that release the GABA that 
mediates heterosynaptic depression. I hypothesized that if it is indeed released from 
intemeurons, depression will be reduced in the presence of endocannabinoid 
agonists, because activation of CB1 receptors inhibits the release of GABA from 
intemeurons (Wilson and Nicoll, 2001). I however did not observe a significant 
change in the magnitude of depression in the presence of endocannabinoid agonists, 
although the small numbers mean that I cannot form any hard conclusions from 
these experiments. Why might a cannabinoid agonist not abolish depression; could 
this suggest that the source of GABA is not intemeurons? There are a number of 
explanations for this result, even if the source of GABA is intemeurons. First, 800 
nM might not be sufficient to prevent GABA release. This seems unlikely because 
Wilson and Nicoll (2001) showed that this concentration was sufficient to decrease 
evoked IPSCs in slices. Second, is it possible that the intemeurons responsible for 
heterosynaptic depression do not express CB1 receptors? CB1 receptors are widely 
expressed throughout the brain (Wilson and Nicoll, 2001). However, they are only
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expressed on certain subtypes of intemeuron. In the hippocampus CB1 is specific to 
cholecystokinin positive basket cells which synapse onto the somata of principal 
cells. There is an absence of CB1 immunostaining in stratum lucidum (Katona et al,
1999). It is therefore possible that CB1 agonists will not reduce GABA release from 
those intemeurons that mediate heterosynaptic depression, for example the mossy 
fibre-associated intemeurons which I described at the beginning of this chapter.
Also, as can be seen in Fig. 5.2, the standard error increased in the presence of WIN, 
and there was a trend towards less depression suggesting that increasing the number 
of experiments in the presence of WIN 55,212-22 might reveal an effect on the 
magnitude of depression.
The final hypothesis was: if GABA is released from mossy fibres, increasing the 
release probability in the terminals within the conditioning train will increase 
depression. I did not observe a significant increase in depression following induction 
of LTP in the conditioning train which lends no support to the hypothesis that mossy 
fibres are the source of GABA. It should be noted though, that there was a non­
significant trend towards more depression following LTP. This non-significant result 
could be due to an insufficient number of experiments, especially if there is a non­
linear correlation between the magnitude of LTP and the increase in GABA detected 
by GABAb receptors (i.e. large LTP results in only a small increase in GABA 
concentration in the extracellular space). Are there other possible explanations for a 
trend towards increased heterosynaptic depression following LTP? Although the 
LTP experiments were done in the presence of NMDA receptor antagonists which
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will prevent NMDA-dependent LTP being induced elsewhere in the hippocampus, 
the potentiated mossy fibres could recruit more CA3 pyramidal cells which in turn 
could recruit more intemeurons as a form of feed back inhibition and hence increase 
depression. Also there have been mixed opinions as to whether LTP occurs at 
synapses between mossy fibres and intemeurons. Some studies have shown that 
either no LTP or depression occurs (Maccaferri et al, 1998), and other more recent 
studies suggest that LTP can be induced (Alle et al, 2001).
The increase in mossy fibre GABA labelling following status epilepticus despite a 
reduction in heterosynaptic depression, and the lack of effect of mossy fibre LTP on 
heterosynaptic depression (despite evidence that this should increase GABA release 
from mossy fibres) provide indirect evidence that mossy fibres are not the main 
source of GABA mediating heterosynaptic depression. The failure of cannabinoids 
to decrease depression can be explained by an insufficient role of CB1-expressing 
intemeurons in mediating heterosynaptic depression. Within the caveats discussed 
above (e.g. insufficient power to detect a difference, due to low n) my results 
suggest that the source of the GABA that mediates heterosynaptic depression is from 
intemeurons and not mossy fibres. Further work is however necessary to provide 
more definitive evidence (see Chapter 9:General Discussion).
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Chapter 6: Is loss of heterosynaptic depression due to a 
reduction in interneuron recruitment or a change in GABA 
uptake?
6.1 Introduction
In chapter 5 ,1 demonstrated that GABAb receptor mediated heterosynaptic 
depression is lost after status epilepticus in two different epilepsy models. The 
source of the GABA that mediates the depression is not clear but could either be 
from local intemeurons that are recmited by the conditioning train, or, less likely, 
from mossy fibres themselves.
Depending on the source of GABA, there are several possible explanations for the 
loss of heterosynaptic depression following status epilepticus. I will be addressing 
these questions over the following chapters. If GABA is released from intemeurons, 
loss of depression could be due to reduced intemeuron recruitment, a reduced 
number of intemeurons or reduced GABA release from intemeurons. If the GABA 
is released from mossy fibres, then loss of heterosynaptic depression could be due to 
a reduced GABA concentration in mossy fibres. However, the results described in 
Chapter 5 argue against this hypothesis. Regardless of the source of GABA, 
increased GABA uptake, decreased functional GABAb receptors or alterations in the 
extracellular space, could also lead to a loss of heterosynaptic depression.
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First, if the source of GABA is intemeurons, inhibitory intemeurons could be lost or 
recmited less efficiently. Both human patients with temporal lobe epilepsy (de 
Lanerolle et al, 1989; Mathem et al, 1995) and animals after experimentally induced 
status epilepticus (Sperk et al, 1992; Sloviter, 1983) have fewer hippocampal 
intemeurons than controls. Several studies have also demonstrated a reduced 
recruitment of intemeurons following status epilepticus. It has been suggested that 
remaining intemeurons are not recmited because of loss of vulnerable excitatory 
mossy cells which would usually recmit the relatively well preserved basket cell 
intemeuron (the dormant basket cell hypothesis) (Bekenstein and Lothman, 1993; 
Sloviter et al, 2003; Sloviter, 1991; Jefferys and Traub, 1998). An upregulation of 
group II metabotropic glutamate receptors leading to a reduced excitatory drive and 
hence reduced recmitment of hilar border intemeurons has also been described 
(Doherty and Dingledine, 2001). Second, GABA uptake could be increased 
following status epilepticus. This could abolish depression regardless of the source 
of GABA. Furthermore, altered GABA transporter function and expression have 
been reported during epileptogenesis. Patrylo et al (2001) reported a downregulation 
of GABA uptake after kainate induced status epilepticus and in patients with 
temporal lobe epilepsy. Dmgs such as tiagabine, that inhibit the neuronal GABA 
transporter GAT1 (Andersen et al, 1993), are antiepileptic. A decrease in 
immunostaining for GAT1 in rodent epilepsy models has been reported in the 
sensorimotor cortex (Silva et al, 2002) and the hippocampus (Andre et al, 2001). 
Third, there could be reduced amount of GABA available to be released from mossy 
fibres and/or intemeurons. However this hypothesis is difficult to reconcile with the
117
reports that show an increase in GABA concentration in mossy fibres after status 
epilepticus (Sloviter et al, 1996; Sandler and Smith, 1991) and emergence of a 
GABAergic current at the mossy fibre-CA3 synapse following seizures (Gutierrez, 
2000; Gutierrez and Heinemann, 2001).
Fourth, GABAb receptor mediated heterosynaptic depression could be lost due to 
reduced expression of functional GABAb receptors. Again this could explain the 
loss of depression regardless of the source of GABA.
Lastly, alterations in the tortuosity of the extracellular space could provide an 
obstacle between the GABA release sites and the target receptors. Do changes in the 
extracellular space occur in epilepsy? Status epilepticus induces CNS oedema which 
may last several days (Roch et al, 2002). Cell swelling during excessive neuronal 
activity can result in a 30% decrease in the volume of the extracellular space (Lux et 
al, 1986) and could change concentrations of extracellular ions and transmitters. A 
decrease in the extracellular space might be expected to increase the extracellular 
GABA concentration following exocytosis, and therefore increase GABAb receptor- 
mediated heterosynaptic depression. However, if this is accompanied by an 
increased tortuosity of the extracellular space, the diffusional path for GABA 
molecules from their release sites to the receptors could be increased, with the 
opposite effect on heterosynaptic depression.
In this chapter I ask:
1. Is the loss of heterosynaptic depression after status epilepticus due to a reduction 
in intemeuron recmitment? I asked this question using two approaches. First, if
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metabotropic glutamate receptor upregulation reduces intemeuron recmitment, it 
might be possible to rescue depression by applying a group II metabotropic 
glutamate receptor antagonist. Second, mossy fibres make many connections with 
intemeurons as well as CA3 pyramidal neurons. Therefore, when mossy fibres are 
stimulated they will recruit several different intemeuron populations (Walker et al, 
2002a; Henze et al, 2000; Lei and McBain, 2002) as well as providing input to CA3 
pyramidal neurons. There are several intemeurons that receive input from mossy 
fibres.
These include:
i) hilar border intemeurons with ascending axons and dendrites (hilar intemeuron 
with commissural-associational pathway-associated axon terminals, HICAP cells), 
with dendrites in both the hilus and molecular layer, and cell bodes in the 
polymorphic zone of the hilus or within stratum granulosum at the hilar border (Han 
et al, 1993; Doherty and Dingledine, 2001). They have their main axon in the hilus 
that gives rise to collaterals that branch in a Y-shaped manner in the molecular layer 
just above the granule cell layer. They mainly synapse onto dentate granule cells in 
the inner third of the molecular layer.
ii) mossy fibre associated intemeurons that have dendrites in stratum oriens and 
stratum radiatum, and axons in stratum lucidum (Vida and Frotscher, 2000). These 
cells form synapses on the proximal apical dendrites of CA3 pyramidal neurons and 
onto other inhibitory intemeurons.
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iii) several intemeuron types that have dendrites in stratum lucidum (Acsady et al, 
1998) and basket cells that provide feedforward inhibition onto CA3 pyramidal 
neurons (Frotscher, 1985).
Since mossy fibres connect with many intemeurons, I increased the length and 
frequency of the conditioning train in order to recruit more intemeurons and hence 
increase GABA release. I hypothesized that if loss of depression is due to a 
decreased recruitment of intemeurons, then increasing the train could potentially 
rescue depression in post-status epilepticus slices.
2. Is loss of heterosynaptic depression due to enhancement of GABA uptake? I 
hypothesized that if GABA uptake was increased acutely after status epilepticus, this 
could explain the loss of heterosynaptic depression. I therefore attempted to rescue 
heterosynaptic depression by interfering with the major hippocampal GABA 
transporter, GAT-1, with the selective blocker N 0711.
6.2 Methods
I prepared acute hippocampal slices as before from animals that had had pilocarpine- 
induced status epilepticus 24 hours previously. I identified two separate pathways of 
mossy fibres as before and applied the two pathway stimulation protocol. The 
frequency facilitation, DCG-IV sensitivity and fEPSP ratios in naloxone only were 
included in the data sets presented in chapter 3 .1 applied the group II metabotropic 
glutamate receptor antagonist LY341495 (500 nM) and the GAT-1 blocker N 0711 
(20 jiM) during the two pathway experiment to slices from animals 24 hours after
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pilocarpine-induced status epilepticus and measured the fEPSP ratio with and without 
presence of drug. I then used another group of post-status epilepticus animals; two 
pilocarpine treated and two perforant path stimulated, and prepared acute slices from 
them. In the presence of naloxone I applied the two pathway protocol with a 50 Hz 5 
pulse train as previously, and then in the same slice increased the train to 100 Hz and 
10 pulses to see if this rescued depression. (These experiments were done in the 
presence of 4mM C a^ and 4mM M g^ as in all other experiments unless stated 
otherwise).
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6.3 Results
Can depression be rescued by blocking group II metabotropic glutamate receptors? I 
applied the group II metabotropic glutamate receptor antagonist LY341495 (500 
nM) during the two pathway experiment to slices from animals 24 hours after 
pilocarpine-induced SE. This concentration of LY341495 was sufficient to 
completely antagonise the effect of the group II mGluR agonist DCG-IV on mossy 
fibre transmission (n = 3, Fig. 6.1).
Figure 6.1: The group II metabotropic glutamate receptor antagonist LY341495 at 
500nM is sufficient to block the effects o f the group II metabotropic glutamate 
receptor agonists DCG-IV on mossy fibre transmission (n=3). Traces are averages 
o f 5 fEPSPs in each o f the three conditions. The fEPSP is abolished in the presence 
o f DCG-IV and returns when LY is applied in the presence o f DCG-IV.
LY341495 failed to rescue heterosynaptic depression (p = 0.18, paired t test, n = 5, 
Fig. 6.2A,B).
In the same slices, bath application of 20 jiM N 0 7 11 failed to restore heterosynaptic 
depression (n = 4, p = 0.88, paired t test, Fig. 6.2, 6.3A). This concentration is 
sufficient to evoke a tonic GABAa receptor-mediated current in pyramidal neurons 
(Semyanov et al, 2003). These results thus lend no support to the hypothesis that
Base-line DCG-IV LY + DCG-IV
Baseline DCG-IV DCG-IV 
LY
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heterosynaptic depression was lost either because of upregulation of group II 
metabotropic glutamate receptors or because of increased GABA uptake.
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Figure 6.2: Heterosynaptic depression could not be rescued after SE by blocking 
group II metabotropic glutamate receptors or by blocking GABA uptake. An example 
o f one experiment. The group II metabotropic glutamate receptor antagonist 
LY341495 (500 nM) failed to restore heterosynaptic depression in a slice obtained 
after pilocarpine-induced SE. Application o f the GABA transporter GAT1 blocker 
NOV 11 (20 pM) also failed to affect the fEPSP ratio. Sample traces: fEPSPs in 
control conditions, and in the presence ofLY, NOV 11 and CGP (each trace is the 
average o f 5 trials. ConditionedfEPSPs: open circles, unconditioned fEPSPs: filled  
circles).
I then asked if changing the stimulation protocol to enhance the recmitment of 
intemeurons could rescue depression. I applied the usual stimulation protocol of 5 
pulses at 50 Hz. I did this in slices from two perforant path stimulated animals and in 
two pilocarpine treated animals. In the same slices, I increased the train to 10 pulses 
at 100 Hz (n = 4, pilocarpine = 2, perforant path = 2) with the aim of increasing the
Time(mins)
conditioned r V V
v r r y
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number o f mossy fibres stimulated and thus potentially also increasing intemeuron 
recruitment. Heterosynaptic depression was not rescued. The fEPSP ratio was 1.0 ± 
0.1 during the 50 Hz protocol and 0.97 ± 0.05 during the 100 Hz protocol. The 
fEPSP ratio was not significantly different between 50 and 100 Hz trains (Fig. 6.3B). 
This provides no evidence for the hypothesis that impaired recruitment of 
intemeurons accounts for the loss of heterosynaptic depression post-SE.
N 0711 LY341495
B 1.2
|  0.8 
a. 0.6 
£  0.4 
® 0.2
50 Hz 100 Hz 
5 pulses 10 pulses
Figure 6.3: A, Summary o f effects ofN0711 (n = 4) and LY341495 (n = 5) on the 
fEPSP ratio in animals after pilocarpine induced SE. B, A 100 Hz train did not 
rescue heterosynaptic depression in slices after SE. The fEPSP ratio did not change 
significantly when the train was increased from 50 Hz to 100 Hz (p = 0.4, paired t 
test)
6.4 Discussion
The results presented here lend no support to the hypothesis that heterosynaptic 
depression is lost after status epilepticus due a loss of intemeuron recruitment. The 
metabotropic glutamate receptor antagonist LY341495 did not rescue depression in 
slices after status epilepticus. The work of Doherty and Dingledine (2001) 
concentrated on intemeurons in the border of the dentate hilus. It is possible that the 
upregulation of metabotropic glutamate receptors that they observed is specific to
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synapses onto these intemeurons and that they are not responsible for heterosynaptic 
depression at the mossy fibre synapse. Their observation could also be specific to the 
kainic acid model.
I also tried to rescue depression by using N 0711 to block the GAT1 GAB A 
transporter. This had no effect on the fEPSP ratio which suggests that an increase in 
GAB A uptake is not responsible for the loss of heterosynaptic depression. Also, if 
an increase in ambient GABA does not rescue depression, it suggests that there may 
be insufficient functional GAB As receptors to induce depression after status 
epilepticus. The question of whether there are fewer GAB As receptors after status 
epilepticus is studied in later chapters.
Lastly, I was unable to rescue depression by increasing the frequency and length of 
the conditioning train. In this experiment I aimed to recruit more intemeurons during 
the facilitation that occurs during the train applied to the mossy fibres. Depression 
did not return. This could be because a) there are insufficient intemeurons left after 
status epilepticus to be recmited b) the prolonged train is insufficient to recruit them 
c) there is insufficient GABA in the remaining intemeurons to be released. This 
experiment also lends no support to the hypothesis that heterosynaptic depression is 
lost after status epilepticus because of reduced recruitment of intemeurons.
There are several limitations to this study and there are questions I did not ask 
regarding intemeuron function following status epilepticus. I did not address the 
question of whether intemeurons were actually lost after status epilepticus. If the
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GABA that causes depression in control slices is released from intemeurons this 
could certainly explain the loss of heterosynaptic depression. Several other studies 
show a loss of intemeurons following status epilepticus (Houser and Esclapez, 1996; 
Andre et al, 2001; Obenaus et al, 1993). However, these studies observed selective 
loss of intemeurons in stratum oriens of CA1 and the hilus of the dentate gyms. The 
intemeurons in CA3 were relatively well-preserved (Andre et al, 2001). Although I 
asked if there was an upregulation of metabotropic glutamate receptors that might 
cause reduced recruitment of intemeurons, reduced intemeuron recruitment could 
occur via other mechanisms such as loss of mossy cells (the dormant basket cell 
hypothesis; see General Introduction). Upregulation of other presynaptic receptors at 
mossy fibre-intemeuron synapses such as GABAb, endocannabinoid (Chen et al, 
2003) or opioid receptors could also reduce intemeuron recruitment. Lastly, I did not 
address the possibility that there is less GABA released from intemeurons after 
status epilepticus.
126
Chapter 7: Are GABAB receptors downregulated after 
status epilepticus?
7.1 Introduction
In previous chapters, I asked if the GABA that mediates heterosynaptic depression is 
released from mossy fibres or intemeurons. The second question that arose from my 
initial finding of the loss of heterosynaptic depression is: why is heterosynaptic 
depression lost after status epilepticus? I have started to address this question in 
previous chapters. I have shown that it is not due to a downregulation of GABA in 
mossy fibres and was also unable to demonstrate any evidence for loss of 
intemeuronal recruitment in my models. Could the loss be due to reduced functional 
GABAb receptors on mossy fibre terminals?
When GABAb receptors are activated, they modulate their effector systems through 
activation of the inhibitory G proteins Gai and Gao (Couve et al, 2000; Odagaki et al,
2000). When presynaptic GABAb receptors are activated, they inhibit transmitter 
release. There are several lines of evidence to support the presynaptic action of the 
GABAb receptor agonist baclofen. First, baclofen suppresses EPSPs but does not 
suppress direct glutamate induced postsynaptic excitation (Howe et al, 1987). 
Second, if its postsynaptic actions are blocked, baclofen still suppresses EPSPs 
(Dutar and Nicoll, 1988). Third, baclofen can suppress release of neurotransmitter 
from slices into the perfusing solution (Bowery et al, 1980) and fourth the 
coefficient of variation of the amplitude of synaptic potentials (CV) increases
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concomitantly with suppression of synaptic transmission (Harrison et al, 1990). 
Several of these lines of evidence are not definitive however. Quantal analysis 
provides a more quantitative measure of the properties of transmitter release and the 
drugs that affect it. A decrease in mean quantal content (m) indicates suppression of 
transmitter release, and a decrease in quantal amplitude (q) indicates a reduction in 
sensitivity of post-synaptic receptors. Inhibition of transmitter release by presynaptic 
receptors arises, at least in part, via a direct effect of the activated G protein on 
voltage-gated calcium channels (Isaacson, 1998; Kajikawa et al, 2001; Edwards et 
al, 1989). In addition, activation of presynaptic GABAb receptors inhibits vesicle 
recruitment via a reduction in cyclic AMP (Sakaba and Neher, 2003).
Mossy fibre synaptic transmission is strongly depressed by application of GABAb 
receptor agonists such as baclofen. However, it does have actions at both pre- and 
post-synaptic GABAb receptors (Hirata et al, 1992). GABAb receptors are present 
pre-synaptically at the mossy fibre-CA3 synapse (Vogt and Nicoll, 1999) and are 
also expressed on CA3 pyramidal neurons (Sodickson and Bean, 1996). Hirata 
(1992) used quantal analysis to study the action of baclofen on transmitter release at 
the mossy fibre synapse of the guinea-pig. They demonstrated both a pre- and post­
synaptic action of baclofen at the guinea-pig mossy fibre synapse. Although, at the 
mossy fibre synapse, baclofen acts at both pre and post-synaptic GABAb receptors, 
most of its inhibitory effect on mossy fibre fEPSPs is likely to be via inhibition of 
transmitter release at presynaptic GABAb receptors. This is because the fEPSP 
represents the change in potential that arises in the dendrites of CA3 due to action of
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glutamate on its receptors. It is possible however that a small part of its action could 
be due to shunting mediated by the opening of potassium channels on the 
postsynaptic membrane.
Here I ask: is heterosynaptic depression lost after status epilepticus because GABAb 
receptors are downregulated? I have used two different methods to address this 
question. In order to measure GABAb receptor function on mossy fibre terminals I 
measured the sensitivity of the mossy fibre fEPSP to the GABAb receptor agonist 
baclofen in control slices, and in slices 24 hours and 3 weeks after pilocarpine- 
induced status epilepticus. I then directly measured receptor density in stratum 
lucidum by measuring the binding of a tritiated GABAb receptor antagonist, 
CGP62349 using autoradiography in controls, 24 hours and 3 weeks after 
pilocarpine induced SE.
7.2 Methods
I prepared acute hippocampal slices as described previously (see Chapter 2: General 
Methods) from 3 groups of animals: controls, 24 hours, and 3 weeks after 
pilocarpine induced status epilepticus. The animals that had had status epilepticus 3 
weeks previously were having spontaneous seizures several times/day. Twenty-four 
hours prior to sacrifice of the animal and slice preparation, the three week animals 
were intermittently observed throughout the day. If at least two clinically evident 
seizures were observed throughout this period that were Racine grade II or above the 
animal was considered to be epileptic. Ideally the animals should have had
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continuous video monitoring to determine seizure frequency and severity but this 
type of equipment was not available in our laboratory. I recorded fEPSPs in stratum 
lucidum while stimulating a single pathway of mossy fibres in the dentate granule 
cell layer at low frequency (0.05 Hz). Mossy fibre fEPSPs were again identified by 
the magnitude of frequency facilitation and DCG-IV sensitivity. I measured the 
sensitivity of the fEPSP to increasing concentrations of baclofen (0.1,1 and 10 jiM).
7.2.1 Autoradiography
I performed the autoradiography experiments in the laboratory of Professor Norman 
Bowery at the University of Birmingham, UK. Prof. Bowery and Dr. Alessandra 
Princivalle instructed me how to perform these experiments but I did the majority of 
the practical procedures myself. The principles of autoradiography are described in 
Chapter 2: General Methods. Brains removed from control or post-status epilepticus 
rats (either 24 hours or 3 weeks following pilocarpine induced status epilepticus) 
were rapidly frozen in isopentane cooled in liquid nitrogen and stored at -70°C. I 
froze the brains at the ION and then transported them to Birmingham where I sliced 
them in preparation for autoradiographic labelling. Sections (12 Jim thick) were cut 
on a cryostat (2800 Frigocut, Reichert Jung) and thaw-mounted onto Superfrost Plus 
slides (75 x 25 x 1.0mm; BDH), then stored at -20°C until used. On the day of 
binding experiments, sections were left to equilibrate to room temperature. Slides 
were then incubated in 50 mM Tris buffer containing 2.5 mM CaCl2 (pH 7.4), for 20 
minutes, before incubating in fresh buffer for 60 minutes. They were then dried in 
room air. Each section was then incubated for 60 minutes and subsequently dried in
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[3H]-CGP 62349 (at concentrations of 0.5, 0.75,1, 2,4, and 8 nM) to determine total 
binding. [3H]-CGP62349 at the same concentrations plus CGP54626A (10 p,M) was 
used for incubation and then dried to determine non-specific binding. The slides 
were then washed in buffer for 2 x 1 minute washes and briefly rinsed in distilled 
water to remove buffer salts. The slides were dried in room air and then apposed to 
film (Amersham Hyperfilm-3H). The films were developed 28 days after exposure to 
the slides. Quantification of receptor autoradiography was achieved by film 
densitometry using an image analysis system (MCID - Microcomputer Imaging 
Device, Imaging Research Inc., Canada), and optical density was converted to 
finol/mg of bound ligand. In each Xray cassette, a standard strip was included that 
had previously been inoculated with different known concentrations of radioligand. 
Before performing image analysis the program was calibrated using this standard. 
The program could then convert optical density into finol/mg of bound ligand. Total 
binding in stratum lucidum was assessed in four to eight sections per concentration 
of [3H]-CGP62349 for each animal. The binding parameters receptor density (Bmax) 
and affinity (Kd) were determined by the use of the Langmuir equation in Prism PC 
software (GraphPad Software, San Diego, CA). [3H]-CGP62349 was a gift from Dr. 
Wolfgang Froestl, Novartis.
7.2.2 Data analysis
Data are expressed as mean ± S.E.M. The baclofen data were analysed using a least- 
squares fit to ImaX/(l + ECso/fbaclofen]), where Imax is the maximal inhibition and the 
EC50 is the half-maximally effective concentration of baclofen (KyPlot, Japan)
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(Sodickson and Bean, 1996). Results were compared using the unpaired Student’s t- 
test. In the autoradiography experiments, the binding parameters Kd and Bmax were 
calculated for each animal using the Langmuir equation.
Y = Bb» * X / ( K d +X)
(where X = concentration of radioligand applied to tissue (nM), Y = concentration of 
bound ligand (finol/mg tissue).
This equation describes the binding of a ligand to a receptor that follows the law of 
mass action. Bmax is the maximal binding and Kd is the concentration of ligand 
required to reach half-maximal binding.
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7.3 Results
Baclofen reduced the amplitude of mossy fibre fEPSPs in both control and epileptic 
slices in a concentration dependent manner (Fig. 7.1, 7.2).
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Figure 7.1: An example o f an experiment in a slice from an animal three weeks after 
status epilepticus. At the beginning o f the experiment, the frequency o f stimulation 
was increased from 0.05 Hz to 1 Hz to confirm that it was a mossy fibre response 
(arrow). Then, increasing concentrations o f baclofen were applied. A concentration 
dependent reduction in amplitude o f the fEPSP was seen.
Baclofen was less potent in reducing the fEPSPs in the 24 hour post-pilocarpine SE 
slices, compared to control. Potency was measured by calculating the IC50 (controls: 
IC50 = 0.47 ± 0.14 jiM, n = 6; 24 hours after SE: IC50 = 1.17 ± 0.27 JJ.M, n = 7; p < 
0.05 for difference; Fig. 7.2). There was no significant difference in the maximal 
inhibition (Im ax) by baclofen (controls: I max -  0.95 ±  0.05, n = 6; SE: I max = 0.87 ±  
0.06, n = 7; p = 0.31 for difference). I then asked whether this decrease in sensitivity 
to baclofen was a transient change or whether it was persistent over time. I applied 
baclofen to slices from animals three weeks after status epilepticus. Although the 
increase in IC50 did not reach significance when compared to controls (controls: IC50
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= 0.47 ± 0.14 jiM; 3 weeks post-SE: IC50 -  0.52 ±0.13 pM, p = 0.79), the Imax was 
significantly reduced (0.74 ± 0.05; p = 0.007, unpaired t test, Fig. 7.2) demonstrating 
a loss in efficacy (efficacy is defined as ability of drug, once bound to the receptor, 
to initiate changes which lead to effects) of the GABAb receptors.
Figure 7.2: Mossy fibre fEPSPs were less sensitive to the GABAb receptor agonist 
baclofen after SE. A, fEPSPs (averages o f 5 traces) illustrating a reduced sensitivity 
to baclofen 24 hours after SE. From left to right, traces are shown under base-line 
conditions, and in 0.1, 1 and 10 juM baclofen. These traces include the presynaptic 
fibre volley however all calculations were performed after the fibre volley was 
subtracted, as in all other experiments in this thesis. B, Baclofen has a less potent 
effect on mossy fibre fEPSPs 24 hours after SE (p < 0.05 unpaired t test on 1C50 - 
values, 6 control slices and 7 post-SE slices) and the lmax was significantly rein 
slices 3 weeks after SE (p = 0.007, n -  6).
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I then asked if the reduced potency of baclofen was due to a change in the number or 
functional properties of GABAb receptors. I used [3H]-CGP62349 autoradiography 
to estimate the density of GABAb receptors in stratum lucidum in control and post­
pilocarpine induced SE tissue (24 hours and 3 weeks after SE). The radiolabelled 
antagonist was applied at concentrations of 0.5, 0.75,1, 2,4, and 8 nM. 
Representative slices were stained with cresyl violet to identify the principal cell 
layers. Stratum lucidum was defined as the region between the margin of the stratum 
pyramidale of CA3 and stratum radiatum of CA3.
The mean Kd for post-SE animals was not significantly different from that for 
control animals, implying that the affinity of the GABAb receptors was unchanged 
(controls: 1.28 ± 0.34 nM, n = 5; SE: 1.09 ± 0.10 nM, n = 4, p = 0.67; Fig. 7.4). 
However, the mean B^x (a measure of GABAb receptor density) 24 hours after SE 
was significantly less than in controls in stratum lucidum (controls: 1322 ± 68 
finol/mg tissue, n = 5; SE: 1080 ± 56 finol/mg tissue, n = 4; p < 0.05 for difference; 
Fig. 7.4). I also observed a non-significant trend for the Bmax to be reduced 3 weeks 
following status epilepticus (1144 ± 54 fmol/mg tissue, n = 4; p = 0.09 for difference 
from control; Fig. 7.4).
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Figure 7.3: The binding parameter Bmax, which reflects maximal binding o f the 
radioactive ligand to GABAb receptors, was significantly lower than control 24 
hours after SE (control: n = 5; SE: n -  4; p  -  0.033for difference) but not 3 weeks 
after SE. Kd was not significantly different either at 24 hours or at 3 weeks after SE.
Other workers have observed altered GABAb receptor function and binding 
elsewhere in the hippocampus. I asked if the reduction in GABAb receptor density 
that I observed is specific to the presynaptic GABAb receptors on mossy fibre 
terminals or whether it is a global change that also occurs in the dentate granule cell 
dendrites.
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Figure 7.4: An example o f an autoradiograph from an animal after pilocarpine 
induced SE. I  measured binding in stratum lucidum, (black arrow). Stratum 
pyramidale o f  CA3 is marked with a white arrow.
In order to address this question I measured binding in the molecular layer of the 
dentate gyrus. The mean Bmax and Kd 24 hours post-SE tissue were not significantly 
different from controls (Bmax: controls 925 ± 74 fmol/mg tissue, n = 5; SE 812 ± 71 
fmol/mg tissue, n = 4, p = 0.29; KD: controls 0.69 ± 0.20 nM; SE 0.82 ± 0.23 nM, p 
= 0.83).
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7.4 Discussion
The main finding of this chapter is that there are fewer presynaptic GABAb 
receptors on mossy fibre terminals following status epilepticus. I have demonstrated 
this as both a loss of function and as a reduction in receptor density. The functional 
change persists for at least three weeks although the change in receptor density does 
not reach significance at this time-point. This is certainly enough to at least partly 
explain the loss of GABAb receptor mediated heterosynaptic depression.
The loss of GABAb receptor function was observed as a loss in the potency of 
baclofen. The potency of a drug depends on its affinity, i.e. its tendency to bind to 
receptors, and its efficacy, i.e. its ability, once bound, to initiate changes which lead 
to effects. This means that the reduced potency could reflect either a loss of 
receptors or uncoupling from second messengers downstream of the receptor. Three 
weeks after status epilepticus there was still a trend towards a reduced potency but 
this did not reach significance. However, there was reduced efficacy measured as a 
reduction in Imax- This suggests that, at this time point, there could have been some 
recovery of receptor number but an increase in uncoupling of receptors from their 
second messengers.
A loss of binding to GABAb receptors in stratum lucidum could reflect reduced 
receptors on mossy fibre terminals. However, an 18 % loss is not sufficient to 
explain a total loss of heterosynaptic depression. This discrepancy could either mean 
that the autoradiography underestimated the loss of receptors from mossy fibre
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terminals, or that other mechanisms downstream of receptor binding become 
dysfunctional and contribute to the loss of function. Possible downstream changes 
are: uncoupling between GABAb receptors and G proteins, or dysfunctional 
signalling between the activated G protein and voltage-gated calcium channels.
Mossy fibre terminals are not the only structures that express GABAb receptors in 
stratum lucidum. What other cells are found in stratum lucidum? Mossy fibre- 
associated intemeurons are present (Vida and Frotscher, 2000) and they synapse onto 
the proximal apical dendrites of CA3 pyramidal neurons. If they bear GABAb 
receptors, they could have been detected by the autoradiographic binding. Also, an 
upregulation of receptors on other cell types could lead to an underestimation of the 
loss on mossy fibre terminals. Indeed, there are intemeurons present in this area 
which express GABAB receptors, and increased expression of GABAb receptors in 
these intemeurons with seizures (Kokaia and Kokaia, 2001) could mask the loss at 
mossy fibre terminals.
My finding that GABAB receptors are downregulated acutely after status epilepticus 
are consistent with other observations that GABAb receptors are altered in seizure 
models. Changes in GABAb receptors have been in observed in both humans with 
TLE and experimental models of epilepsy. In this study however, binding to GABAb 
receptors in the CA3 pyramidal neuronal layer is reduced in human patients with 
TLE (Princivalle et al, 2002) although GABAb receptors are upregulated if the data 
were corrected for cell loss. Binding was not measured in stratum lucidum. In the 
dentate gyms, both presynaptic (Haas et al., 1996; Buhl et al, 1996) and postsynaptic
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GABAb receptor function (Wasterlain et al., 1996) is downregulated after kainic acid 
induced seizures and perforant path stimulation respectively. Also, Wu and Leung,
(1997) showed a decrease in efficacy of GABAb receptors on CA1 intemeurons. 
GABAb receptors are not always downregulated in seizure models however. Gloveli 
et al (2003) observed an increase in presynaptic GABAb receptors in layer 3 of the 
entorhinal cortex in kindled rats. Our results are surprising in that the loss of 
GABAb receptors occurs so soon after SE. However, others have shown that 
receptors can alter rapidly after SE (Kapur and Macdonald, 1997).
By what mechanisms could GABAb receptors be lost after status epilepticus? Could 
the reduction be due to loss of mossy fibre terminals? This is unlikely because 
dentate granule cells are relatively resistant to seizures. In fact, the total surface area 
and active zones of mossy fibre terminals (at mossy cell connections ) actually 
increases after seizures induced by pentylenetetrazol (Pierce and Milner, 2001). 
Alternatively a change in subunit composition could render the receptors unable to 
bind with either their endogenous ligand and/or exogenous agonist. GABAb(i) 
requires GABAb(2) to be trafficked to the cell membrane (White et al, 1998; 
Margeta-Mitrovic et al, 2000) so for instance if GABAb(2> failed to be expressed, 
functional receptors would not reach the membrane surface. Also, internalization of 
existing receptors following status epilepticus could explain the loss in function and 
binding density.
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Chapter 8: The role of GABAb receptor agonism in the 
treatment of status epilepticus
8.1 Introduction
Status epilepticus is a life-threatening neurological emergency. Thus, the initial aim 
of treatment is to stop seizures as quickly as possible. This is achieved by the 
administration of one or more antiepileptic drugs. There are several basic 
mechanisms thought to be involved in the action of antiepileptic drugs (Soderpalm, 
2002; Kwan et al, 2001). First, they may induce a functional block of voltage-gated 
sodium channels (Remy et al, 2003) (phenytoin, carbamazepine, lamotrigine, 
valproate, topiramate), second, they can directly or indirectly enhance inhibitory 
GABAergic transmission (Sills and Brodie, 2001) (benzodiazepines, barbiturates, 
tiagabine), third, they can inhibit excitatory glutamatergic neurotransmission 
(Waugh and Goa, 2003) (topiramate) and fourth they can modulate calcium ion 
channels (Huguenard, 1999) (ethosuximide, topiramate). Several different 
antiepileptic drugs have been shown to be useful in the treatment of status 
epilepticus. In humans, the traditional approach has been to treat initially with 
benzodiazepines, followed by phenytoin and barbiturates if necessary, although it 
has been suggested that the treatment plan should be tailored to the specific patient 
rather than strictly following this protocol (Lowenstein, 2003).
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The antiepileptic drugs that facilitate GABAergic inhibition have several different 
mechanisms of action. For example, diazepam potentiates GABAa receptor 
responses via two pharmacologically separate mechanisms which are dependent on 
the concentration of diazepam used (Walters et al, 2000). The mechanism at the 
lower concentration depends on the presence of the y2 subunit of the GABAa 
receptor whereas at higher concentrations the potentiation is independent of the y2 
subunit. The barbiturate pentobarbitone potentiates GABA-evoked responses at low 
micromolar concentrations and opens GABAa receptors directly at high micromolar 
concentrations (Serafini et al, 2000). Other antiepileptic drugs such as vigabatrin, 
valproate and gabapentin are believed to enhance GABAergic transmission 
indirectly via enzyme inhibition, causing a reduced GABA metabolism and/or 
promoting GABA release through unknown mechanisms (Soderpalm, 2002).
There is some evidence that the GABAb receptor agonist baclofen has anti-epileptic 
properties although this is not a consistent finding in all epilepsy models. It reduces 
epileptiform bursting in several in vitro models of epilepsy (Ault et al, 1986), 
inhibits kainic acid induced epileptiform activity in vivo (Sokal and Large, 2001) 
and prevents development of seizures in the lithium-pilocarpine model (George and 
Kulkami, 1996). Furthermore, GABAb receptor antagonists produce seizures in 
normal animals (Vergnes et al, 1997). GABAb(i> null mice are viable and have 
generalized seizures (Schuler et al, 2001). By what mechanisms could baclofen be 
antiepileptic? GABAb receptors are present on presynaptic terminals of both 
GABAergic and glutamatergic cells. Therefore they can decrease inhibition and 
excitation depending on the site of action. Post-synaptic GABAb receptors
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hypeipolarize the cell due to potassium efflux and hence reduce neuronal 
excitability. Presynaptic GABAb receptors, on the other hand, reduce either 
excitatory or inhibitory transmitter release by inhibiting voltage-gated calcium 
channels. In addition, GABAb receptors are altered in epileptic states as shown by 
this study and others. The effect of baclofen on seizures is thus difficult to predict 
and its mode of action as an antiepileptic drug is unclear. If baclofen has 
antiepileptic properties in several seizure models, does loss of GABAb receptors in 
my models lead to a resistance to the antiepileptic effects of baclofen? I thus asked if 
baclofen was antiepileptic in the perforant path and pilocarpine models of status 
epilepticus.
Is GABAb receptor agonism involved in the mechanisms of action of other 
antiepileptic drugs? Tiagabine is a relatively new antiepileptic drug which was 
developed from the GABA uptake inhibitor nipecotic acid (Andersen et al, 1993). It 
is a potent and selective inhibitor of the GABA transporter GAT-1 (Borden et al, 
1994). The exact mechanisms by which GABA uptake inhibition leads to cessation 
of seizures are not understood. Tiagabine may enhance inhibition by increasing 
synaptic GABAa receptor mediated currents and/or tonic inhibition. The time course 
of the GABA transient in the synaptic cleft may be partly determined by GABA 
uptake; therefore tiagabine is able to prolong the synaptic GABA transient (Draguhn 
and Heinemann, 1996), although this effect is age-dependent. Increasing ambient 
GABA may also have some pro-epileptic effects due to desensitization of GABAa 
receptors (Overstreet and Westbrook, 2001) however it will also lead to enhanced
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GABAa receptor mediated tonic currents (Semyanov et al, 2003) which is likely to 
have complex effects on network excitability. The increased ambient GABA that is 
produced by blocking uptake leads to increased spill-over (Rossi and Hamann, 1998) 
from the synaptic cleft onto extrasynaptic receptors. This will also increase GABAb 
receptor activation which may lead to oscillatory activity (Scanziani, 2000). Also, 
activation of post-synaptic GABAb receptors in the thalamus has been proposed to 
underlie absence seizures (von Krosigk et al, 1993). Although the antiepileptic 
effects of tiagabine are usually attributed to GABAa receptor activation, GABAb 
receptors could certainly be activated by the increased ambient GABA. Indeed, 
tiagabine’s antinociceptive properties have been proposed to be due to GABAb 
receptor activation via increased GABA levels in the medial thalamus (Ipponi et al, 
1999). I therefore tested the following hypothesis: the antiepileptic action of 
tiagabine in the perforant path stimulation model of status epilepticus is due to 
GABAb receptor activation. I did this by treating animals in SE with GABAb 
receptor antagonists before administration of tiagabine.
8.2 Methods
Status epilepticus was induced in adult rats by stimulation of the perforant path, as 
described in Chapter 2: General Methods. Stimulation of the perforant path was 
stopped after two hours. The behavioural status of the animals and the electrographic 
recording was monitored for ten minutes following the termination of stimulation, to 
ensure that the seizures were self-sustaining. Typically, electrographic discharges 
were observed which were characterized by the presence of spikes occurring at
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least 1 Hz in frequency. The seizure severity, and frequency and amplitude of spikes 
was noted 10 minutes after cessation of stimulation (this is time = 0 on all figures in 
this chapter), and then 0.9 % saline or baclofen was administered by intraperitoneal 
injection. The frequency and amplitude of epileptiform spikes and seizure severity 
(using the Racine scale) were recorded every 10 minutes for three hours following 
administration of the drag. The EEG was stored on computer as described in Chapter 
2: General Methods. Sedation was measured using the following scale:
0 Spontaneous movement
1 Intermittent spontaneous movement
2 No spontaneous movement
3 No response to auditory stimuli
4 Loss of corneal reflex
5 Loss of tail pinch
Table 8.1
Scale used to measure level o f sedation during treatment.
8.3 Results
Twelve animals underwent perforant path stimulation. Six were used as controls and 
were given saline only following status epilepticus. One animal failed to go into self- 
sustaining status epilepticus after perforant path stimulation. Possible reasons for 
this could have been: incorrect positioning of the stimulating electrode during
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stereotaxic placement, movement of the electrode after implantation or high seizure 
threshold in that particular animal. I administered baclofen to this animal ten 
minutes after the end of stimulation anyway, in order to see how sedative the drug 
was at the chosen dose (5 mg/kg) but did not include it in the final data set (Table 
8.2). I chose the dose of 5 mg/kg because it had been used by others at similar dose 
ranges (Margineanu and Klitgaard, 2003) and this dose was shown to have 
physiological effects on dentate gyrus inhibition in vivo.
Time
(mins)
Drugs given, level of sedation observed
0 Baclofen 5 mg/kg i/p
3 Reduced explorative behaviour
10 Reduced auditory reflex
15 No explorative behaviour, present righting reflex
30 Absent righting reaction, deeply sedated
120 Absent righting reaction, deeply sedated
180 Recovery of righting reaction, less sedation
Table 8.2
Evolution o f sedation after baclofen administration in one animal that failed to go 
into status epilepticus after stimulation o f the perforant path. Sedation was 
measured semiquantitatively in later experiments using the scale in Table 8.1.
Three minutes after drug administration the animal showed signs of mild sedation
but was responsive to auditory stimuli. The gait in the pelvic limbs became wide-
based. The auditory reflex was reduced 10 minutes after administration. At 15
minutes, the animal stopped exploring its environment and stood still in the cage
although the righting reaction remained intact. (This is tested by placing the animal
in lateral recumbency to see if it is able to right itself. The ability of the animal to do
this depends on the visual and vestibular systems and proprioceptive function). The
auditory reflex was still reduced. At 30 minutes, the righting reaction was abolished,
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but muscle tone was normal. The animal had reduced postural reactions in all four 
limbs. At the end of the three hours of recording, the animal appeared less sedated 
and began to explore the cage again. It recovered uneventfully over night. I therefore 
used the same dose of baclofen for the next experiment.
Status epilepticus was successfully induced in the remaining five out of twelve 
animals. The pattern of seizures that was observed when the perforant path was 
stimulated was as follows: initially the animal had “wet dog shakes” which are 
partial seizures characterized by vigorous shaking movements. This then progressed 
to freezing and blank staring, rearing (Racine stage 5), falling (Racine stage 6) and 
occasionally “running” seizures. This is a similar pattern of seizures to that which 
has been observed previously when using this model in our laboratory. Baclofen was 
administered to one of the five animals at 5 mg/kg intraperitoneally during self- 
sustaining status epilepticus ten minutes after the end of stimulation. This had no 
significant effect on seizure activity, spike amplitude or frequency. Seizure severity 
remained at Racine scale 3 throughout the 3 hours of treatment.
Since 5 mg/kg had did no effect on the seizures in this animal, a dose of 10 mg/kg 
was administered to the remaining 4 stimulated animals. In 2/4 animals, clinically 
detectable seizures stopped completely two hours after treatment. By the end of the 
three hour recording period, one more animal had stopped seizing and the other was 
having stage 1 seizures only. When the data was averaged for all four animals, 
seizure severity was significantly reduced 2 hours after administration of baclofen
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when compared to the six animals that had been administered saline vehicle only 
(mean seizure severity, before drug administration = 3.0 ± 0.3; 120 mins after 
baclofen, seizure severity = 1.0 ± 0.6, n = 4, p = 0.03 paired t test, Fig. 8.1, 8.3).
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Figure 8.1: Seizure severity was significantly reduced two hours after treatment 
when compared to seizure severity before treatment. There was no significant 
reduction two hours after administration o f saline.
Saline vehicle had no significant effect on seizure severity (p = 0.12 for comparison 
of seizure severity at 0 and 120 mins after saline, paired t test, Fig. 8.1)
Time (mins)
Figure 8.2: The mean level o f sedation during baclofen treatment (10 mg/kg, n = 4), 
using the scale shown in Table 8.1.
Interestingly, the response to baclofen was extremely variable in the four animals 
with respect to seizure severity (Fig. 8.3). However this type of analysis is
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potentially flawed because the Racine seizure scale relies on clinical observation and 
contains a great deal of subjectivity. Seizure types are given arbitrary numbers 
which correlate to the temporal evolution of seizures after kindling (Racine, 1972 ). 
One baclofen-treated animal died at the end of the recording period of unknown 
cause. There were no gross abnormalities seen on postmortem examination.
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Figure 8.3: Seizure severity as measured by the Racine scale was significantly 
reduced two hours after administration o f baclofen at 10 mg/kg but was variable in 
different individuals (n = 4). In 2/4 animals seizures stopped less than 50 minutes 
after administration o f drug. (This data is summarized in Fig. 8.1 and Fig. 8.5).
The EEG was also monitored throughout the three hour period. Baclofen (10 mg/kg) 
reduced spike amplitude and frequency (Fig. 8.4, 8.5). The spike frequency was 
significantly reduced 60 minutes after drug administration (0 mins: 1.6 ±0.17 Hz,
60 mins: 0.58 ± 0.3 Hz; p = 0.04 paired t test). The spike amplitude however was not 
significantly reduced at 60 minutes after drug administration (p = 0. 56 paired t test), 
but became significant at 2 hours after drug (0 mins: 7.3 ± 1.6 mV, 120 mins: 1.8 ±
1.2 mV; p = 0.04). Saline vehicle did not significantly change spike amplitude when 
measured at 2 hours after administration (0 mins: 8.3 ± 1.5 mV, 120 mins: 7.5 ± 0.6 
mV, n = 6, p = 0.68, paired t test comparing values at 0 and 120 mins).
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Figure 8.4: EEG traces recorded in the dentate gyrus, taken from one experiment. The 
top trace shows the typical spontaneous spikes that appear after stimulation is 
stopped, recorded just prior to drug adminstration. The bottom trace is taken two 
hours after administration o f baclofen (10 mg/kg). Scale bar: horizontal line = 2 s, 
vertical line = 10 mV.
In the two animals that still had spikes at the end of the recording period, the 
amplitude and frequency were reduced in the middle of the experiment and then 
increased again, suggesting that baclofen had a transient inhibitory effect on seizure 
severity. This can be seen as a reduction in the activity and then an increase, in the 
graphs on the left shown in Fig. 8.5.
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Figure 8.5: Baclofen significantly reduced spike amplitude and frequency when 
compared to saline vehicle. The top panels show spike frequency plotted against 
time in baclofen (n = 4) (10 mg/kg) and saline (n = 6). The bottom panel shows 
spike amplitude against time in baclofen and saline (in the same animals as top 
panel).
I then asked if baclofen also had antiepileptic effects in the pilocarpine model of 
status epilepticus. I induced status epilepticus with pilocarpine in 4 animals as 
described previously. These animals had had a recording electrode implanted in the 
dentate gyrus (using the same stereotaxic methods used for the perforant path 
model). After 90 minutes of status epilepticus I administered baclofen (10 mg/kg
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i/p). Three out of 4 animals became deeply unconscious and showed increased 
respiratory effort and so I euthanased them on humane grounds before the end of the 
experiments. In the 4th animal, behavioural seizures stopped completely, 10 minutes 
after the administration of baclofen. This animal recovered well. No further 
experiments were done using pilocarpine and baclofen because of the high level of 
mortality.
I next asked if the antiepileptic efficacy of tiagabine in status epilepticus could be 
explained by its effect on GABAb receptors. Tiagabine has been previously shown 
to be antiepileptic in our perforant path model of status epilepticus, in all animals 
tested ( X Wang, Institute of Neurology, unpublished data).
I induced status epilepticus in 3 rats by stimulation of the perforant path. Ten 
minutes after the cessation of stimulation, I administered the GABAb receptor 
antagonist SCH50911 (10 mg/kg n = 2,40 mg/kg n = 1) and then 10 minutes later 
treated them with tiagabine (40 mg/kg). I did not observe any change in behaviour or 
seizure activity after administration of SCH50911. Within approximately 30 minutes 
of administration of tiagabine, seizure activity was reduced in all animals (Fig. 8.6). 
In both animals, the spike amplitude reduced after 20 minutes and had ceased 
completely after 40 minutes. This is similar to previous data from our laboratory 
using tiagabine as an antiepileptic drug without pre-treatment with SCH50911.
It can therefore be concluded that SCH50911, either at 10 mg/kg or 40 mg/kg, does 
not prevent the antiepileptic effect of tiagabine.
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Figure 8.6: Seizure severity, spike frequency and amplitude and sedation were 
measured during treatment o f animals in status epilepticus with tiagabine that had 
been pre-treated with SCH 50911. Pretreating with the GABAb receptor antagonist 
SCH50911 (10 and 40 mg/kg) did not affect the efficacy o f the antiepileptic drug 
tiagabine (40 mg/kg). Tiagabine had a clear effect on seizure activity which started 
approximately 20 minutes after administration.
8.4 Discussion
Baclofen had a weak anti-epileptic effect in the perforant path model of status 
epilepticus although it took a minimum of one hour to reduce significantly seizure 
activity. Its effect was variable in different individuals and in two animals there were 
was only a transient reduction in seizure severity and spike amplitude and frequency. 
When the data were averaged, there was no significant effect on seizure severity for 
at least two hours. The antiepileptic effect is consistent with the work of others in the 
kainic acid (Ault et al, 1986) and lithium-pilocarpine models (George and Kulkami, 
1996).
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One perforant path-stimulated animal died of unknown cause three hours after 
administration of baclofen. Occasionally perforant path stimulated animals die 
unexpectedly; usually if the seizures are very severe. Likely causes of death in status 
epilepticus are: abnormalities within the brain such as cerebral oedema or ischaemia, 
or conditions in other body systems such as aspiration of gastric contents, 
cardiorespiratory arrest, pulmonary oedema or metabolic acidosis.
In the pilocarpine model, there was a 75 % mortality rate after the administration of 
baclofen and so no further experiments using this protocol were done. Pilocarpine- 
induced seizures tend to be more severe than those induced by perforant path 
stimulation. The animals are often weak for several hours afterwards. Systemic 
effects such as dehydration, acid-base disturbances and pulmonary oedema may 
have been possible causes of death in these animals. Could baclofen itself have 
contributed to mortality in these experiments? Baclofen is used in humans with 
conditions such as multiple sclerosis, spinal cord disease, cerebrovascular accidents 
or neoplastic or degenerative brain disease, to control spasticity. It is reported to be 
toxic in patients with renal failure because it is primarily excreted through the 
kidneys (Chen et al, 1997). Baclofen overdose has been reported (Chappie et al, 
2001). This is characterised by severe respiratory depression, coma and brainstem 
dysfunction. In humans these symptoms may be further aggravated by other agents 
that act on the CNS. It is therefore possible that baclofen contributed to the high 
mortality in these animals. Since baclofen takes 1-2 hours to have an effect on status 
epilepticus, this prolonged seizure time could also have contributed to the animals’
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death. A direct interaction between pilocarpine and baclofen also cannot be ruled 
out.
Why was there only a transient antiepileptic effect seen in two animals? This could 
have been for several reasons. First, the pharmacokinetics of baclofen could be such 
that the drug is redistributed or metabolised more rapidly in some individuals. Also, 
GABAb receptors could become resistant to baclofen later in status, similar to 
GABAa receptor resistance to benzodiazepines late in status epilepticus (Kapur and 
MacDonald, 1997) and this may be variable within individuals. Changes in other 
receptor function may occur later which induces hyperexcitability in the brain that is 
resistant to baclofen.
GABAb receptor activation is unlikely to play a significant role in the antiepileptic 
effects of tiagabine in this model. First, the efficacy compared to the degree of 
sedation for tiagabine was very different from that observed for baclofen. Second, 
pre-treatment with the GABAb receptor antagonist SCH50911 did not affect the 
antiepileptic properties of tiagabine. This suggests that its antiepileptic effect in this 
model is mainly via GABAAreceptors. The highest dose of SCH50911 that I used 
was 40 mg/kg. It is possible that this was not high enough to block receptors 
sufficiently to have a significant effect on the action of tiagabine. However, 10 
mg/kg given subcutaneously is sufficient to reduce the physiological effects of 
baclofen in rats (Phillis et al, 2001) and doses as low as 2.9 mg/kg are sufficient to 
block the anti-tussive effects of baclofen in guinea-pigs (Bolser et al, 1995). Ideally,
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the brain concentration needs to be measured directly to ensure there is a sufficient 
concentration to antagonize the tiagabine, by using a method such as microdialysis.
From this study, I propose that GABAb receptors may be a useful target for 
antiepileptic drugs. Baclofen was antiepileptic in the perforant path model, even 
though GABAb receptors are downregulated. It should be noted however, that the 
drug was tested in animals during status epilepticus and the downregulation of 
GABAb receptors that I observed occurred 24 hours after the termination of status 
epilepticus. The GABAb receptors may still be functioning normally at the time that 
baclofen was given. Baclofen took 2 hours to have a maximal effect which is too 
long to be useful clinically in the treatment of status epilepticus. I did not try higher 
doses in this study because it was already markedly sedative at 10 mg/kg. Since the 
number of animals tested with baclofen was small, more animals need to be tested to 
make firm conclusions from these data.
Other studies have shown that baclofen can be both pro- and antiepileptic depending 
on the model used. The antiepileptic effects of baclofen may be unpredictable in 
different models for several reasons. GABAb receptors are present pre- and 
postsynaptically, and presynaptic receptors inhibit transmitter release on both 
excitatory and inhibitory cells. This means baclofen can be pro- or anti-epileptic 
depending on its site of action. The drug is given intraperitoneally and it is not 
known how much of this reaches the brain, and whether it reaches higher 
concentrations in different brain regions. It is, however, known to cross the blood-
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brain barrier (Deguchi et al, 1995). It may be more effective if it is given 
intravenously, intrathecally or directly onto the brain. As discussed in previous 
chapters, the expression and function of GABAb receptors is altered in the epileptic 
brain. This too will change the effect that baclofen has on network excitability. It is 
therefore difficult to predict the anti-epileptic effect of baclofen because of the 
complex changes in GABAb receptor expression and multiple sites of action.
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Chapter 9: General Discussion and Further Work
9.1 Summary of Findings
In this thesis I have achieved the following:
• I have established a protocol for inducing status epilepticus with pilocarpine 
that achieves a high success rate with a low mortality.
• I have characterised heterosynaptic depression in the adult rat mossy fibre -  
CA3 synapse
• I have demonstrated that heterosynaptic depression is altered after status 
epilepticus
• I have addressed the question of why heterosynaptic depression is altered 
after status epilepticus and have attempted to determine the source of GAB A 
that mediates the depression
• I have explored the role of GABAb agonism in the treatment of status 
epilepticus by a) testing the antiepileptic effects of baclofen in my models of 
status epilepticus and b) asking if the action of the antiepileptic drug 
tiagabine is partially mediated by GABAb receptors
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9.2 Limitations of this thesis
How are my findings relevant to naturally occurring epilepsy in humans? It is not 
known whether heterosynaptic depression at the mossy fibre synapse occurs in vivo, 
and if so, whether it is absent in epilepsy. If such a depression occurs between 
adjacent mossy fibre pathways in the living animal, then loss of heterosynaptic 
depression could lead to hyperexcitability of the hippocampus in the epileptic human 
or animal. However, regardless of whether such a depression occurs between mossy 
fibres in vivo, my findings clearly show a loss of GABAb receptors which is 
extremely likely to have an effect on network excitability. The GABAb receptor has 
not yet been studied specifically at the mossy fibre synapse in humans, although 
changes in GABAb receptors have been observed at certain regions in the epileptic 
hippocampus, which are discussed later.
GABAb receptors were only studied at one synapse in the hippocampus, but they 
occur both pre- and post-synaptically throughout the brain. Changes at other sites 
need to be taken into account in order to determine the effect on the network. Since 
there is plasticity of numerous other receptors, neurotransmitter systems, and axons 
in epilepsy, my data need to be interpreted in this context.
I only studied GABAb receptors up to 3 weeks after an episode of status epilepticus. 
Heterosynaptic depression was only studied 24 hours after status epilepticus. It was 
not possible to identify two separate mossy fibre pathways after this time point,
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presumably because of axonal reorganisation in the dentate gyrus (mossy fibre 
sprouting). Three weeks after status epilepticus I observed that GABAb binding 
partially recovered. However the baclofen data revealed that a significant reduction 
in efficacy of GABAb receptors remained. Taken together this suggests that an 
uncoupling of receptors from their second messengers could have occurred at this 
late time point. I did not investigate this possibility in this study.
I was unable to confirm definitively that the GABA that mediates heterosynaptic 
depression is released from intemeurons rather than mossy fibres. Other approaches 
that might have yielded a definitive answer are discussed at the end of this chapter.
One important point that has arisen from this thesis is the difficulties in investigating 
a disease in which a universal animal model does not exist. Epilepsy is not a 
homogeneous condition and it is therefore difficult to produce an ideal model. In the 
existing models, the animal suffers some sort of insult: e.g. chemical, electrical, 
genetic mutation, which leads to a propensity to have seizures. The models can then 
be justified to a greater or lesser degree by comparing such parameters as seizure 
type and brain pathology to the human diseases. If these parameters are similar, they 
are considered to be a good model. In these models, the outcome of the insult 
appears similar to the human disease but the insult is very different in the model 
compared to humans, e.g. pilocarpine or kainic acid administration. In fact, in 
human epilepsies such as temporal lobe epilepsy, the aetiology is not fully 
understood anyway. To what extent then, are we justified in calling them appropriate
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models? One way of testing them out, is to see how seizure models behave when 
they are treated with antiepileptic drugs. Several of these models are useful for the 
preclinical tests of antiepileptic drugs. However, interestingly and not surprisingly, 
different models respond differently to antiepileptic drugs. A comparison of chronic 
epilepsy models, such as the post-status epilepticus spontaneous seizure models, 
with the acute models such as maximal electroshock, demonstrates that drug testing 
in chronic models of epilepsy yield data which are more predictive of clinical 
efficacy and adverse effects. In fact, if chronic models such as fully kindled rats and 
spontaneous recurrent seizures in post-status models are compared to each other, the 
pharmacological properties of the seizures, i.e. the way they respond to antiepileptic 
drugs, is remarkably similar. The acute models on the other hand have a number of 
problems. The maximal electroshock test preselects drugs with certain mechanisms 
of action but misses others (Meldrum, 1997). This is because electroconvulsive 
seizures are particularly sensitive to drugs that block sodium channels. Differences 
in models are also problematic for the study of the effect of drugs on the 
epileptogenic process. This arises presumably because since each model is produced 
by a different insult on the brain, the epileptogenic process could occur via different 
mechanisms. The in vitro models of seizures are also used widely. Can they be 
considered to be useful models for human diseases? They usually consist of slices of 
hippocampus or hippocampus plus entorhinal cortex and they are perfused with 
artificial CSF either containing a convulsant such as pilocarpine or 4-aminopyridine, 
or solution containing zero Mg++ in order to produce epileptiform activity. The 
epileptiform activity can then be monitored by recording field potentials in different
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parts of the slice simultaneously or by measuring the intrinsic optical signal (Avoli 
et al, 2002). The latter are produced by changes in light scattering and absorption 
that reflect swelling of neurons and glia leading to alterations in the extracellular 
space volume. The spread of epileptic discharge can be monitored across the slice, 
presumably because as cells depolarise they become swollen. Certainly in vitro 
models of seizures are useful to ask questions in epilepsy research but epileptiform 
activity in a slice is not necessarily analogous to an epileptic seizure in the whole 
animal. Epilepsy is a network phenomenon. We study it in slice preparations, 
computer simulations and in single channels expressed in cell systems such as 
Xenopus oocytes. The study of a thin slice of brain, receptors expressed in single 
cells or simple mathematical models of neural networks is not sufficient to 
understand fully how and why a seizure arises and propagates through a whole brain. 
It is important to be aware of this and to work towards combining all of these 
approaches with work done in vivo.
How do we get around these problems? I tried to avoid it by using two very different 
models of status epilepticus. Finding the same change in the two models makes the 
result more likely to be relevant to naturally occurring epilepsy. How else could we 
ensure that we are using appropriate models? More work, particularly 
electrophysiological studies, needs to be done using tissue from human epileptic 
patients. It is now possible to make recordings from fresh human tissue. For 
example, Cohen et al (2002) recorded synchronous rhythmic activity in tissue 
resected from temporal lobe epilepsy patients that was very similar to interictal
162
activity recorded in vivo. It is also now possible to express channels originating from 
fresh human tissue in simple systems such as Xenopus oocytes. This has been 
achieved both by injecting human mRNA (Palma et al., 2002) and neuronal 
membrane (Palma et al, 2002; Miledi et al, 2002) into oocytes. This has resulted in 
comparisons of channels from epileptic tissue with that from control human tissue. 
However, in human studies control tissue is difficult to obtain. Palma et al (2002) 
used tissue from non-epileptic patients who had temporal lobe glioma. Clearly it is 
not ideal to use tissue from patients with other neurological disease because there 
could be expression of abnormal channels in the diseased tissue. Finally, the ideal 
way in which to study synaptic function in epilepsy, is to make cellular recordings in 
vivo. Patch clamping now has been achieved in vivo (Khazipov and Holmes, 2003; 
Leinekugel et al, 2002).
9.3 Possible mechanisms to explain my findings
Why is there an apparent species difference in heterosynaptic depression?
In chapter 3 ,1 demonstrated that heterosynaptic depression is mediated solely by 
GABAb receptors in adult rats. This differs from the situation in the guinea-pig in 
which there is a group I/II metabotropic glutamate receptor mediated component 
(Vogt and Nicoll, 1999; Min et al, 1998). Why should this be the case? It could 
either be due to different receptor subtypes or amount of receptors on mossy fibre 
terminals, or less glutamate spillover in rats compared to guinea-pigs. Is there 
evidence for any of these possibilities? There appear to be subtle pharmacological 
differences in metabotropic glutamate receptors at guinea pig and rat mossy fibre
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synapses (Henze et al, 2000). Lanthom et al (1984) observed that the specific group 
III metabotropic glutamate receptor agonist L-AP4 inhibits transmission at the 
guinea-pig but not rat mossy fibre synapse although rat mossy fibre synapses are 
sensitive to the group II/III metabotropic glutamate receptor agonist DCG-IV 
(Kamiya et al, 1996). This suggests that the rat expresses group II receptors but does 
not express group III receptors at the mossy fibre synapse. It could also be a 
difference in receptor expression in juvenile and adult animals, since Vogt and 
Nicoll (1999) and Min et al (1998) used 5-15 day old guinea pigs in their 
experiments. Could the findings of Vogt and Nicoll (1999) and Min et al (1998) be 
attributed to group I receptors and if so, could they be absent on rat mossy fibres? 
This is very unlikely because group I metabotropic glutamate receptors are usually 
considered to be excitatory and have not reported to induce presynaptic inhibition at 
the mossy fibre synapse. Group I metabotropic glutamate receptors are expressed 
post-synaptically at the mossy fibre -  CA3 synapse (Yeckel et al, 1999). Could it 
then be due to a species difference in spillover? This is certainly possible. 
Extracellular glutamate concentration is determined by three processes. Differences 
in: amount of vesicular release into the synaptic cleft, diffusion from the 
extracellular pool, the size and tortuosity of the extracellular space and glutamate 
uptake mechanisms could all contribute to species variation in the degree of 
spillover.
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How can complex changes in receptor expression be explained?
Another interesting question is: if in vivo, GABAb receptors are both up and 
downregulated at different synapses, as well as changes in other types of receptors, 
how does this complex set of changes arise? For example, does altered GABAb 
receptor expression in the dentate gyrus affect the transcription and translation of 
GABAb receptor genes in CA1, and if so, by what mechanisms is it controlled? If 
excitability is increased at one synapse, does a gating phenomenon come into play at 
another synapse? How could such communication occur? Communication through 
axonal transport and neurotransmitter or peptide signalling molecules would be 
possible mechanisms. These kinds of phenomena could arise as physiological 
mechanisms that stop seizure activity (and then fail when seizures develop into 
status epilepticus). Certainly there is evidence of markedly altered gene expression 
during epileptogenesis in epilepsy models. Hendriksen et al (2001) used serial 
analysis of gene expression (SAGE) to study changes in gene expression after 
perforant path stimulation. They found 92 genes which were differentially expressed 
compared to controls.
9.4 Implications of my work
GABAb receptors are altered in temporal lobe epilepsy
My work demonstrates a loss in functional GABAb receptors following status 
epilepticus induced by two different stimuli. How does this finding add to what is 
already known about changes in GABAb receptors in epilepsy? GABAb receptors 
are already known to be involved in the pathogenesis of absence epilepsy, as
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discussed previously. There is now burgeoning evidence that alterations in GABAb 
receptors play a role in temporal lobe epilepsy. Table 9.1 below summarises the 
findings of the studies that have reported changes in GABAb receptors in temporal 
lobe epilepsy and models of the disease. GABAb receptors are either up- or down- 
regulated depending on the model and site studied. However a downregulation is 
more commonly observed than an upregulation. Two studies in humans with TLE 
report a downregulation of receptors. Is it possible then that the models in which an 
upregulation is observed are not particularly good models of the human disease? In 
contrast, Furtinger et al (2003b) report an increase in GABAb receptor mRNA in the 
dentate granule cells of patients with TLE. They also observed a marked increase of 
mRNA in the dentate hilus in TLE patients with non-sclerotic pathology. The same 
group reported a downregulation of GABAb receptor mRNA in granule cells and 
CA3 5-12 hours after kainate induced seizures in rats which recovered to control 
levels in CA3 and was upregulated in dentate granule cells at later time points 
(Furtinger et al, 2003a). It appears then, to complicate matters further, that changes 
in receptor expression vary throughout the course of the disease.
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Table 9.1 : Sum m ary  of changes reported  in GABA b recep tors in TL E  and
experimental models
Author, date Site, cell type, 
pre- or post- 
synaptic
Experimental
model/
human
disease
Up- or down­
regulation of 
receptors
Proposed 
effect on 
excitability
Haas et al, 
1996
DG,
intemeurons,
presynaptic
Kainic acid Down-regulation Increased
inhibition
Buhl et al, 
1996
DG,
intemeurons,
Presynaptic
Perforant path Down-regulation Increased
inhibition
Wasterlain et 
al, 1996
DG, dentate 
granule cells, 
postsynaptic
Perforant path Down-regulation Decreased 
inhibition 
onto DG 
cells
Wu and 
Leung, 1997
CA1,
intemeurons,
presynaptic
Partial
hippocampal
kindling
Down-regulation Increased
inhibition
Kokaia and 
Kokaia, 2001
DG, CA1-CA3 Rapid
kindling
Mixed. Early up­
regulation
? decreased 
inhibition
Princivalle et 
al, 2002
DG, hilus, CA3 Humans TLE Down-regulation Decreased
inhibition
Munoz et al, 
2002
DG Humans TLE Down-regulation Decreased
inhibition
Gloveli et al, 
2003
ER cortex layer
HI,
intemeurons,
presynaptic
Amygdala
Kindling
Up-regulation Enhanced 
activation 
of EC-CA1
Chandler et al, 
2003
Mossy fibre
terminals,
presynaptic
Pilocarpine 
and perforant 
path
Do wn-regul ation Increased 
excitation 
into CA3
Straessle et al, 
2003
CA1, CA3, DG Mouse 
intracerebral 
kainic acid
Early down- 
regulation, 
recovery later
Decreased
inhibition
Furtinger et al, 
2003
CA1, CA3, 
DG
Humans TLE Mixed. Up­
regulation 
mRNA, down­
regulation 
receptor binding
Increased
inhibition
Furtinger et al, 
2003
CA3, DG Kainic acid Early down­
regulation, 
recovery later
Decreased
inhibition
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What is the global effect of these changes In GABAb receptors on excitability?
GABAb receptors are present both pre and post synaptically. Presynaptic receptors 
inhibit transmitter release at both inhibitory and excitatory neurons (Lei and 
McBain, 2003) and post-synaptic receptors cause hyperpolarisation by opening 
potassium channels (Gage, 1992). This means that they can decrease inhibition or 
increase excitation depending on their location. I have summarised the proposed 
effects on excitation in Table 9.1. The role of GABAb receptors in limbic network 
excitability has also been studied in in vitro models of epileptiform activity. Avoli et 
al (2004) recently reported that baclofen inhibits interictal activity in 4- 
aminopyridine treated entorhinal cortex-hippocampal slices. Baclofen inhibited ictal 
activity originating in entorhinal cortex and initiated ictal activity in CA3. The ictal 
activity in the absence of baclofen was NMDA receptor dependent and was NMDA 
independent in the presence of baclofen. Hence, in this slice model of epileptiform 
activity, modulating GABAb receptors altered the site of initiation of ictal events 
and changed the receptors that were involved. The net effect of changes in GABAb 
receptors on the hippocampal network is still unclear. It is extremely difficult to 
predict the net effect of GABAb receptor plasticity on seizure propagation through 
the hippocampus. However, more studies show reduced GABAb receptors which 
tend to be associated with increased excitability.
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From this complex situation, several questions arise. First, how could we determine 
the role of GABAb receptor changes at each site in the hippocampus? There are 
several ways that we could address this question. If we could selectively alter the 
expression of receptors at specific synapses, we could then observe the net effect on 
excitability. This might be possible using transgenic technology such as the cre/lox 
system. Cre is a gene that encodes for a “site-specific recombinase”. The cre protein 
can recombine DNA when it locates specific sites in a DNA molecule. These 
specific sites are known as loxP. Transgenic mice containing a gene surrounded by 
loxP sites are mated with transgenic mice that have the cre gene expressed only in 
one cell type. The resulting mice will have both the cre gene and the /axP-flanked 
gene. In tissues with no cre gene the target gene with be present and function 
normally. In a cell where cre is expressed, the target gene of interest will be deleted. 
Therefore, if the cre gene is bound to a promoter that only allows cre production in 
neuronal cells, the target gene will only be deleted in those cells.
This technology can already be used to knock out genes from specific parts of the 
brain such as the hippocampus. If cre could be expressed in specific neuron types in 
the hippocampus, it would be possible to prevent the expression of GABAb 
receptors at specific synapses and determine the effect on excitability. However, this 
relies on identifying a gene that is only expressed in the neuron type in question (i.e. 
dentate granule cells). A line of cre-transgenics has already been produced in which 
the cre-mediated gene deletion is restricted to granule cells of the cerebellum and 
dentate gyrus of the hippocampus (Guo et al, 2000).
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An alternative approach would be development of a mathematical model of the 
hippocampal circuitry. It would then be possible to incorporate changes in GABAb 
receptor function at specific synapses. If we were able to determine which receptor 
alterations were the most important, theoretically we could then target antiepileptic 
drugs at specific synaptic sites; either by using local application of drug, or by using 
pharmacological differences in receptors at different sites to target a drug to a 
specific synapse.
The relevance of my findings to temporal lobe epilepsy in humans
Are my findings relevant to human disease? What is the evidence that GABAb 
receptor plasticity has any role in human epilepsies? Altered expression of GABAb 
receptors has been observed in tissue from human patients (Princivalle et al, 2002; 
Munoz et al, 2002; Billinton et al, 2001). Also, a polymorphism in the GABAb(i> 
gene has recently been associated with an increased susceptibility to temporal lobe 
epilepsy and it may be associated with a more severe phenotype of the disease 
(Gambardella, 2003). As discussed in detail in the introduction, GABAb receptor 
activation also plays a very important role in setting the oscillatory rhythm 3 Hz 
spike-wave absence seizures. Taken together, there is certainly burgeoning evidence 
that GABAb receptors play an important role in human epilepsy. Could GABAb 
receptors be a useful target for antiepileptic drugs? GABAb receptor agonists have 
both pro- and anti-convulsant properties in experimental models, as discussed in the 
introduction. Also, Kofler et al (1994) reported three human patients that had 
seizures following intrathecal baclofen administration. However, these patients had
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previously suffered brain trauma which could have lowered their seizure threshold. 
From my work and those of others then, GABAb agonism has a complex 
inconsistent effect on the excitability of the network. Some factors that might lead to 
this inconsistency are the nature of the network itself (brain slice compared to whole 
brain) and the nature of any seizure activity (i.e. the model used). The effect may 
vary in different individual humans or animals, due to differences in genetic 
background.
Heterosynaptic depression and memory
Heterosynaptic depression is an important mechanism for gating input into the 
hippocampus proper and is therefore in a position to prevent seizure propagation. 
Vogt and Nicoll (1999) also suggest that it is important because it makes the input 
into CA3 more sparse. CA3 is a highly interconnected autoassociative network. It is 
proposed that such networks store patterns of inputs and retrieve them -  if presented 
with a part of a learned pattern, the full pattern is returned. Sparse coding will 
increase the storage capacity of the autoassociative network. The loss of depression 
also has implications for memory function. Heterosynaptic depression makes coding 
into CA3 more sparse and if it is not present, then associative memory in the CA3 
network could be affected. Cognitive deficits, including amnesia (“transient epileptic 
amnesia”), are associated with temporal lobe epilepsy. It is not clear whether these 
episodes are seizures or post-ictal abnormalities. The characteristics of this memory 
impairment are variable. Zeman et al (1998) reported that all patients in their study 
had retrograde amnesia, including loss of recall of salient episodes from their
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personal lives. Some also had topographical amnesia, with failure to recognise 
familiar landmarks and to recall familiar routes. The loss of heterosynaptic 
depression could be one reason why memory recall can be abnormal.
The evolution of the theories about epilepsy: current ideas
Epilepsy is often referred to as being an imbalance between excitation and inhibition 
(Dalby and Mody, 2001). This theory has emerged because if inhibition is decreased 
by blocking GABAa receptors for example, seizures occur (Fisher et al, 1989), drugs 
that potentiate GABAa receptors are antiepileptic (Soderpalm, 2002) and increased 
excitation can be observed in the epileptic brain. However, this hypothesis does not 
always hold true. It is now known that rhythmic inhibitory intemeuronal activity is 
involved in oscillatory phenomena in the hippocampus (see Chapter 1: General 
Introduction). Does this mean that increased inhibition can also be involved in 
epilepsy? Another common idea is that epilepsy arises when synchronization of 
neuronal firing increases. However recent work proposes that synchronization 
decreases just before a seizure occurs (Mormann et al, 2003). In very recent years, 
several mutations in ion channels have been associated with idiopathic generalised 
epilepsies in humans. These include mutations in the genes that encode for subunits 
of the GABAa receptor (Wallace et al, 2001a; Baulac et al, 2001), sodium channels 
(Wallace et al, 2001b; Wallace et al, 1998), potassium channels (Singh et al, 2003) 
and nicotinic acetylcholine receptors (Steinlein et al, 1995). The functional 
abnormality that ensues from the expression of these abnormal channels is a fault in 
excitability, thus leading us back to the imbalance between excitation and inhibition.
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These types of observations seem to shed light onto how the normal brain may 
become epileptic. However, it is not quite as simple as that. People who express 
these abnormal channels do not necessarily have seizures as part of their phenotype. 
For example, episodic ataxia type I, which is caused by a mutation encoding the 
gene for the potassium channel K vl.l, is characterised by gait abnormalities either 
with or without seizures. Why do people expressing this abnormal channel not 
always have seizures? There are several possible explanations for this variable 
phenotype. First, perhaps other inhibitory phenomena are able to come into play to 
prevent seizures in some individuals. Second, does the genetic background of the 
individual alter seizure threshold? Taken together, what does this tell us about 
epilepsy? The excitability of the brain can be altered by several different insults and 
phenomena. It is associated with changes in circuitry e.g. mossy fibre sprouting, 
changes in channel function e.g. sodium channels with altered kinetics and changes 
in receptor expression e.g. downregulation of GABAb receptors on mossy fibres. 
These types of alterations can “tip the balance” and induce seizures. However, the 
brain has mechanisms to stop seizures, which is why most seizures only last a 
maximum of a couple of minutes, and status epilepticus rarely develops. Even the 
presence of a mutated ion channel can apparently be compensated by other unknown 
phenomenona.
9.4 Further work
I would like to determine whether the GAB A that mediates heterosynaptic 
depression is definitely released from intemeurons and not mossy fibres. I could do
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this using a whole cell recording approach. A slice could be perfused with solution 
containing AMPA/kainate receptor antagonists. Since intemeurons express AMPA 
and kainate receptors which depolarise the cell if activated (Toth and McBain, 1998; 
Freund and Buzsaki, 1996), this will prevent intemeuron recruitment. NMDA 
receptor mediated EPSCs can then be recorded in CA3, while the two pathway 
protocol is performed. If depression still occurs, then the GABA must be being 
released from the mossy fibres since intemeurons will not be recmited.
In order to be sure that tiagabine does not mediate its effect by GABAb receptors I 
need to perform more experiments that ensure that the GABAb receptor antagonist 
reaches the GABAb receptors in sufficient concentration to block them. In the 
experiments in Chapter 8, the concentration of the drug that reaches the brain is not 
known. I could confirm that GABAb receptors are not activated by tiagabine in the 
following ways: I could induce seizures in an anaesthetized animal while monitoring 
the EEG. I could then apply the antagonist directly onto the brain. Tiagabine could 
then be administered to determine if it is still antiepileptic. Alternatively I could use 
an in vitro model of epileptogenesis in a brain slice, and apply tiagabine with and 
without the GABAb antagonist. In this kind of model it is easier to get high 
concentrations of drug to the tissue, without concerns about pharmacokinetics, 
blood-brain barrier and so on.
I discussed in chapter 7 the possible reasons for the discrepancy between an 18% 
reduction in binding and total loss of depression. One possible problem was that
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some of the binding detected in stratum lucidum will not be on mossy fibres. In 
order to measure definitively GABAb receptors on mossy fibre terminals, I could use 
immunogold labelling of GABAb receptors and identify the terminals by using the 
modified Timm’s stain. Immunogold labelling has already been used to label 
GABAb receptors (Gonchar et al, 2001) and so this approach is feasible using 
currently available techniques.
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Plasticity of GABAb Receptor-Mediated Heterosynaptic 
Interactions at Mossy Fibers after Status Epilepticus
Kate E. Chandler,1 Alessandra P. Princivalle,2 Ruth Fabian-Fine,3 Norman G. Bowery,2 Dimitri M. Kullmann,1 and 
Matthew C. Walker1
’Institute of Neurology, University College London, London WC1N 3BG, United Kingdom, department of Pharmacology, University of Birmingham, 
Birmingham B15 2TT, United Kingdom, and department of Psychology and Neuroscience Institute, Dalhousie University, Halifax, Nova Scotia B3H 4J1, 
Canada
Several neurotransmitters, including GABA acting at presynaptic GABAb receptors, modulate glutamate release at synapses between 
hippocampal mossy fibers and CA3 pyramidal neurons. This phenomenon gates excitation of the hippocampus and may therefore 
prevent limbic seizure propagation. Here we report that status epilepticus, triggered by either perforant path stimulation or pilocarpine 
administration, was followed 24 hr later by a loss of GABAb receptor-mediated heterosynaptic depression among populations of mossy 
fibers. This was accompanied by a decrease in the sensitivity of mossy fiber transmission to the exogenous GABAb receptor agonist 
baclofen. Autoradiography revealed a reduction in GABAb receptor binding in the stratum lucidum after status epilepticus. Failure of 
GABAb receptor-mediated modulation of mossy fiber transmission at mossy fibers may contribute to the development of spontaneous 
seizures after status epilepticus.
Key words: epilepsy; GABAb receptor; status epilepticus; mossy fibers; CA3; seizures
Introduction
Hippocampal mossy fibers represent a major input from dentate 
granule cells to the hippocampal CA3 field. They exhibit several 
forms of presynaptic modulation of transmitter release, includ­
ing marked short-term (Salin et al., 1996) and long-term (Harris 
and Cotman, 1986) use-dependent plasticity. They are sensitive 
to several neurotransmitters that depress transmitter release, in­
cluding glutamate (Kamiya et al., 1996), GABA (Min et al., 1998; 
Vogt and Nicoll, 1999), and peptides (Weisskopf et al., 1993) 
acting at metabotropic receptors. Mossy fiber transmission may 
be under such profound modulation because hippocampal prin­
cipal cells are highly vulnerable to excitotoxicity (Meldrum, 
1993). Nevertheless, these modulatory mechanisms can break 
down: excessive activity in the dentate gyrus can spread into the 
hippocampus and can result in neuronal loss that resembles that 
seen with kainate administration (Sloviter, 1991).
Failure of modulation of mossy fiber transmission may also 
contribute to the delayed development of spontaneous seizures 
(epileptogenesis) after an insult. An important example of such a 
phenomenon is the occurrence of spontaneous seizures after an 
episode of status epilepticus (SE), defined as seizure activity last­
ing >30 min (Shorvon, 1994). SE results in acute changes in 
transmission in the dentate gyrus that could contribute to the 
maintenance of ongoing seizure activity and the later occurrence
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of spontaneous seizures (Lothman et al., 1990). Much attention 
has been given to reductions in inhibition in the dentate gyrus 
after SE (Sloviter, 1987; Hellier et al., 1999; Doherty and Dingle- 
dine, 2001; Kobayashi and Buckmaster, 2003). However, changes 
also occur in the modulation of excitatory transmission at mossy 
fiber —* CA3 synapses (Goussakov et al., 2000).
We have focused on a form of modulation of mossy fiber —> 
CA3 transmission that reflects the release of endogenous neuro­
transmitters from neighboring mossy fibers. In acute slices from 
guinea pigs, a train of stimuli delivered to one group of mossy 
fibers depresses transmission mediated by another population of 
mossy fibers. This “heterosynaptic depression” can be mediated 
both by group II metabotropic glutamate receptors and by 
GABAb receptors (Min et al., 1998; Vogt and Nicoll, 1999). The 
source of GABA that contributes to heterosynaptic depression is 
unclear. It could originate from interneurons, but another possi­
ble source is mossy fibers themselves, which, in addition to glu­
tamate, contain GABA (Sloviter et al., 1996). Indirect evidence 
for mossy fiber GABAergic transmission has been reported in 
guinea pigs (Walker et al., 2001) and after seizure-like activity in 
rats (Gutierrez and Heinemann, 2001).
Here we show that GABAb receptor-mediated heterosynaptic 
depression is present at the normal rat mossy fiber synapse, but it 
is significantly reduced 24 hr after SE in two rodent models. The 
loss of heterosynaptic depression was seen despite an increase in 
immunogold staining for mossy fiber GABA. However, it was 
accompanied by a reduction in the sensitivity of mossy fiber 
transmission to a GABAb receptor agonist and by a loss of GABAb 
receptor binding revealed by autoradiography. Downregulation 
of presynaptic GABAb receptors may play an important role in
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the maintenance of seizure activity during SE and in the develop­
ment of epilepsy.
Materials and Methods
Epilepsy models
All animal procedures followed the Animal (Scientific Procedures) Act of 
1986.
Pilocarpine model Limbic status epilepticus was induced in adult male 
Sprague Dawley rats (270-330 gm) by injection of the muscarinic agonist 
pilocarpine (310-340 mg/kg, i.p.) (Turski et al., 1989). To lessen periph­
eral cholinergic effects, scopolamine methyl nitrate (1 mg/kg, i.p.) was 
administered 30 min before and 30 min after pilocarpine. The onset of SE 
was defined as the appearance of stage 3 (Racine, 1972) seizures followed 
by continuous clinically detectable seizure activity. Clinically overt SE 
was terminated after 90-120 min by injection of diazepam (10 mg/kg, 
i.p.).
Perforant path stimulation model. This method has been described in 
detail previously (Walker et al., 1999). In brief, male Sprague Dawley rats 
(270-330 gm) were anesthetized with 1-2% halothane in 0 2 An earth 
electrode was positioned subcutaneously, and a monopolar recording 
electrode was implanted stereotaxically into the right hippocampus (co­
ordinates, 2.5 mm lateral and 4 mm caudal from bregma). A bipolar 
stimulating electrode was implanted in the right hemisphere and ad­
vanced into the angular bundle (coordinates, 4.4 mm lateral and 8.1 mm 
caudal from bregma) to stimulate the perforant path. The depths of the 
electrodes were adjusted to maximize the slope of the dentate granule cell 
field potential (Walker et al., 1999). The electrodes were held in place 
with dental acrylic and skull screws. The animals were allowed to recover 
from anesthesia. Seven days later, the perforant path was electrically 
stimulated with 2-3 mA 50-150 /xsec monopolar pulses at 20 Hz for 2 hr; 
this induced self-sustaining SE that was terminated after 3 hr with propo- 
fol (50 mg/kg, i.p.).
Animals were killed 24 hr or 3 weeks after SE with an overdose of 
pentobarbitone (500 mg/kg, i.p).
Electrophysiology
Transverse hippocampal slices (400 /xm thick) were obtained from con­
trol rats and rats after SE and were stored in an interface chamber for at 
least 1 hr before transfer to a submersion recording chamber. The storage 
and perfusion solution contained (in mM): 119 NaCl, 2.5 KC1,4 MgS04, 
4 CaCl2, 26.2 NaHC03, 1 NaH2P 04, and 11 glucose and was gassed with 
95% Oz and 5% C 02 (23-25°C). Field EPSPs (fEPSPs) were recorded 
using glass microelectrodes (resistance, ~  1 Mfl) filled with the perfusion 
solution, positioned in the stratum lucidum, the mossy fiber termination 
zone. Two bipolar stainless steel stimulating electrodes were positioned 
in the dentate granule cell layer, and 0.5-1 mA pulses (80 /xsec duration) 
were applied with constant current stimulators. The electrode positions 
and stimulus intensities were adjusted until mossy fiber fEPSPs of 
maximal amplitude were recorded. Slices were discarded if mossy fiber 
fEPSPs could not be elicited (see Results), probably reflecting noncon­
gruence of the slicing plane and the plane containing the mossy fibers, 
which run in a lamellar pattern from the dentate gyrus. This occurred 
with similar frequency in control and post-SE animals.
Naloxone (10 /xm ) was present in all two-pathway experiments to 
avoid interference from opioid receptor-mediated heterosynaptic depres­
sion (Weisskopf et al., 1993). Sensitivity to the group II metabotropic gluta­
mate receptor agonist (2S,2'R,3'R)-2-(2',3'-dicarboxycyclopropyl)-glycine 
(DCG-IV, 1 /xm) was used in all experiments to verify that fEPSPs were 
mediated by mossy fiber synapses (Kamiyaetal., 1996). The following drugs 
were used to block GABAb AMPA/kainate, and group II metabotropic glu­
tamate receptors (mGluRs); CGP52432 (5 /xm ), SCH50911 (20 /xm ), 2,3- 
dihydroxy-6-nitro-7-sulfamoylbenzo[/]quinoxaline (NBQX) (50 /xm ), and 
LY341495 (500 nM ). N0711 (20 /xm ) was used to block GABA uptake. The 
GABAb receptor agonist baclofen (0.1-10 /xm) was used to determine 
GABAb receptor sensitivity. Drugs were obtained from (Tocris Cookson, 
Bristol, UK), except for DCG-IV and N 0711 (Sigma, St. Louis, MO).
Immunogold labeling for GABA
For electron microscopic postembedding immunogold labeling, ultra- 
thin brain sections were obtained from adult male Sprague Dawley rats
(three controls and two after SE, induced by pilocarpine as described 
above). Ultrathin sections (50 nm) were cut with a Reichert (Depew, NY) 
Ultracut and collected on pioloform-coated single-slot nickel grids. 
Grids were then mounted in a grid support plate, soaked in phosphate 
buffer (PB) for 30 min, and preincubated in an incubation medium (IM) 
consisting of PB with 1% bovine serum albumin (A4503; Sigma) and 5% 
fetal calf serum for 30 min at room temperature. Sections were then 
incubated with a rabbit anti-GABA antibody (1:4000 in IM; A2052; 
Sigma) overnight at 4°C. After thorough washing (four times for 10 min 
in PB) and preincubation in IM (30 min), the secondary antibody (goat 
anti-rabbit IgG coupled to 10 nm gold particles; Sigma) was applied at a 
dilution of 1:100 in IM for 4 hr at 37°C. Preparations were washed sub­
sequently in PB (five times for 10 min) before final rinsing in double­
distilled water. The sections were contrasted with uranyl acetate (4 min) 
and Reynold’s lead citrate (50 sec) according to standard electron micro­
scopic methods. Preparations were examined using a Philips (Eind­
hoven, The Netherlands) 201C electron microscope. A control prepara­
tion from which the primary antibody was omitted showed no 
immunolabeling.
Autoradiography
Brains removed from control or post-SE rats were rapidly frozen in iso- 
pentane cooled in liquid nitrogen and stored at — 70°C. Sections (12 /xm 
thick) were cut on a cryostat (2800 Frigocut; Reichert), thaw-mounted 
onto Superfrost Plus slides (75 X  25 X  1.0 mm; BDH Chemicals, Poole, 
UK), and then stored at — 20°C until used. On the day of binding exper­
iments, sections were left to equilibrate to room temperature. Slides were 
then incubated in 50 m M  Tris buffer containing 2.5 m M  CaCl2, pH 7.4, for 
20 min before incubating in fresh buffer for 60 min. They were then dried 
in room air. Each section was then incubated for 60 min and subse­
quently dried in [3H]CGP62349 (at concentrations of 0.5, 0.75, 1, 2, 4, 
and 8 nM ) to determine total binding. [3H]CGP62349 at the same con­
centrations plus CGP54626A (10 /xm ) was used for incubation and then 
dried to determine nonspecific binding. The slides were then washed in 
buffer two times for 1 min and briefly rinsed in distilled water to remove 
buffer salts. The slides were dried in room air and then apposed to film 
(Hyperfilm-3H; Amersham Biosciences, Arlington Heights, IL). The 
films were developed 28 d after exposure to the slides. Quantification of 
receptor autoradiography was achieved by film densitometry using an 
image analysis system (Microcomputer Imaging Device; Imaging Re­
search Inc., St. Catharines, Ontario, Canada), and optical density was 
converted to femtomoles per milligram of bound ligand. Total binding in 
the stratum lucidum was assessed in four to eight sections per concen­
tration of [ 3H]CGP62349 for each animal. Binding parameters, receptor 
density (Bmaj?), and affinity (KD) were determined by the use of the 
Langmuir equation in Prism PC software (Graph Pad, San Diego, CA). 
[3H]CGP62349 was a gift from Dr. Wolfgang Froestl (Novartis, Basel, 
Switzerland).
Data are expressed as mean ±  SEM. The baclofen data were analyzed 
using a best least squares fit to Imax/( 1 +  IC50/[baclofen]), where Jmax is 
the maximal inhibition, and the IC50 is the concentration of baclofen that 
results in half-maximal inhibition (KyPlot; KyensLab Inc., Tokyo, Ja­
pan). Results were compared using two-tailed paired or unpaired Stu­
dent’s t  test, as appropriate.
Results
GABAb receptors mediate heterosynaptic depression in rats
Because the role of GABAb receptors in heterosynaptic depres­
sion has hitherto only been studied in juvenile guinea pigs, we 
first asked whether it could be induced at the mossy fiber —> CA3 
synapse in acute hippocampal slices from adult control rats. All 
data were obtained with the opioid receptor antagonist naloxone, 
( 1 0  / x m )  in the perfusion solution to remove any confounding 
effect of presynaptic opioid receptors (Weisskopf et al., 1993).  ^
The recording solution normally contained 4 mM Ca2+ and 4 mM, 
Mg2+ to reduce the likelihood of epileptiform bursting. We first 
verified that the two stimulating electrodes in stratum granulo- 
sum evoked fEPSPs recorded in the stratum lucidum with prop-,
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Figure 1. M ossy fiber fEPSPs w e re  iden tified  by d e m o n s tra tin g  m arked  frequency  fac ilita ­
tion  (Freq Facil.) an d  sensitiv ity  to  th e  g ro u p  II m e ta b o tro p ic  g lu ta m a te  recep to r ag o n is t DCG- 
IV. A, fEPSPs (trace s  a re  av e ra g e s  o f 5 tr ia ls , tak en  from  ex p e r im e n t sho w n  in B) reco rded  in th e  
s tra tu m  lucidum  w h ile  s tim u la tin g  th e  s tra tu m  g ran u lo sum  o f th e  d e n ta te  gyrus a t  baseline  
freq u enc ie s  o f 0 .0 5 ,1 ,  an d  0 .05  Hz in th e  p resence  o f th e  g ro u p  II m e tab o tro p ic  g lu ta m a te  
recep to r DCG-IV (1 / xm). B, Left g ra p h , Exam ple o f a n  ex p e r im e n t d em o n s tra tin g  th e  iden tifica­
tion  o f m ossy fibe r fEPSPs by freq u ency  facilita tion  (arrow s, c h an g e  in s tim u la tion  frequency  
from  0 .05 to  1 Hz) an d  DCG-IV sensitiv ity . Right g rap h , S am e e x p e r im e n t sho w in g  th e  effec t o f 
an  inc rease  in freq u ency  p lo tted  a g a in s t stim u lu s  n u m b er . C, S um m ary  d a ta  [n =  8). The fEPSP 
a m p litu d e  inc reased  to  a t  le a s t 2 0 0%  o f base line  ( 2 0 th / l s t  re sp o n se) w h e n  th e  s tim u lus fre ­
q uency  w as  inc reased  from  0 .05  to  1 Hz, an d  th e  mGluR ag o n is t DCG-IV (1 /x m ) d ecreased  fEPSP 
a m p litu d e  to  < 3 0 %  o f base lin e .
erties consistent with mossy fibers. fEPSPs showed marked short­
term frequency-dependent facilitation (increase in fEPSP 
amplitude more than twice baseline) when the stimulation fre­
quency was increased from 0.05 to 1 Hz (Fig. 1A -C ) .  In all ex­
perim ents, we confirm ed that they showed high sensitivity to the 
group II mGluR agonist DCG-IV ( I / x m ) ,  characteristic o f mossy 
fiber synapses (Kamiya et al., 1996) (Fig. 1A,B,C).
In addition, we verified that the two pathways were separate 
by confirm ing that the fEPSP elicited in one pathway was not 
facilitated by a preceding stimulus to the other pathway (cross­
facilitation was 4 ±  3%; n  —  6).
At the end o f  each experiment, we applied the AMPA/kainate 
receptor antagonist NBQX (50 / x m )  to record the remaining pre­
synaptic fiber volley, which was then subtracted from the fEPSP 
before analysis o f  the results. A high concentration o f NBQX was 
used to ensure that all AMPA and kainate receptors were blocked 
(Bortolotto et al., 1999).
Once tw o separate m ossy fiber pathways had been identified, 
we used the following stimulation protocol to induce heterosyn­
aptic depression. Single stimuli were applied to the “test” path­
way at a frequency o f  0.05 Hz. Three hundred milliseconds before 
every 10th stimulus, a train o f  five stimuli at 50 Hz was applied to
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Figure 2. H eterosynap tic  depress io n  evoked  in contro l slices is m e d ia te d  by GABAb recep ­
to rs . A cond ition ing  tra in  w as ap p lied  to  th e  cond ition ing  p a th w a y  p reced ing  every  10 th  s tim ­
ulus delivered  to  th e  te s t  p a th w ay . A, Exam ple o f  o n e  e x p e r im e n t from  a contro l slice. H et­
e ro sy n ap tic  depression  w as o bserved  as a reduc tion  in am p litu d e  o f th e  fEPSPs th a t  w e re  
p receded  by a tra in  (o p en  circles) co m p ared  w ith  fEPSPs n o t p receded  by a tra in  (each filled 
circle rep re sen ts  th e  a v e rag e  o f th e  9  unco n d itio ned  fEPSPs in each  cycle). The op ioid  a n ta g o n is t 
n a lo x on e  (10 / xm) h ad  no  effect on  th e  m a g n itu d e  o f depress io n . The GABAb re c e p to r a n ta g o ­
n is t SCH50911 (20 / xm) ab o lish ed  th e  d epression . fEPSPs (av erag es  o f 5 tria ls each) a re  sho w n  in 
th e  ab se n c e  (1) an d  p re sen ce  (2) o f SCH50911. B, S um m ary  o f th e  ratio  o f co nd itio n e d /u n c o n ­
d itio n ed  fEPSP a m p litu d e s  in 8 contro l slices show ing  th e  abolition  of h e te ro sy n ap tic  d epression  
by b locking GABAb recep to rs . C, Exam ple o f p resynap tic  fibe r volleys from  o n e  e x p e r im en t 
sho w in g  th a t  th e  cond itioned  p resynap tic  fiber volley  [p receded  by a co nd itio n in g  tra in  (c)] is 
n o t d iffe ren t in am p litu d e  or sh a p e  from  th e  u n co n d itio ned  fibe r volley [n o t p receded  by a train  
(u)]. T races a re  av e ra g e s  o f resp o n ses  in th e  p resen ce  o f 50/ x m  NBQX from  tw o  cycles o f n ine  
u n co n d itio ned  stim uli a n d  on e  co nd itio n ed  stim u lus.
the “conditioning” pathway. The magnitude o f heterosynaptic 
depression was calculated by com paring the am plitude o f  
every 10th fEPSP recorded [conditioned  fEPSP (fEPSPc )] to  
the average am plitude o f  the nine preceding fEPSPs [u n con ­
d ition ed  fEPSP (fEPSPu)]. The fEPSP ratio was calculated as 
fEPSPc/fEPSPu.
Heterosynaptic depression, expressed as (1 — fEPSP ratio) X 
100%, was observed in all slices from adult control rats (21 ±  7% 
depression; n  —  8 slices from different animals) (Fig. 2 A , B ) .  Bath 
perfusion o f  GABAb receptor antagonists (20 / x m  SC H 50911; n = 
6; or 5 / x m  CGP52432; n  —  2) completely abolished heterosynap­
tic depression in all cases (0 ±  6% depression; p  <  0.001 for 
comparison with baseline) (Fig. 2A , B ) .  Thus, in slices from con­
trol adult rats, heterosynaptic depression evoked with this proto­
col was entirely mediated by GABAb receptors, with no detectable 
contribution from mGluRs (M in et al., 1998; Vogt and Nicoll, 
1999).
Blocking GABAb receptors also caused a small increase in the 
size o f  the unconditioned fEPSPs in two o f  eight control slices 
(Fig. 2A ). This did not reach significance in either control or
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post-SE slices when all experiments were included ( p  = 0.45; 
paired t test). Because heterosynaptic interactions mediated by 
spillover o f the transmitter are tem perature-dependent (Asztely 
et al., 1997; Mitchell and Silver, 2000), we also measured het­
erosynaptic depression at 34°C, using the same stim ulation pro­
tocol. GABAb receptor-mediated heterosynaptic depression was 
identical to that recorded at room temperature (21 ±  8% depres­
sion; n =  3 slices from different animals; p  = 0.9; unpaired t test, 
when compared with depression at room  temperature).
To verify that this phenom enon is present at more physiolog­
ical concentrations o f  divalent cations, we repeated the experi­
ments with a perfusion solution containing 2.5 m M  C a2+ and 1.3 
m M  M g2 t . In two slices, this yielded heterosynaptic depression o f  
33 ±  4%, which was reduced to 4 ±  2% with GABAb receptor 
antagonists.
Although GABAb receptors profoundly depress transmitter 
release, a potentially confounding effect is efflux o f  K + from  
neurons, which could alter axon recruitment, action potential 
propagation, or both. We therefore compared the presynaptic 
fiber volleys (recorded in the presence o f  NBQX to abolish the 
fEPSP) with and w ithout the 50 Hz train in the conditioning  
pathway. N either the amplitude ( p  — 0.69; paired t test; n = 8) 
nor the shape o f  the fiber volley was significantly affected (Fig. 
2 D ), implying that heterosynaptic depression is not mediated by 
an increase in extracellular K + .
SE abolishes GABAb receptor-mediated 
heterosynaptic depression
W e interleaved the experiments described above with identical 
experim ents performed on hippocampal slices taken from rats 24 
hr after pilocarpine-induced SE. We used the same criteria to 
identify two separate mossy fiber pathways (cross-facilitation, 
0 ±  6%; n = 11).
The degree o f frequency-dependent facilitation was not sig­
nificantly different from that measured in control slices (post-SE, 
232 ±  25% o f  baseline, n =  12; control, 358 ±  67%, n — 8; 
measured as 20th fEPSP/1st fEPSP amplitude when stimulation  
was increased from 0.05 to 1Hz; p  — 0.1) (Fig. 3A). The nonsig­
nificant trend for less frequency facilitation in the post-SE ani­
mals is consistent with the findings o f  Goussakov et al. (2000), 
who showed a significant loss o f  facilitation after kainic acid- 
induced SE. The m ore marked changes observed by Goussakov et 
al. (2000) may be attributable to differences in stimuli to induce 
SE (kainic acid vs pilocarpine), stimulation frequency (100 in ­
stead o f  1 Hz), a longer interval from SE to killing o f  the animals 
(several weeks instead o f  24 hr), or a com bination thereof.
In post-SE slices, DCG-IV perfusion reduced the fEPSPs to 
22 ±  5% o f  baseline. This depression was also indistinguishable 
from that seen in control slices (19 ±  8%; p  =  0.8) (Fig. 3A).
In contrast to control animals, heterosynaptic depression was 
not detected after pilocarpine-induced SE (1 ±  4% depression; 
n =  12; p  =  0.75; paired t test comparing conditioned with un ­
conditioned fEPSPs) (Fig. 3B,C).  Thus, despite the apparently 
normal short-term plasticity and mGluR sensitivity o f  m ossy fi­
ber synapses, they were unaffected by trains o f  stimuli delivered 
to neighboring axons.
These results do not distinguish between a generic effect o f  
limbic seizures and a specific result o f  the chem oconvulsant used 
to evoke SE. W e therefore asked whether a different m odel o f  SE, 
which does not involve the use o f an exogenous convulsant, also 
interfered with GABAg receptor-mediated m odulation o f  m ossy  
fiber transmission. W e examined hippocampal slices taken from  
six animals 24 hr after SE evoked by perforant path stim ulation
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Figure 3. GABAb re c e p to r-m e d ia te d  h e te ro sy n ap tic  depression  w as a b s e n t a f te r  SE. A, 
M ossy fiberfEPSPs in slices a fte r  p ilo carp in e-in d u ced  SE(n =  12) sh o w ed  frequency  fac ilita tion  
a n d  DCG-IV sensitiv ity , w hich  w as  n o t sign ificantly  d iffe ren t from  th a t  of contro l slices. B, H et­
e ro sy n ap tic  d epression  w as a b s e n t a f te r  p ilocarp ine-induced  SE: ex am ple  o f on e  expe r im en t. 
fEPSPs a re  show n  in th e  ab sence  an d  p re sen ce  o f SCH50911 (each trace  is th e  av erage  o f 5 tria ls; 
filled circles, cond itioned ; open  circles, u n co n d itio ned ). The GABAb recep to r a n ta g o n is t 
SCH50911 had  no sign ifican t effect. C, T here w as no  sign ificant h e te ro sy n ap tic  depress io n  in 
an im als  a f te r  p ilocarp ine-induced  (Pilo) o r p e rfo ran t p a th  (PP) stim u la tion -in du ced  SE in con­
tr a s t  to  th e  m arked  depression  seen  in contro l (Con) an im als. D, Size o f GABAb recep to r- 
m e d ia te d  h e te ro sy n ap tic  d ep ress io n , e s tim a te d  from  th e  effec t o f  th e  GABAb a n ta g o n is ts  
SCH50911 an d  CGP52432 on th e  fEPSP ra tio  (SE: bo th  m ode ls co m b ined ; n =  18).
(see Materials and M ethods). Heterosynaptic depression was 
again absent in slices from all six animals ( —2 ±  5% depression; 
n  —  6) (Fig. 3 C ) .  W e also examined slices from two animals 
treated with pilocarpine that had not developed SE. Both animals 
received diazepam injections identical to those administered to 
the animals that experienced SE. Heterosynaptic depression was 
observed in slices from these animals (45 ±  4% depression). 
Thus, we conclude that loss o f  heterosynaptic depression is re­
lated to SE per se rather than to the stimulus used to evoke it.
To test whether the loss o f  heterosynaptic depression after SE
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was attributable to the em ergence o f  a 
com pensatory heterosynaptic facilitation, 
we applied the GABAb receptor antago­
nists SC H 50911 (20 /l l m )  and CGP52432 
(5/u.m) during the tw o-pathw ay protocol in 
slices after SE. This had no significant ef­
fect on the fEPSP ratio in slices from the 
post-SE animals (5 ±  4% change in the 
fEPSP ratio; n =  18). This was significantly 
different from that o f  controls (22 ±  3% 
change in the fEPSP ratio; n — 8) when 
GABAb receptor antagonists were applied 
( p  — 0.026; unpaired t test for difference 
between SE and control animals). This re­
sult im plies that loss o f  heterosynaptic de­
pression after SE was not attributable to 
the emergence o f  a compensatory het­
erosynaptic facilitation but because o f failure 
o f GABAb receptor-mediated depression.
SE is accompanied by an increase in 
mossy fiber GABA
The loss o f  heterosynaptic depression 
could contribute to the persistence o f sei­
zure activity during SE, to the subsequent 
developm ent o f  epilepsy, or to both. The 
precise relationship o f  the failure o f  
GABAg receptor-m ediated heterosynaptic 
depression to these phenom ena is beyond  
the scope o f  the present study. Instead, we 
asked what cellular alterations could un­
derlie this result.
There are two main sources o f  GABA 
that could mediate this heterosynaptic de­
pression. First, the GABA could originate 
from m ossy fibers because there is circum ­
stantial evidence that m ossy fibers themselves can release GABA 
(see Introduction). Second, interneurons recruited by the mossy  
fibers could release GABA that spills into the extracellular space. 
From the first hypothesis, a possible explanation for loss o f  
GABAg receptor-mediated heterosynaptic depression is that 
there is a reduction in the releasable GABA in m ossy fibers after 
SE. This is, however, difficult to reconcile with reports that im- 
munolabeling for GABA and glutamic acid decarboxylase in­
creases after seizure-like activity (Sloviter et al., 1996) and that 
this is accom panied by the em ergence o f  a monosynaptic 
GABAergic signal (Gutierrez and H einem ann, 2001). Neverthe­
less, m uch o f  the evidence for increased mossy fiber GABA is 
difficult to relate directly to the present study because o f  different 
seizure m odels or because different criteria were used to identify 
mossy fibers. Indeed, m ost reports have relied on light m icros­
copy, which does not ensure that the epitope is localized to mossy 
fiber terminals. W e therefore applied im m unogold electron m i­
croscopy to detect GABA-like im m unoreactivity in m ossy fiber 
terminals.
Figure 4 shows examples o f  electron micrographs taken from  
the stratum lucidum . Mossy fiber terminals were identified by 
their large size, multiple active zones, and numerous vesicle pro­
files. In addition, we also used a m odified T im m ’s reaction in one 
control animal and one post-SE animal to confirm the identity o f  
the m ossy fiber terminals on the basis o f  their high zinc content 
(Seress and Galiyas, 2000). We did not use these animals for 
quantitative analysis because a different fixation m ethod was
used. Im m unogold particles in m ossy terminals o f  control ani­
mals (Fig. 4C,D) were present at a density o f  12 ±  l / p m 2 (56 
terminals from two animals). This was significantly greater than 
the background density o f  4 ±  l//x m 2 ( p  <  0.001). W e repeated 
these measurements in two post-SE animals (Fig. 4 A,B).  The 
GABA im m unogold particle density in mossy fiber terminals was 
doubled 24 hr after SE induced by pilocarpine to 24 ±  2/jU,m2 (45 
terminals from two animals; p  <  0.001 compared with controls). 
Thus, the im m unolabeling, although confirm ing m ore indirect 
evidence for GABA in m ossy fibers, lends no support to the hy­
pothesis that the am ount available to be released is decreased 
after SE. On the contrary, there is more GABA in m ossy fibers 
after SE, in keeping with previous reports that seizure-like activity 
is followed by the emergence o f a m onosynaptic GABAergic sig­
nal in CA3 pyramidal neurons (Gutierrez and Heinem ann, 
2001). Thus, to explain the loss o f  heterosynaptic depression after 
SE, it is necessary to postulate either that (1) the source o f  GABA 
m ediating heterosynaptic depression is not m ossy fibers but in­
terneurons, or (2) a change downstream o f GABA release is 
responsible.
Heterosynaptic depression is not restored by blocking 
mGluRs or GABA uptake
If the GABA that mediates heterosynaptic depression is released 
from interneurons, a possible explanation for the effect o f  SE is 
impaired recruitment o f  interneurons, which has been described 
in several models o f  epilepsy (Sloviter, 1991; Lothman et al., 1996; 
D oherty and Dingledine, 2001). Reduced recruitment o f inter-
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Figure 5. H eterosynap tic  depress io n  could n o t be  rescued  a f te r  SE by blocking g ro u p  II 
m e ta b o tro p ic  g lu ta m a te  recep to rs  by b locking GABA u p tak e  or by inc reasing  th e  n u m b er  of 
co n d itio n in g  stim u li. A, E xam ple o f o n e  e x p e r im en t. The g ro u p  II m e ta b o tro p ic  g lu ta m a te  re ­
ce p to r  a n ta g o n is t  LY341495 (LY; 500 nM) failed  to  re s to re  h e te ro sy n ap tic  d ep ress io n  in a slice 
o b ta in e d  a f te r  p ilo carp in e-in d u ced  SE. A pplication  o f th e  GABA tra n sp o r te r  GAT1 b locker N 0 7 1 1 
(20 / xm) also  fa iled  to  a ffec t th e  fEPSP ra tio . S am p le  traces , fEPSPs in contro l cond itions an d  in 
th e  p re se n ce  o f LY34195, N 0711, an d  CGP52432 (each  trac e  is th e  a v e ra g e  o f 5 tr ia ls). B, S um ­
m ary  o f effec ts  o f  N0711 (n =  4) an d  LY341495 (n =  5) on  th e  fEPSP ra tio  in a n im a ls  a fte r  
p ilo ca rp in e -in d u ced  SE. C, A 100 Hz train  did n o t rescue h e te ro sy n ap tic  depress io n  in slices a f te r  
SE. T he fEPSP ra tio  did n o t c h an g e  sign ificantly  w h e n  th e  tra in  w as inc reased  from  50  to  100 Hz 
( p  =  0 .4 ; p a ired  f te s t) .
neurons in the dentate hilus after SE has been proposed to be 
m ediated by enhanced activity o f  group II mGluRs (Doherty and 
D ingledine, 2001). W e therefore asked whether heterosynaptic 
depression could be rescued in slices from post-status animals by 
blocking group II mGluRs. We applied the group II mGluR an­
tagonist LY341495 (500 n M )  during the two-pathway experiment 
to slices from animals 24 hr after pilocarpine-induced SE. This 
had no significant effect on the magnitude o f heterosynaptic de­
pression ( p  =  0.18; paired f test; n =  5) (Fig. 5A,B).  This concen­
tration o f  LY341495 was sufficient to antagonize the effect o f  the 
group II mGluR agonist DCG-IV on mossy fiber transmission  
com pletely (n =  3; data not show n). W e then asked whether 
changing the stimulation protocol to enhance the recruitment o f  
interneurons could rescue depression. We applied the same stim ­
ulation protocol o f  five pulses at 50 Hz and then in the same slices 
increased the train to 10 pulses at 100 Hz (we tested this protocol 
in slices from four rats, two o f  which had pilocarpine-induced  
status epilepticus and two o f  which had perforant path 
stim ulation-induced status epilepticus). Heterosynaptic depres­
sion was not rescued. The fEPSP ratio was 1 ±  0.1 during the 50
Hz protocol and 0.97 ±  0.05 during the 100 Hz protocol. The 
fEPSP ratio was not significantly different between 50 and 100 Hz 
trains (Fig. 5C). This provides no evidence for the hypothesis that 
impaired recruitment o f  interneurons accounts for the loss o f  
heterosynaptic depression after SE.
Another possible explanation is that GABA uptake is en­
hanced. Altered GABA transport has been implicated :n the 
pathogenesis o f  epilepsy (Patrylo et al., 2001). The antiepdeptic 
drug tiagabine is a blocker o f  neuronal GABA transporter 1 
(GAT1) (Andersen et al., 1993). A decrease in immunostaining 
for GAT1 has been reported in the sensorim otor cortex (Silva et 
al., 2002) and the hippocam pus (Andre et al., 2001). W e therefore 
attempted to rescue heterosynaptic depression by interfering 
with the major hippocampal GABA transporter GAT1 with the 
selective blocker N 0 7 1 1. W e applied the same two-pathway pro­
tocol as described previously in slices from rats 24 hr after 
pilocarpine-induced SE. Bath application o f 20 j l i m  N 0711  
(which is sufficient to evoke a tonic GABAa receptor-mediated 
current in pyramidal neurons; Semyanov et al., 2003) faded to 
restore heterosynaptic depression (n =  4; p  — 0.88; paired t test) 
(Fig. 5A,B).  These results thus lend no support to the hypothesis 
that heterosynaptic depression was lost because o f increased 
uptake.
Status epilepticus alters GABAb receptors on mossy fibers
A further explanation for loss o f  heterosynaptic depression is an 
alteration in the target GABAb receptors. Altered expression o f  
GABAb receptors in CA3 pyramidal neurons has been reported in 
human temporal lobe epilepsy patients (Princivalle et al.,2002), 
and decreased presynaptic GABAb receptor activity has been pro­
posed to underlie increased inhibitory activity in the dentate gy­
rus during epileptogenesis (Haas et al., 1996). We therefore asked 
whether there was loss o f  GABAb receptor function after >E. We 
stimulated a single m ossy fiber pathway at 0.05 Hz in accte hip­
pocampal slices taken either from control animals or frcm ani­
mals after pilocarpine-induced SE and measured the sensitivity o f  
the fEPSP to increasing concentrations o f  the GABAb receptor 
agonist baclofen. Baclofen was less potent in reducing the fEPSP 
in the postpilocarpine SE slices compared with its effect in zontrol 
slices (controls, IC50, 0.47 ± 0 .1 4  / x m ,  n =  6; SE, IC50, 1.17 ±  0.27 
/ x m ,  n — 7; p <  0.05 for difference) (Fig. 6). There was nc signif­
icant difference in the 7max by baclofen (controls, 7max, 0.95 ±  
0.05, n = 6; SE, 7max, 0.87 ±  0.06, n — 7;p =  0.31 for difference). 
Loss o f  GABAb receptor function may contribute to the cbvelop- 
ment o f  self-sustaining seizures in SE. This could leac to in ­
creased excitability in the hippocam pus and could play e role in 
the later developm ent o f  spontaneous seizures. W e therefore 
asked whether this change in GABAb receptor function vas per­
sistent. We treated six animals with pilocarpine to induce90 m in  
o f SE. These were killed 3 weeks later when they were exhibiting 
spontaneous seizures (all animals had several limbic seizures per 
day). We recorded fEPSPs in the stratum lucidum  while stim u­
lating in the dentate gyrus as above. A lthough the increase in IC50 
for baclofen did not reach significance when compared vith that 
in controls, the 7max was significantly reduced (0.74 ±  005; p  =  
0.007; unpaired f test) (Fig. 677).
We then asked whether the reduced potency o f  baclofen at 24 
hr was attributable to a change in the num ber or functioml prop­
erties o f GABAb receptors. W e used [ 3H]CG P62349 auttradiog- 
raphy to estimate the density o f  GABAb receptors in the stratum  
lucidum in control and post-pilocarpine-induced SE tissie (24 hr 
after SE). The radiolabeled antagonist was applied at coicentra- 
tions o f 0.5, 0.75, 1, 2, 4, and 8 n M .  The mean K D for post-SE
11388  • J. Neurosci., December 10 ,2003  • 23(36):! 1382-11391 Chandler et al. •  Plasticity of GABAb Receptor-Mediated Modulation
A
B
W0Ut/3a.W
oeo
ISiS5
F ig u re  6 .
a fte r SE. A, fEPSPs (averages of 5 traces) illustrating reduced sensitivity to  baclofen 24 hr a fter 
SE. Left to  right, Traces are  show n a t  baseline and in 0 .1 ,1 , and 10 /xm baclofen. B, Baclofen has 
a less p o ten t effec t on mossy fiber fEPSPs 24 hr a fte r SE ( p <  0 .05; unpaired f te s t on IC50 values; 
6 control slices a  nd 7 post-SE slices), and th e /max w as significantly reduced in slices 3 w eeks a fte r 
S E ( p  =  0.007; n =  6).
animals was not significantly different from that for control ani­
mals, im plying that the affinity o f  the GABAb receptors was un­
changed (controls, 1.28 ±  0.34 n M ,  n =  5; SE, 1.09 ±  0.10 n M ,  n =  
4; p  — 0 .67). However, the mean Bmax (a measure o f  GABAb 
receptor density) 24 hr after SE was significantly less than in 
controls (controls, 1322 ±  68 fm ol/m g o f  tissue, n =  5; SE, 
1080 ±  56 fm ol/m g o f tissue, n =  4; p <  0.05 for difference) (Fig. 
7). We also observed a nonsignificant trend for the Bmax to be 
reduced at 3 weeks (1144 ±  54 fm ol/m g o f  tissue; n =  4; p  =  0.09 
for difference from control).
Is the reduction in GABAb receptor density specific to the 
presynaptic GABAb receptors on m ossy fiber terminals, or is it a 
global change that also occurs in the dentate granule cell den­
drites? To address this question, we measured binding in the 
molecular layer o f  the dentate gyrus. The mean Bmax and K D in 24 
hr post-SE tissue were not significantly different from those o f  
controls ( # max: controls, 925 ±  74 fm ol/m g o f tissue, n =  5; SE, 
812 ±  71 fm ol/m g o f  tissue, n =  4;p  =  0.29; KD: controls, 0.69 ±  
0.20 n M ;  SE, 0.82 ±  0.23 n M ;  p  =  0.83).
Thus, the loss o f  GABAb receptor-mediated heterosynaptic 
depression at 24 hr is accom panied by a selective reduction in 
GABAb receptor density in the stratum lucidum  and an associ­
ated reduction in the sensitivity o f  m ossy fiber signaling to 
GABAb receptor agonists. The 18% reduction in GABAb receptor 
binding in the stratum lucidum is nevertheless modest compared  
with the com plete loss o f  GABAb receptor-mediated heterosyn­
aptic depression. A m ong possible explanations for this discrep­
ancy are nonlinear amplification o f  the intracellular signaling 
cascade linking receptors to transmitter release and the fact that,
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Figure 7. R eduction  o f b ind ing  o f  [ 3H]CGP62349 to  GABAe recep to rs  in th e  s tr a tu m  lucidum  
a f te r  p ilo carp ine-induced  SE. A, Exam ple o f an  au to ra d io g ra p h  from  an  an im a l a f te r  
p ilo carp in e-in d u ced  SE. W e m easu red  b ind ing  in th e  s tra tu m  lucidum , (b lack  a rro w ). The s tr a ­
tu m  p y ram id a le  o f CA3 is m ark ed  w ith  a w h ite  a rro w . B, The b in d in g  p a ra m e te r  Bmix, w hich  
reflec ts  m axim al b ind ing  o f th e  rad ioactive  ligand  to  GABAb recep to rs , w as  sign ificantly  lo w er 
th a n  th a t  o f th e  contro l a f te r  SE (con tro l, n = 5; SE ,n = A;p = 0 .033  fo r d iffe rence).
within the stratum lucidum , other cell types also express GABAb 
receptors, som e o f which may be upregulated (see D iscussion).
Discussion
W e have demonstrated that GABAb receptor-mediated het­
erosynaptic depression at the rat mossy fiber synapse is lost after 
SE, whether this is evoked by pilocarpine or perforant path stim ­
ulation. This loss is not attributable to a com pensatory het­
erosynaptic facilitation or to depletion o f  GABA from m ossy fiber 
terminals. We could not rescue it by applying group II mGluR  
antagonists or GABA transporter inhibitors. Instead, we find that 
the sensitivity o f mossy fiber synapses to GABAb receptor ago­
nists dim inishes after SE, and this is mirrored by a decrease in 
GABAb receptor binding density. Thus, SE results in a loss o f  
GABAb receptors that is sufficient to impair the detection o f  
physiological levels o f  their endogenous ligand.
The role o f heterosynaptic interactions am ong mossy fibers in 
gating excitatory afferent traffic to the hippocam pus in vivo re­
mains to be determined. Impairment o f  mutual activity- 
dependent depression am ong m ossy fibers could contribute to 
lowering the threshold for seizure spread through mesial tem po­
ral structures. These changes could play a role in the developm ent 
o f temporal lobe epilepsy (TLE) and the ancillary damage to prin­
cipal neurons in the hippocam pus. The plasticity revealed in the 
present study must be seen within the broader context o f  other 
changes in inhibition occurring in the hippocam pus during epi- 
leptogenesis, such as those occurring within the dentate gyrus 
and in the hippocam pus proper. Altered inhibition is observed  
frequently in both experimental and human epilepsy. Both in­
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creases (Haas et al., 1996) and decreases (Sloviter, 1987; Beken- 
stein and Lothman, 1993; Doherty and Dingledine, 2001) in hip­
pocampal inhibition have been reported. Most studies have, 
however, concentrated on changes in GABAa receptor-mediated 
inhibition (Buhl et al., 1996; Kapur and Macdonald, 1997; 
Brooks-Kayal et al., 1998).
The loss of heterosynaptic depression observed in this study 
did not appear to be attributable to decreased GABA release or 
increased GABA uptake. There are two potential sources of 
GABA release after the conditioning train: mossy fibers them­
selves and interneurons recruited by mossy fibers, such as mossy 
fiber associated interneurons in the stratum lucidum (Vida and 
Frotscher, 2000) and other intemeurons in the hilus. Mossy fi­
bers have been shown to contain GABA in addition to glutamate 
and zinc, and recent evidence suggests that mossy fibers may 
release GABA in an action potential-dependent manner (Gutier­
rez and Heinemann, 2001; Walker et al., 2001). After perforant 
path stimulation, the GABA content of mossy fibers increases 
(Sloviter et al., 1996). We have confirmed that this is also the case 
after SE induced by pilocarpine administration using immuno­
gold labeling for GABA. This increase in GABA content is asso­
ciated with an increased expression of vesicular GABA trans­
porter and an associated enhancement of the putative GABAergic 
mossy fiber signal (Gutierrez and Heinemann, 2001; Lamas et al., 
2001; Gutierrez et al., 2003). Decreased GABA release from 
mossy fibers, therefore, cannot explain our observation of a loss 
of heterosynaptic depression because, if anything, the increased 
GABA released from mossy fibers should enhance heterosynaptic 
depression.
Intemeurons recruited by mossy fibers are other possible 
sources of GABA. Loss of interneurons could undoubtedly con­
tribute to a decrease in GABA release and so a decrease in het­
erosynaptic depression. Although populations of intemeurons 
are lost after SE, intemeurons in CA3 are relatively well preserved 
after lithium- and pilocarpine-induced seizures (Andre et al., 
2001). Nevertheless, we cannot exclude intemeuronal dysfunc­
tion as a contributor to the loss of heterosynaptic depression in 
our models. There are also other possible mechanisms, including 
decreased recruitment of intemeurons via enhancement of pre­
synaptic group II mGluR depression of mossy fiber transmission 
(Doherty and Dingledine, 2001). We were, however, unable to 
rescue heterosynaptic depression by applying a group II mGluR 
antagonist. This argues against the hypothesis that overactivity of 
group II mGluRs explains the loss of heterosynaptic depression 
after SE.
The concentration of GABA detected by mossy fiber terminals 
depends not only on the amount of GABA released but also on 
the efficiency of GABA uptake. The loss of heterosynaptic depres­
sion could thus be explained by enhanced GABA uptake after SE. 
Anatomical and functional studies have, however, suggested that 
GABA uptake is decreased after SE. The predominant GABA 
transporter GAT1 is downregulated in rodent epilepsy models 
(Andre et al., 2001), and functional impairment of GABA trans­
port has also been reported in tissue obtained either from patients 
with mesial temporal sclerosis or from rats after kainic acid- 
induced SE (Patrylo et al., 2001). Our finding that inhibiting 
GABA uptake does not lead to enhanced heterosynaptic depres­
sion in epileptic animals further argues that increased GABA up­
take does not play a part in the loss of heterosynaptic depression.
Finally, we explored the possibility that the target GABAb re­
ceptors are lost or fail to modulate transmitter release by measur­
ing the effect of the GABAb receptor agonist baclofen on the 
amplitude of mossy fiber fEPSPs. We observed reduced sensitiv­
ity of the mossy fiber fEPSP to baclofen after SE. Autoradiogra­
phy revealed that the GABAb receptor density is reduced in the 
stratum lucidum without decreased binding affinity. This was 
unlikely to be attributable to a change in the number of mossy 
fibers because granule cells tend to be relatively resistant to sei­
zures, and mossy fiber sprouting starts several days after excito- 
toxic insults (Mello et al., 1993). GABAb receptors have been 
strongly implicated in the pathogenesis of absences (Liu et al., 
1992), and rats lacking the GABAB1 subunit have spontaneous 
absence, clonic, and tonic-clonic seizures (Schuler et al., 2001). 
Their role in temporal lobe epilepsy, however, is unclear. 
Changes in GABAb receptors have been observed in both humans 
with TLE and experimental models of epilepsy. Binding to 
GABAb receptors in the CA3 pyramidal neuronal layer is reduced 
in human patients with TLE (Princivalle et al., 2002), although 
GABAb receptors are upregulated when the data are corrected for 
cell loss. In the dentate gyrus, both presynaptic (Buhl et al., 1996; 
Haas et al., 1996) and postsynaptic GABAb receptor functions 
(Wasterlain et al., 1996) are downregulated after kainic acid- 
induced seizures and perforant path stimulation, respectively. 
Also, Wu and Leung (1997) showed a decrease in efficacy of 
GABAb receptors on CA1 intemeurons. Our results are surpris­
ing in that the loss of GABAb receptors occurs so soon after SE. 
However, others have shown that receptors can alter rapidly after 
SE (Kapur and Macdonald, 1997).
Thus, our data are consistent with a loss of presynaptic 
GABAb receptors on mossy fiber terminals. This parallels the 
recent finding that GABAB1 and GABAB2 receptor mRNA levels 
are transiently reduced after kainic acid-induced SE (Furtinger et 
al., 2003). Loss of presynaptic GABAb receptors renders mossy 
fibers relatively resistant to GABA, whether this is released di­
rectly from the mossy fibers themselves or from interneurons 
recmited by mossy fibers, explaining the loss of heterosynaptic 
depression after SE. A possible weakness of this hypothesis is 
that there is a quantitative discrepancy between the complete 
loss of heterosynaptic depression and the ~20% decrease in 
[ 3H]CGP62349 binding density. This can be partly explained by 
the GABAb receptor binding detected in the stratum lucidum 
being not exclusively attributable to receptors on presynaptic 
mossy fiber terminals. Indeed, there are also intemeurons present 
in this area that express GABAb receptors, and increased ex­
pression of GABAb receptors in these interneurons with sei­
zures (Kokaia and Kokaia, 2001) could mask the loss at mossy 
fiber terminals. Also, intracellular amplification of metabo­
tropic receptor-mediated actions may lead to a nonlinear 
relationship between receptor density and sensitivity to GABA 
spillover.
Could changes in the extracellular space contribute to the loss 
of heterosynaptic depression? Status epilepticus induces CNS 
edema, which may last several days (Roch et al., 2002). Cell swell­
ing during excessive neuronal activity can result in a 30% de­
crease in the volume of the extracellular space (Lux et al., 1986) 
and could change concentrations of extracellular ions and trans­
mitters. Although an experimental investigation of this possibil­
ity was beyond the scope of this study, a decrease in the extracel­
lular space might be expected to increase the extracellular GABA , 
concentration after exocytosis and, therefore, to increase GABAb 
receptor-mediated heterosynaptic depression. However, if this is 
accompanied by increased tortuosity of the extracellular space, 
the diffusional path for GABA molecules from their release sites 
to the receptors could be increased, with the opposite effect on 
heterosynaptic depression. ;
Loss of heterosynaptic depression may lead to propagation of ,
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excessive excitatory afferent traffic into the hippocampus proper. 
This could also play a role in epileptogenesis if it allows further 
seizure spread through the entorhinal cortex-dentate gyrus- 
hippocampus-entorhinal cortex circuit. It could also contribute 
to the excitotoxic pattern of principal cell loss in the hippocam­
pus proper, which is a hallmark of chronic temporal lobe epi­
lepsy. In addition, because heterosynaptic depression is recruited 
by synchronous mossy fiber discharges, it could contribute to 
seizure termination; a breakdown in this phenomenon could 
thus lead to the persistence of seizure activity during status epi­
lepticus. Others have noted a downregulation of GABAb recep­
tors on presynaptic terminals of inhibitory cells in the dentate 
gyrus in animals 2 weeks after kainic acid-induced seizures, lead­
ing to reduced disinhibition and an increase in GABA release 
(Haas et al., 1996). Although we were unable to detect a signifi­
cant loss in autoradiographic labeling in the molecular layer of 
the dentate gyrus, such an effect could reflect a compensatory 
antiepileptic effect in the chronic stages of epilepsy. Complex 
changes in GABAb receptor expression have also been reported in 
the entorhinal cortex during epileptogenesis, including pre­
sumed loss of postsynaptic GABAb receptors (Kokaia and Ko­
kaia, 2001) and an increase in presynaptic GABAb receptor- 
mediated autoinhibition in layer III of the entorhinal cortex 
(Gloveli et al., 2003). These changes are likely to have a proepi­
leptic effect, enhancing the entorhinal cortex to hippocampus 
signaling. Thus, changes in GABAb receptor expression at multi­
ple sites in the hippocampal formation during epileptogenesis 
may have complex effects on excitability.
In summary, we have shown that GABAb receptor-mediated 
heterosynaptic depression at the mossy fiber synapse is reduced 
acutely after SE, despite an increase in the GABA concentration in 
mossy fibers. This is associated with a decrease in the sensitivity of 
the mossy fiber response to the GABAa agonist baclofen, a change 
that persists for at least 3 weeks. This can be explained by a loss of 
presynaptic GABAb receptors on mossy fiber terminals, revealed 
by autoradiographic detection of bound GABAb receptor radio­
ligand in the stratum lucidum. Reduced GABAb receptor- 
mediated heterosynaptic depression after SE may play a role in 
the maintenance of self-sustaining seizure activity and the later 
^development of spontaneous seizures.
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